Spinal cord decompression sickness and its treatment by Leitch, David Richard
SPINAL CORD DECOMPRESSION SICKNESS
AND ITS TREATMENT
DAVID RICHARD LEITCH





All the original work described in this thesis was





Anaesthetised dogs were used in terminal experiments to
establish the optimum combination of pressure and oxygen in the
delayed treatment of spinal cord decompression sickness (DCS). The
DCS was produced by decompressing the dogs in about 5.5 min after
a 15 min air dive at 10 bar. Decompression sickness was diagnosed,
monitored and quantified using an array of spinal cord evoked
potentials (SEP). These were produced by stimulation at three
peripheral nerve sites and were recorded simultaneously from three
equidistant cord sites. To establish the method studies of the effects
of anaesthesia, temperature, treatment gases, time, stimulation and
recording variables were undertaken. It was shown that major
changes in spinal cord blood flow were required, to cause observable
changes in the SEPs. It was shown that cord ischaemia lasting more
than 15 minutes reduced the likelihood of SEP recovery after restora¬
tion of blood flow. Preliminary studies in the evolution of the
model and early comparisons of treatments are described. In the final
studies treatment began 15 min after the diagnosis of cord DCS.
To find the optimum oxygen pressure 5 groups of 5 dogs were treated
with 1.0, 1.5, 2.0, 2.5 or 3.0 bar of oxygen at a total pressure of
5.0 bar. This showed an optimal response in the 2.0 and 2.5 bar
groups with 70 and 66 percent recovery after 2 hours of treatment.
The lower P02 was used in the next study where 3 groups of 5 dogs
were treated with 2.0 bar of oxygen at 3.0, 5.0 or 7.0 bar total
pressure. A fourth group was given the currently used treatment of
2.8 bar breathing oxygen. There was no statistical difference between
the four groups which supported the hypothesis that once beyond a
threshold in the region of 3.0 bar no advantage was gained by additional
compression. It is proposed that a new treatment using only 2.0 bar
of oxygen at 3.0 bar total pressure be tried. While this would
probably not alter outcome it would greatly reduce the risks of oxygen
toxicity. The form of decompression sickness observed largely
supported the venous obstruction model but suggested that autochthonous
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AoP aortic pressure
BP blood pressure
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gm gram
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The experiments reported herein were conducted according to the
principles set forth in the "Guide for the Care and Use of Laboratory
Animals". Institute of Laboratory Animal Resources, National
Research Council, DHEW, Pub. No. (NIH) 78-23. The opinions and
assertions contained herein are the private ones of the author and are
not to be construed as official or reflecting the views of the
United States Navy Department or the Naval Service at large.
As the work was conducted in the United States of America the
pressure units were necessarily not SI units. Therefore feet of
seawater are generally reported but are related to the standard
European units as follows:
2 bar (absolute pressure) = 10 metres of seawater = 33 feet
of seawater
3 Bar = 20 metres of seawater = 66 feet
of seawater
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For many hundreds of years man has ventured underwater. The
duration of his time underwater has only recently increased as breath¬
ing appratus was developed to overcome the limitations of breath hold
diving. The development of the caisson by Triger in 1839 (1841), for
digging in water bearing sails, enabled men to stay long enough at
pressure to develop decompression sickness (DCS) when decompressed. The
majority of cases of decompression sickness suffer from limb pain.
However a significant minority develop varying degrees of neurological
impairment. Although Boyle (1670)observed bubbles in a vipers eye and
blood when the viper was subjected to reduced presure, it was Bucquoy
(1861) who first suggested that the sickness associated with decompression
might be the result of dissolved gas coming out of solution. With animal
experiments, Paul Bert (1878) demonstrated that nitrogen coming out of
solution in blood and tissues, formed the bubbles which caused DCS.
It is believed that Pol and Watelle (1854) first suggested that
recompression might be the treatment of choice for DCS. They observed
that workers with DCS had discovered that reentering the workings cured
their pain. Paul Bert's experiments led him to the same conclusion.
Although Smith (1873) who coined the term 'caisson disease' while associa¬
ted with the building cf the Brooklyn Bridge had no idea of the mechanism
of DCS, he recommended that a medical treatment lock should be provided.
The first such lock was probably that of Sir Ernest Moir during the
building of the Hudson River Tunnel in 1893 (Keays, 1909). Certainly
by 1895, Snell (1896) was using a medical lock on the Blackwall Tunnel
site.
Once the cause of DCS was recognised, pressure became and remains
the mainstay of treatment. Pol and Watelle (1854) also considered
the advantages of using oxygen as well as pressure. This was resur¬
rected by Bert (1878). However fears of toxicity prevented its
introduction and world wide acceptance until the middle of this century.
Oxygen is now regarded by many as of equal importance in treatment, as
is pressure.
Although there are many standard treatment routines available
(Berghage et al., 1978), there have been no properly conducted assess¬
ments of the factors of pressure and oxygen in treatment. The standard
treatments are based on little experimental evidence and mostly on
empirical applications of theoretical concepts (Barnard, 1978). Early
treatment of spinal cord DCS is usually effective and problem free,
but delay in treatment leads to poor recovery (Rivera, 1964; Slark,
1965).
The purpose of this project was to look at the problem of delayed
treatment of spinal cord DCS. The first objective was to find the
lowest effective P02 for use at a fixed absolute pressure. The second
objective was then to vary absolute pressure around the established
optimum P02 and discover whether increasing pressure beyond a presumed
threshold improved the outcome of treatment. To achieve these goals
an animal model of cord DCS which lent itself to delayed treatment
was required. Clinical assessment of the preparations would not be
possible so development of a quantifiable electro-physiological method
was needed. Somatosensory averaged evoked potentials from peripheral
nerves were expected to enable the spinal cord to be interrogated and
to allow some degree of lesion localisation. The electrophysiological
method would have to be validated by testing the effects on it of many
variables, including spinal cord blood flow.
1.2 PRESENTATION OF DECOMPRESSION SICKNESS
The multitude of alternative terms used to describe DCS, compressed
air illness or caisson disease gives some indication of the extent
of its possible symptoms and signs. There are graphic terms such as
bends and niggles which describe pain, and hits, chokes and staggers
used to describe more serious forms of DCS. The compressed air working
fraternity are responsible for giving us the Type I, Type II classifica¬
tion for mild and serious DCS. The diving fraternity generally
differentiates between mild and serious DCS. Serious DCS being mostly
neurological in origin but also including cardiopulmonary DCS or
"chokes".
Approximately 10 - 35% of those cases of DCS which come to active
treatment will show some signs of central nervous system involvement
(Rivera, 1964; Slark, 1965). Rarely will the cases exclusively show
only central nervous system involvement. About one third of cases
with musculo-skeletal DCS will also exhibit central nervous system
problems. In addition, other systems may commonly be involved (Slark,
1965).
These cases present the most difficult treatment problems and
significant numbers will never achieve a complete cure inspite of all
known treatments. It is to these cases that all further discussion
will be confined.
Prodromal indications of neurological decompression sickness may
include pain in conjunction with cardiopulmonary and constitutional
upset. This can take the form of a cardiopulmonary embarrassment known
as the "chokes", which may progress to clinical shock. The prelude
can simply be a severe disproportionate fatigue leading to peripheral
vasoconstriction, nausea, sweating, hypertension and malaise.
The "chokes" are a triad of signs and symptoms. There is a burning
substernal pain of increasing severity. At first, it may only be apparent
on coughing, but it progresses to frank inspiratory and expiratory
pain. A cough, intermittent at first and readily provoked by smoking,
develops into uncontrollable paroxysms. There is progressive dyspnoea
and respiratory distress. The cause is presumed to be the combined
effect of gaseous embolisation of the pulmonary artery, and the release,
in the lung, of smooth muscle active substances causing vasoconstriction
leading to pulmonary oedema, and possibly bronchoconstriction
(Chryssanthou et al., 1970).
The ensuing shock with which the "chokes" is sometimes associated
may be due to a combination of mechanisms, such as a loss of vascular
tone due to cord involvement, myocardial depression from hypoxaemia
and acidosis, pulmonary embolisation and hypovolaemia. The hypovolaemia
probably results from a widespread increase in capillary permeability
and cell sludging, leading to loss of plasma water and an increased
haematocrit (Cockett and Nakamura, 1964a, b).
As DCS is caused largely by vascular obstruction consequent on
random 'in situ' bubble formation within the vascular system, neuro¬
logical decompression sickness presentation is unpredictable. Where
or how the peripheral nervous system is involved remains unknown, so
it is safer to assume that all nervous system involvement is central
in origin. Because of its comparatively tenuous blood supply, the
spinal cord is the most frequent area afflicted (Woollam and Mil ler ,1958).
Aviators frequently suffer cerebral lesions presenting in any
number of ways, but commonly as migraine-like headaches with visual
disturbances, and occasional hemiparesis (Fryer and Roxburgh, 1965).
Spinal lesions are more common in divers, presenting classically
as regional sensory disturbances, paraplegia and bladder paralysis
with urine retention and faecal incontinance. Less commonly, trunk
pain may also indicate cord involvement.
These various forms of DCS tend to develop rapidly after the offend¬
ing decompression, and because of the dominantly vascdar nature of
the disease, the first aid and subsequent treatment lends itself to
measures of circulatory support and restriction of coagulability, in
addition to the necessary oxygen and recompression for the removal
of the root cause.
The complexity and duration of very severe cases can be seen in
the following example:
An "experienced" professional diver carried out an energetic wreck
survey in about 180 ft (55 m) of water. After 25 minutes, he
surfaced directly. While getting another diving set ready to
go in order to complete his task, he developed shoulder pain which
disappeared when he dived again. After another 20 minutes, he
again surfaced directly, but was so fatigued that he had to be
lifted into the boat for transport to the nearby ship in order
to undergo surface decompression. On his way across the deck
to the chamber, within 5-10 minutes of surfacing, he became
unsteady and had to be assisted into the chamber. They continued
with the surface decompression table and during the initial decom¬
pression to 40 feet the diver became aphasic, lost the coordination
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of both arms and developed severe tremor in both legs. During
several unorthodox treatment manoeuvres before expert help was
was summoned, he twice lost consciousness and also briefly, lost
the sight in one eye. After the subsequent stormy therapy using
pressure, oxygen, drugs and fluids, he was left with an almost
complete paraplegia, various sensory deficits, mostly below T ,
o
although one arm was patchily involved; asymmetric weakness of
both forearms and hands, a paralysed bladder and faecal incontinence
Subsequent intensive rehabilitation enabled him to walk without
aid after 8 months. Bladder control returned within 8 weeks and
he even regained the capacity for sexual intercourse, although
there was some residual sensory deficit.
Usually neurological DCS will be preceded by musculo-skeletal
pain, "chokes", general malaise, or any combination of these. It is
generally stated that a high proportion of "chokes" will go on to
neurological DCS (Heller et al., 1900; Behnke and Shaw, 1937; Hallenbeck
et al., 1975).
The onset of these serious forms of DCS, tends to be more rapid
than for pain only bends. A detailed series of cases monitored by
Kidd and Elliott (1975) had all the neurological cases presenting within
about 90 minutes of surfacing, while pain only cases continued to occur
for up to 15 hours.
A recurrent problem is one of failure to diagnose neurological
DCS, because in its more subtle forms, it is less apparent than the
very obvious severe joint pain in the milder form of DCS. There is
often some functional power loss associated with severe pain and the
differentiation between the two problems is never easy, even with
experience. There is thus a risk of overlooking what is in fact the
main problem and consequently undertreating it. From such situations
arise complicated and hard to treat cases of serious DCS.
Slark (1965) in a retrospective survey of cases treated by the
Royal Navy, suggests that his apportioning of serious cases into categories,
may in fact, be an underestimate of their frequency for this very reason.
In addition, many cases are seen and treated by medically unskilled
personnel, so that their reporting is naturally less than satisfactory.
The diversity of sites for bubble formation and damage in all
tissues renders the symptomatology protean (Rivera, 1964), it may also
be multifocal and is always unpredictable. Unlike aviators, the spinal
cord is the site of most neurological DCS in divers, although occasional
cerebral presentations do occur.
A summary of perhaps the three best known surveys of DCS in divers
is given in Table 1. These leave no doubt that the neurological cases
are dominated by cord lesions, but that a good number of cases involve
cranial nerves and their end organs, brain stem and cerebrum.
The infinite number of possible sites for bubble lodgement in
the brain results in many possible manifestations of cerebral DCS,
among them: behavioural disorders (moodiness, change of affect, upset
judgement/psychoses), visual blurring, diplopia (cranial nerve),
scotomata, hemianopia, fortification spectra, migrainous headaches
(usually in those with a history of migraine), speech disorders, through
to unconsciousness and frank convulsions (Rivera, 1964).
The development of cord lesions is often insidious and the slowly
evolving paraesthesia and slight limb weakness can bemasked by localized
pain or the "chokes", until well advanced. Pins and needles may be
felt in the feet which later feel wooly and cold. The progress may
be slow or fast and lead to paraplegia with loss of bladder and sphincter
control. Several different cord segments may be afflicted at once
giving patchy neurological deficits, sometimes also showingas a unilateral
loss. The lower extremities are more commonly affected than the arms.
Lesions may not be strictly segmental and cases of glove and stocking
sensory deficit have been seen.
Back, chest and abdominal girdle pain often are indicators of
a cord problem. Previous conditions or injuries may predispose to
the onset and even dictate the site of the lesions. The author has
seen two cases where the site of cord DCS was associated with an old
prolapsed intervertebral disc. Kidd and Elliot (1975) recorded a case




DISTRIBUTION OF SIGNS AND SYMPTOMS IN SERIOUS DECOMPRESSION SICKNESS
Rivera (1964) Percentage of all cases Slark (1965) Percentage of all cas<
surveyed ( n = 935) surveyed (n = 137)
Numbness/Paraesthesia 21.2 Disorder of Sensation 8.0
Muscular Weakness 20.6 Disorder of Power 11.0
Paralysis 6.1 Vertigo 4. A
Urinary Disturbance 2.5 Nausea/Vomiting 5.1
Muscular Twitching 1.2 Visual Disorder 2.2
Incoordination 0.9 Headache 3.6
Dizziness/Vertigo 8.5 Unconsciousness 2.9
Nausea/Vomiting 7.9 Shock 5.8
Visual Disturbance 6.8
Headache 3.9 Kidd and Elliott (1975) Percentage
Unconsciousness 2.7 serious cases only (n = 250+)
Personality Change 1.6 Sensory Impairment 25
Agitation/Restlessness 1.3 Motor Impairment 13
Convulsion 1.1 Dizziness 19
Equilibrium Disturbances 0.7 Nausea/Vomiting 5
Auditory 0.3 Visual Disorder 10
Cranial Nerves 0.2 Confusion/Disorientation. 1A
Aphasia 0.2 Dysarthria 3
Dyspnoea 2.0 Dyspnoea/Coughing 17
Fatigue 1.2
The high proportion of cerebral cases seen in follow up by Rozsahegyi
(1959) and Peters et al. (1977) and some of the bizarre findings attributed
to cord lesions suggest that there may be a higher incidence of cerebral
occurrences in divers than is generally believed. It is not easy to
explain glove and stocking sensory loss through a spinal cord lesion;
the possibility of more peripheral lesions seems less feasible than
the probability of a more central problem.
Follow up surveys may well be biased towards what authors think
they are going to show. Cases with residual problems may well be easier
to find and probably more willing to participate than those without
evident problems. So necessarily, these cases may come from the most
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severely, acutely affected group and this may well explain the high
proportion of cerebral problems. This line of reasoning may be more
clear after consideration of the pathological mechanisms of the disease.
1.3 MECHANISMS OF NEUROLOGICAL DECOMPRESSION SICKNESS
The basic cause of DCS is bubble formation. The exact site of
their initial development remains unknown. On the basis of Guyton and
Coleman's (1968) view that interstitial fluid pressure and intralymphatic
pressure are slightly lower than ambient pressure at one atmosphere,
these regions would be reasonable sites for bubble nucleation. Certainly,
ultrasonic monitoring indicates that the first circulating bubbles are
usually detected in the venous rather than the arterial circulation
(Spencer et al., 1975).
The bubbles cause mechanical disruption and vascular obstruction,
but they also set in train a series of far reaching pathological reactions
through the surface activity at the blood-gas interface.
The surface activity results from the interface generated electro-
kinetic forces distorting the circulating globular proteins. Ordinarily,
these proteins are oriented so that the hydrophobic part is on the inside
of the molecule and the hydrophilic part is in aqueous blood. The blood-
gas interface causes this configuration to be altered so that the hydro¬
phobic part points across the interface into the gas of the bubble (Lee
and Hairston, 1971). Enzyme activation or protein denaturation may
then occur. The Hageman factor is activated and active sites on enzymes
may be exposed. These events can lead to some proteins becoming lyophobic
and causing RBC clumping and the adherence, release and aggregation
of platelets (Hallenbeck, et al., 1973).
Fat emboli develop from the coalescence of intravascular lipid
and intravasation of depot fat (Bergentz, 1971). Reduction of blood
flow rates in the microvasculature, results in decreased blood shear
strain rates which effectively increase intracapillary pressure. This
in turn induces vascular fluid loss into the tissues. The consequent
haemoconcentration generates a vicious circle, which with time becomes
increasingly difficult to break, as fibrinogen concentration increases
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and cell agglutination occurs. Substances released by bubble formation
cause increased capillary permeability causing further fluid loss. If
the process is sufficiently widespread, venous return declines and so,
in its turn, does cardiac output. The process rapidly shows as a marked
increase in haematocrit which may easily exceed 50 percent (Hallenbeck
et al., 1975b).
The mechanisms are tightly interlocked and many other substances
are released and activated including vasoactive amines, kinins and
complement. The resultant hastening of coagulation in the area of stasis
leads to fibrin deposition which reinforces the vascular obstruction
started by the platelet and red blood cell aggregates and bubbles.
The resulting local ischaemia causes prostaglandins to be re 1 eased,wtich
in the same way compound the problem further (Hallenbeck and Anderson
1982).
Post mortem examination of the cord in dogs has shown the resulting
neurological lesions to be largely confined to the white matter
(Hallenbeck et al. , 1976). The lesions were usually found in the thoracic
and lumbosacral regions but also occasionally in the cervical region.
No lesions were found in the brain. The infarctions showed only small
perivascular haemorrhages and this with the grey matter sparing, is
indicative of venous not arterial obstruction (Henson and Parsons ,1967) -
Studies of the cords of goats which have dived gave similar
findings with lesions mainly in the white matter at the watershed of
the arterial supply, adjacent to the grey matter (Palmer et al., 1978).
The main area affected was the cervical region. Interestingly, a large
portion of those with lesions had never been treated for, ncr shown signs
of neurological involvement. Again no lesions were found in the brain.
The possibility of extravascular bubbles in the cord remains. These
were observed by Boycott et al., (1908) in goat cords but not by
Catchpole and Gersh (1947). Hills and James (1982) expound a model
of extravascular bubbles in the cord as the main mechanism in cord DCS.
It had long been thought that the cord damage was the result of
i 1
arterial embolisation with bubbles (Catchpole and Gersh, 1947), but
the evidence against this is now strong. In embolic phenomena, the
brain is the main target organ and in one large survey of neurological
vascular disease no cases of cord embolisation were found (Blackwood,
1958).
This is not surprising when it is considered that the human brain
constitutes about 98% of the CNS (Truex and Carpenter, 1969) and receives
75 to 85 times more blood flow than the cord (Kety, 1960). In divers
it is largely the cord which is affected by DCS while arterial gas
embolism affects the brain. Although both have their origins in vascular
bubble formation the mechanisms of their selection of a target organ
are clearly different.
Some understanding of the cord vasculature sheds light upon the
mechanism of cord DCS. According to Batson (1940), the epidural
vertebral venous system (EVVS) in man is a large, valveless plexiform
lake. It is connected at each intervertebral foramen with ascending
lumbar veins in the abdomen, with azygos and hemiazygos veins in the
thorax, and with the vertebral veins in the neck. The EVVS also
communicates with cranial dural sinuses via ventral occipital sinuses
and with posterior bronchial and parietal pleural veins. The direction
of flow in the EVVS changes frequently in response to respiratory and
intracavity pressure changes. Radicular veins drain cord blood into
the EVVS, and like the arterial supply it is nonsegmental and rather
tenuous (Woollam and Miller, 1958). Clemens (1970) states that the
volume of the system is some 20 times greater than the arterial supply
to the region, so that only about 5% of the EVVS blood volume needs
to be flowing at any one time.
The EVVS thus differs from other veins in that it is not just a
unidirectional duct returning blood towards the heart, but more an almost
stagnant pool with an ordinarily sluggish flow which frequently changes
direction. So it becomes apparent that any obstruction to its flow
may rapidly proceed into the sequence of coagulation previously described.
The situation has been clarified using a dog model of cord DCS
(Hallenbeck, 1976). The dog EVVS is less complex than man's, being
basically a pair of venous trunks extending from skull to sacrum within
the spinal column. It joins the cranial dural sinuses and anastomoses
with the azygos and hemiazygos veins (Miller et al . , 1964).
Some of these studies have shown that bubbles and the products
of blood-gas interface activity form peripherally and return to the
lungs via the heart (Chrysanthou et al., 1970). So called 'silent bubbles'
(they do not appear to cause DCS) have been detected enroute to the
lungs by using ultrasonics (Spencer et al., 1975). This gives rise
to the conclusion that the lungs can dispose of and remove bubbles and
it is known that they can inactivate many of the products of the bubble
surface activity (Fishman and Pietra, 1974a, b). However, if the bubble
assault becomes too large, the lung mechanisms will be overwhelmed;
vascular obstruction will occur causing a rise in pulmonary artery
pressure and in turn, of central venous pressure. This is thought to
be reflected back into the EVVS so reducing its blood flow. The EVVS
already has a small flow rate so that bubbles simultaneously forming
in it will tend to grow and coalesce. The venous back pressure will
bring about stasis in the EVVS so encouraging the bubble growth process
to the point of obstruction (Hallenbeck, 1976). If the stasis lasts
longer than the silicon clotting time, the coagulation process will
be initiated and vascular fluid loss begin (Botti and Ratnoff, 1964).
In dogs decompressed from a deep dive there was, generally within
20 minutes a rise in right ventricular pressure associated with some
respiratory distress indicating bubble embolisation of the pulmonary
artery. This was usually followed immediately by a rise in CSF pressure
indicating the pressure rise in the EVVS transmitted from the pulmonary
circulation. Signs of neurological deficit immediately followed this.
A few cases of cord lesions were seen without the preceding cardio¬
pulmonary changes indicating the possibility that EVVS bubbles alone
may cause the obstructions (Hallenbeck, 1976). These findings may explain
why not all clinical cases seen experience the pulmonary disturbances
often described.
Once the haemostatic process has been initiated, fibrin is laid
down and consolidation of the obstruction begins. The resulting ischaemic
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damage initiates the mechanisms implicated in the no-reflow phenomenon
(Hallenbeck and Furlow, 1978). It can be seen that prompt treatment is
essential to avoid permanent damage.
This mechanism cannot necessarily be invoked to explain the
occasional episodes of cranial involvement with the brains'more
secure anastomotic circulation. Inevitably, venous outflow must be
reduced, but in a generalised not a focal way. However, as the brain
is a frequent target of arterial embolic episodes, it seems possible
that a sufficiently great rise in pulmonary artery pressure could open
up arteriovenous shunts allowing bubbles to embolise cerebral end arteries
where they may grow in the resulting vascular stasis.
The question of extravascular bubbles remains, and in occasional
cases these are a possible explanation for cases such as that described
by Kidd and Elliott (19759.
1.4 RESIDUAL PROBLEMS
Case surveys clearly show that delay between onset and treatment
decreases the likelihood of complete recovery and frequently complicates
the treatment (Rivera, 1964; Slark, 1965; Kidd and Elliott, 1975).
The reasons for this must be self evident from the understanding of
the mechanism. Rivera (1964) observed that onsets within 15 minutes
of surfacing tended to have more residual defects. This is presumed
to be because the earlier the onset, the more severe the case.
While following up tunnel workers treated for neurological DCS
Rozsahegyi (1959) found that after 2.5 - 5.5 years, many of them had
significant neurological disturbances, even among a number who had
been sign and symptom free on completion of the compression therapy.
Those who were not completely free of problems within 6 weekscftreatment
were like]y to have problems for several years at least. Of those
who suffered with problems only 4% were completely clear after 2.5
years. Progress over the first 6 months can be good but thereafter
small improvements may continue for several years although complete
recovery is highly unlikely. Rozsahegyi also reported some sequelae
of late onset.
A contribution to the problem of the late sequelae may be the
failure to make a correct judgement as to the seriousness of a case
when it presents for treatment. Sequelae most commonly seen are varying
degrees of sensory and motor loss sometimes with bladder control and
impotency problems; occasionally there may be various cerebral changes.
1.5. AN HISTORICAL VIEW OF TREATMENT
By the end of the nineteenth century recompression was firmly
established as the treatment for DCS. What was not clear then, no
more is it now, was to what pressures should patients be taken for
optimal effect. At the Blackwall Tunnel Snells' (1896) general policy
was to recompress to the depth of relief and not to exceed working
pressure. Time at treatment pressure was up to 30 minutes.
Keays (1909) recommended returning to working pressure. Although
many cases recovered at lower pressures, there was a high recurrence
rate if the higher pressure was not used. Using only two thirds of
the working pressure with a wait of up to 60 minutes was recommended
by Ryan (1912).
Yarborough and Behnke (1939a)summarised US Navy experiences and
the available treatment options around a discussion of Boyles Law,
as recompression to:
a. Pressure of relief
b. Pressure of relief plus an arbitrary amount
c. Pressure of the causative dive
d. Pressure greater than the pressure of the causative dive.
Behnke and Shaw (1937) demonstrated that 3 bar (66 ft, 20 m) was adequate
to stop the cardiopulmonary DCS arising in dogs after long dives at
5.4 bar. Breathing air did not however prevent recurrences. Yarborough
and Behnke (1939a) practised recompression to depth of relief plus
one bar. They developed guidelines within a minimum pressure of 4
bar (100 ft, 30 m) and a maximum pressure of 6 bar (165 ft, 50 m).
They also set a minimum time at maximum pressure of 30 minutes. They
observed "that those patients who respondto pressure treatment, do
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so rather promptly". The approach to those with a poor response was
empirical in "that as long a improvement occurs the maximum pressure
should be maintained for a period of at least 2 hours". They modified
their Haldanian type decompression to use oxygen from 2.8 bar (60 ft,
18 m) back to the surface. In the event of recurrence they recompressed
to the depth of relief which was invariably less than 3 bar and stayed
12 to 24 hours.
These treatment practices had about a 50 percent recurrence, as
did modified versions (Yarborough and Behnke, 1939b). Van der Aue
et al. (1945) produced treatment outlines embodying the Yarborough
and Behnke principles in formal tables. For neurological DCS these
required compression to an arbitrary pressure of 6 bar (165 ft, 50 m).
These were highly effective until the number of delayed treatments
increased with the advent of sports diving (Rivera, 1963).
The earlier Behnke and Shaw (1937) experiments with dogs treated
at 3 bar had included a group which breathed oxygen. On return to
the surface they did not have a recurrence of cardiopulmonary problems
as had their air breathing counterparts, thus demonstrating the advantages
of oxygen in gas clearance. However, the result was not a success
as some dogs went on to develop cord lesions while at 3 bar. It was
for this reason that deeper compression was recommended with oxygen
breathing during some of the decompression.
Driven by the falling success rate of the Van der Aue tables,
Goodman and Workman (1965) introduced the minimal pressure oxygen
compression therapies used at 2.8 bar (60 ft, 18 m). These tables
were very successful and increased the success rate from about 45 percent
to 65 percent (Bornmann, 1967). They form the first choice in treatment
throughout the world today.
The use of oxygen at such high partial pressures is not without
hazard. Sustained exposure to 2.8 bar of oxygen causes cerebral
oxygen toxicity. The problem is largely avoided by breathing oxygen
for a series of 20 minute periods broken by 5 minute periods breathing
air. This stemmed from experimental observations by Kaufman et al. (1956)
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who showed that the time to convulsion in guinea pigs could be extended
by a factor of three if they intermittently breathed air. It is the
author's experience that although oxygen convulsions during treatment
are not common, when they do occur, the often prolonged post-ictal
phase greatly complicates treatment. If 2.8 bar of oxygen was shown
to be more than adequate for treatment then it would be wise to use
a lesser but equally effective oxygen tension. Some groups actually
use oxygen at a higher pressure for shorter periods, Hart (1974) reports
successful treatment of DCS with continuous oxygen breathing beginning
with 30 minutes at 3.0 bar followed by 60 minutes at 2.5 bar before
decompression. Ballantine (1979) has reported central cord necrosis
in rats exposed to 3.0 bar of oxygen for 5 hours. He suggested that
it probably occurs between 2.5 and 5 hours. It has been demonstrated
that high levels of oxygen cause vasoconstriction in the CNS (Ledingham,
1977). Intuitively this must be a disadvantage in treating a disease
believed to be largely the result of impaired perfusion.
The most commonly used pressures for treating DCS arising as a
result of air diving are 2.8, 4.0 and 6.0 bar. The available range
of tables extends to 8.0 bar for the Royal Navy and 10.7 bar in Russia
(BergJrage et al.,1978). There is little published experimental work
to justify these higher pressures, but Barnard (1978) cites Russian
experiments purporting to show that increasing the maximum treatment
pressure increased the effectiveness of treatment in animals with severe
DCS. This is contrary to his own work (Barnard and Hanson, 1973).
Mice dived in oxyhelium to depths between 125 m and 225m were decompressed
and then recompressed after a short interval to six depths between
0 m and 80 m. They showed that irrespective of the depth of the dive
there appeared to be an optimal treatment pressure of between 2.5 and
5.0 bar, although they considered the real upper limit to be 3.5 bar.
Similarly in studies into the optimal pressure for treating cerebral
arterial gas embolism no improvement in recovery was seen at pressures
above 2.8 bar (Leitch et al., 1984).
1 .. 6 THE RATIONALE OF TREATMENT
It is generally believed that most decompressions result in some
bubble formation, but that tiieir numbers and size are small so they
remain 'silent'. Barring the fortuitous location of a bubble or bubbles
in a sensitive and vulnerable tissue, DCS occurs when an undefined
tolerable dose is exceeded (Spencer et al., 1975). Therefore once
DCS presents, the first objective is to stop further bubble growth.
The manifestations of DCS arise either because of mechanical disruption
or as a result of ischaemia. Breathing oxygen, even at one bar, should
slow bubble growth and possibly even reverse it by increasing the
inert gas gradient. In addition tissue oxygenation should be improved.
This is a standard first aid measure. As fluid loss from the intravascula
space occurs in serious cases fluid replacement is required to prevent
the less treatable processes such as coagulation and vascular stasis.
Plasma has been used (Barnard et al., 1966) and low molecular weight
dextrans were popular until recently. Now it is generally believed
that crystalloid solutions such as lactated Ringers car Hartmanns may
be preferable (Davis, 1979). The principal treatment is pressure,
preferably with a raised P02• Given adequate time bubbles should be
cleared. In cases which do not wholly recover at pressure it is impossibl
to define what is adequate time. This problem has given rise to the
saturation therapy where non-responding cases are held for many hours
in air or oxynitrogen mixes at pressures usually between 2.8 and 4.0
bar (Miller et al., 1978). This is an increasingly used alternative
to the option previously used, of just going deeper. There are several
problems with going deeper. Using air causes increased narcosis.
The P02 rises so that pulmonary oxygen toxicity will have an earlier
onset which can only be prevented by using nitrogen or helium for further
pressurisation. As soon as you start to control the P02 you need a
chamber equipped for saturation. You only go deeper with very ill
patients and by doing so you get further away from help. The final
problem is the return to the surface without causing a recurrence or a
new problem. Such decompressions are generally slow. The whole is
further complicated by the possibility of oedema. The treatment of
cerebral oedema has been reviewed by Pierce and Jacobson (1977). Dexa-
methasone is widely used to counter vasogenic oedema but its efficiency
is much debated (Rap and Dabrowiecki, 1978; Ito et al., 1980). The
antioedema effects of hyperbaric oxygen are clearly beneficial (Miller,
1963). In times of crisis mannitol or glycerol have been used.
Where cases arrive at surface pressure with notable neurological
deficits, it has been the author's and others practice to repeat hyperbari
oxygen therapies up to twice a day. This is only continued as long
as improvements, even if only transient, are associated with the treatments.
While clearly hastening recovery it remains unknown whether the final
outcome is improved.
A purely theoretical approach applying Boyles Law to bubbles gives
some indication of the relative merits of pressure in treatment. Volume
is inversely related to pressure, so every doubling of pressure halves
volume as shown in Table 2. However:-
Diameter = ^6V
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therefore while volume may be halved diameter is not. Much of the
problem created by spherical bubbles can be attributed to their linear
dimension rather than their volume where disruption and obstruction
are concerned. Table 2 illustrates how the effects of increasing
compression on spherical bubble dimension has quite a small effect
in diameter compared with that on volume, and quickly enters the realms
of diminishing returns. When cylindrical bubbles are compressed they
reduce in length first until they become spherical thus the volume reduc¬
tion is most effective.
Compressing a spherical bubble to 50 m (6 bar) will reduce volume
to one sixth (17%) and diameter to 55 percent. The reduction in radius
will increase the surface tension forces thus further raising bubble
PN2 above tissue PN2 causing an outward diffusion gradient. Oxygen
partial pressure using air will increase to 1.2 bar, so improving oxy¬
genation. The raised PN2 will cause generalised increased inert gas
uptake which creates a further risk on decompression. This, with the
raised P02 puts a limit on the holding time at pressure. There has
to be a balance between how much pulmonary oxygen toxicity can be
permitted to develop while still allowing time for safe decompression
to a pressure where oxygen will no longer be a problem. While at 50 m
there is the problem of nitrogen narcosis which impairs mental performance
and the problem of easy access to the patient.
Haemoglobin is effectively saturated while breathing air and plasma
carries 0.31 ml of oxygen per 100 ml of whole blood. About 20 ml of
TABLE 2
THE EFFECT OF COMPRESSION ON BUBBLE SIZE
PRESSURE DEPTH VOLUME DIAMETER
(bar) (metre) (feet) (percent) (percent
1 0 0 100 100
2 10 33 50 79
3 20 66 33 69
4 30 99 25 63
5 40 132 20 58
6 50 165 17 55
7 60 198 14 52
8 70 231 12 50
9 80 264 11 48
10 90 297 10 46
oxygen is carried in 100 ml of arterial blood. Mixed venous blood
carries about 14 ml at rest so the mean resting tissue requirement
is about 6 ml per 100 ml of blood. The effect of pressure on oxygen
carried in saturation in blood (per 100 ml) is:
BREATHING GAS
PRESSURE AIR OXYGEN
1 bar 0.3 2.0 ml
2 bar 0.8 4.5 ml
3 bar 1.3 6.5 ml
Therefore at 3 bar breathing oxygen, tissue requirements can be met
from oxygen in solution. A minor drawback to this is the loss of
haemoglobin buffering. However the length of the diffusion pathway
into hypoxic tissue is greatly increased so that survival of larger
volumes of ischaemic tissue is possible.
Applying the standard oxygen treatment to a spherical bubble with
compression to 2.8 bar will theoretically reduce bubble volume to 36
percent and diameter to 71 percent. The absence of inert gas greatly
increases the nitrogen gradient so accelerating the outward diffusion
of nitrogen. The vasoconstriction reduces intracranial and therefore
spinal canal pressure and oedema is reduced (Miller, 1973). The major
disadvantage is oxygen toxicity.
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Kunkle and Beckinan ( 1983) calculated that the rate of bubble
clearance should be the same with air at 6.0 bar as with oxygen at
2.8 bar. The added advantages are the increased availability of oxygen,
the accessibility of the patient, and the reduced decompression risk
associated with treatment lasting about one seventh of the time of
the standard air table in uncomplicated cases.
The French try to get the best of both approaches as suggested
by Behnke and Shaw (1937) with a middle range compression to 4 bar
(30 m) and breathing oxygen rich mixtures (50 percent)(Berghage et
al., 1978).
1.7 CASE EXPERIENCE
At the start of this study the author had cause to conduct a three
year review of treatment experience in the Royal Navy (Leitch, 1979).
A large number of cases came from civilian sources. There were 27
cases of serious DCS. Of these 20 presented within one hour of surfacing,
one within 6 hours, one later than 6 hours and there were 5 unknown
intervals. The time delay between onset and treatment was less than
one hour in 2 cases, 1 to 5 hours in 11 cases, 5 to 10 hours in 6 cases,
10 to 24 hours in 7 cases and one later than 24 hours. Twenty one
cases were treated with oxygen at 2.8 bar. This included an untreated
case of spontaneous recovery which later relapsed. Once at pressure
43 percent were cured by 10 minutes, 57 percent by 45 minutes and 67
percent by the time they surfaced. One case relapsed, 5 surfaced with
mild symptoms and 2 with signs. Four of these received extra oxygen
at pressure. Six cases were treated with air. Only 3 surfaced sign
and symptom free and all 6 treatments were complicated.
The effect of delay before treatment was well demonstrated. Of
those treated within 5 hours, 44 percent were cured by 10 minutes,
78 percent by 45 minutes and 78 percent by the time of surfacing.
This compared with 20, 20 and 50 percent respectively in cases where
treatment was delayed more than 5 hours. Four cases which were unable
to walk on surfacing were given up to 9 additional one hour oxygen
treatments at 2 bar. By 8 months all wetE able to walk unaided.
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1 .8 EVOKED POTENTIALS
Spinal evoked potentials (SEP) and cortical evoked potentials
(CEP) are being increasingly used experimentally, diagnostically, and
for monitoring in neurosurgical procedures (Grossman, 1979). Dawson
(1946-7) discovered that if recordings of EEGs were time-locked to
a peripheral nerve stimulus, then the random signals were averaged
out by self-cancelling, leaving the time-locked evoked potential. The
same principle can be applied to electrospinograms.
For the proposed studies of the treatment of spinal cord DCS a
system permitting remote interrogation of the neuraxis was required.
It also needed to be able to localise lesions to the major cord divisions.
Design constraints required that the model be control led and maintained
remotely in a pressurised chamber for periods of up to 5 hours. A
chamber containing an animal, once pressurised, cannot be easily
decompressed and opened without putting the experiment at risk; not
even in the brief period when it is near atmospheric pressure between
the first dive and the treatment. In addition, the neuraxis and its
integument could not be invaded, as such procedures might predispose
to localised DCS (Kidd and Elliot, 1975). The development of lesions
resulting from DCS is often rapid (Rivera, 1964; Hallenbeck et al,
1975a; Leitch, 1979) so it was imperative that each interrogation and
recording be short, in order that the onset times of DCS be known within
narrow limits, and the degree of severity be known before treatment.
The selected inputs were left and right peroneal nerve, usual
roots in the dog L^, , S^, S^), left tenth or eleventh intercostal
nerve, and left median nerve (usual roots CD, T , T„) (Hoerlein, 1978).
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The evoked potentials (EP) were recorded at segments L or L„, T ori Z o
Tq, C^ or Cg, and right somatosensory cortex. This arrangement would
permit localisation to five broad regions, lumbar, caudal thoracic,
rostra] thoracic and caudal cervical cords, and the cortical and inter¬
vening regions. Interest lay largely in the first two and last cord
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This study progressed through a series of developmental steps
towards the two ultimate goals. These were to study the relative
merits of oxygen and pressure in the treatment of spinal cord DCS.
Therefore the parts of the method common to all experiments, studies
of the method and some particular details are described below. Minor
variations and experimental plans relating to each stage are described
in relation to the relevant study in the results sections.
2.2 BASIC MATERIALS AND SUPPORT
Adult male mongrel dogs weighing between 7 and 21 kg were used
in these investigations. Studies were terminated with the intracardiac
injection of saturated potassium chloride. The dogs were sedated with
xylazine (1.1 mg kg ^ s.c.) and atropine (0.05 mg kg ^ s.c.). They
were then anaesthetised with sodium pentobarbital (13.5 mg kg ^ i.v.)
and maintained on a routine of half the initial dose after 20 minutes
and a maintenance dose of 4 mg kg * h ^ given in divided doses at 20
minute intervals. Small adjustments to the maintenance regimen were
made if required. After intubation, ventilation was maintained
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with a modified Bird^Mark 7 respirator. A catheter was placed in
the left forepaw cephalic vein for anaesthesia maintenance and infusions.
When preparation for physiological monitoring was complete the dogs
were placed prone in a rigid head-holding stand, modelled after a
stereotaxic frame, and secured by ear bars. Rectal temperature was
continuously recorded and maintained between 37.5 and 39.0°C by means
of a hot water circulating plate incorporated into the base of the
head-holding stand.
2.3 PHYSIOLOGICAL MONITORING
Left and right femoral arteries were catheterized with polyethylene
tubing (OD 2.42 mm) for respectively arterial pressure (AoP) monitoring
and blood sampling. A 7F gauge preformed catheter (Becton-Dickinson
No. 9423) filled with heparinized saline (2 i.u. ml ^) was advanced
from the right femoral vein to the right ventrical for pressure (RVP)
measurement. Pressures were measured using vented Gould Statham P23
ID physiological transducers with matching transducer amplifiers and
recorded on a Gould recorder (Model 2800). A five-lead ECG harness
was connected (4 limb leads and V5) and a Lead II recording made
continuously. A urinary catheter was inserted into the bladder and
connected to a collection bag. A fluid babnce chart was maintained.
Early in the preparation the haematocrit was checked. All dogs with
a haematocrit below 35% were rejected. All dogs with a haematocrit
above 47% were given normal saline or lactated Ringers solution sufficient
to drop the haematocrit to 42%. This was to correct any dehydration.
If the fluid was surplus then it was cleared and the haematocrit rose
again by the time the control period was reached. The urine bag was
emptied at the end of the control period.
Once the dog was placed in the stand, the skull was exposed by
reflecting skin, muscle, and periosteum over the right somatosensory
cortex. Skin from over the distal part of the nasal bones was also
excised. The skull and nasal bones were drilled into cancellous bone.
The holes were filled with electrode gel and a pair of stainless steel
electrodes inserted. A two lead EEG was recorded from these on the
Gould recorder after being amplified and filtered (1-30 Hz) by a
Gould Universal amplifier.
When preparation was complete the dog and stand were moved into
the compression chamber (Bethlehem Corporation Size 1.68 x 0.76 m)
and all connections made. The heating plate was connected to a hard
piped hot water system supplied from outside the chamber. End tidal
C02 was continuously monitored by a Beckman LB2 C02 analyser, and maintained
at 3.0 to 4.5 percent of surface equivalent by altering cycle time
and inspiratory flow rate. The ventilator could also be manually operated
from outside the chamber. Pentobarbital anaesthesia was provided through
a port in the chamber wall, connected to the forepaw venous line.
The right arterial line was connected to another port so that blood
samples could be drawn when the chamber was pressurised. After the
electrophysiological system described below was tested a needle was
inserted percutaneously into the cisterna magna, and connected to another
transducer for the measurement of cerebrospinal fluid pressure (CSFP).
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Arterial blood samples were taken at intervals during preparation
and control periods for blood gas, pH and haematocrit measurements.
Samples were also taken during DCS and its subsequent treatment.
Haematocrit rises and pH falls were corrected by infusion of lactated
Ringers solution and 8 percent bicarbonate solution
2.4 AUTORADIOGRAPHIC BLOOD FLOW STUDIES
The dogs used in this study had an additional catheter placed
distally into the right femoral artery so that when the proximal
and distal catheters were connected through a Y-connector, the leg
arterial circulation was externalized, permitting rapid sampling
during the autoradiographic blood flow study. When the one minute
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C-iodoantipyrine autoradiographic blood flow study was required,
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50 pCi kg of C-iodoantipyrine was infused at a constant rate
through the forepaw venous catheter over a one minute period while
arterial blood was serially sampled every 4-6 seconds. The cardiac
arrest that terminated this procedure was produced by the injection
of saturated potassium chloride into the right ventricle. The brain,
spinal cord and heart were then removed, frozen in liquid freon
suspended over liquid nitrogen and cut into 20-micron sections. The
tissue concentration of the isotope was determined autoradiographically.
The spinal cord was divided approximately at the electrode sites
into four gross segments, and up to 24 sections were taken at intervals
from each gross segment. The sections were laid on standard X-ray
film and incubated for several days. The films were then processed
and the images analysed by densitometry to derive the tissue isotope
concentration. Local blood flow was calculated from the following
formula:
at time T; X = the tissue-blood partition coefficient for the tracer
weight of tissue multiplied by the reciprocal of the partition co¬
efficient for that tissue: and C = the concentration of trace sub-
a
stance in the arterial blood (Reivich et al., 1969).
where C^(T) = the concentration of tracer substance in the tissue
material (approximated as 1); k^ = the rate of blood flow per unit
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2.5 EVOKED POTENTIAL MEASUREMENT
The CEPs were recorded by tapping the EEG signal. The SEPs were
recorded from an array of spinal electrodes. Pairs of insulated 1 mm
diameter stainless steel wire electrodes were introduced percutaneously
into the interspinous space at about L , T_, and C . They were hammered1 O /
into the spinal lamina of adjacent vertebrae until their points were
securely embedded. Impedance of the cortical and spinal electrodes
was less than 2 and 6 kohms respectively.
Stimulating electrodes were pairs of 20 guage stainless steel
needles carried on double banana plugs and secured with heat shrink
plastic. The peroneal nerve electrodes were curved down and inserted
percutaneously astride the neck of the fibula where the peroneal nerve
was palpable. The median nerve electrodes were inserted with the cathode
proximal on the medial aspect of the distal end of the humerus where
the median nerve was palpable. The intercostal nerve electrodes were
inserted astride the 11th rib from its inferior aspect. The electrode
holders were secured to the skin by safety pins. Stimuli of 100 -
140 V (3 x motcr threshold) with a duration of 0.3 ms and a current
of 10 mA was given at a rate not exceeding 2.5 s
The stimulator (Grass S88) and two Nicolet Computers of Average
Transients (CAT) (Models 1074 and 1072) were driven by a Nicolet Stimulus
Pulse Generator (NIC-502). The stimulus was delivered through a Grass
Photoelectric Stimulus Isolation and Constant Current Unit (PISU 6C)
and directed through a four-way switching box on the outside of the
chamber. The output from the three spinal and the cortical sites was
averaged simultaneously (n = 128) on the two CATs; the three SEPs
by the 1074 with a 26 - 30 ms span, and the CEP by the 1072 with a
110 ms span. The outputs were observed on two Tektronix oscilloscopes
(5110) and recorded on three Hewlett-Packard X-Y plotters (HP 7045
A and B). On leaving the chamber through a CONAX high pressure penetrator,
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the signals went to differential amplifiers (NIC-200A) (gain 10 ) before
being further amplified (gain 40) and filtered on a 30-3000 Hz bandpass
(NIC-501 A). The cortical signal was split at this point for the EEG
and CEP output. Each output was calibrated with a 50 pV and 20 ms
square wave signal derived from a Nicolet calibrator (NIC CAL-100).
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Latencies were measured from the start of the stimulus and all peak to
peak amplitudes were derived from peak deviation from a baseline.
2.6 ELECTRODES
Reusable cortical electrodes were made from stainless steel slotted
OH sheet metal screws (size no. 4 length 19 mm) by drilling a 1.02 x 7.00mm
hole down the shaft from the centre slot. The connectors were gold
plated copper-beryllium alloy pins (1.02 x 8.00mm - AMPinc 205089-1).
The reusable spinal electrodes were made in lengths of 8.0 and
6.5 cm from stainless steel orthopaedic finger wires (0.89 x 127 mm
- C - wires Concept Inc.). The point was given a longer tapered bevel
and the whole was coarse sanded before a pin connector (as above) was
soldered to the cut end. The junction was sheathed in heat shrink
plastic. The entire electrode except the pin was dipped in clear
polyurethane to give three or four coats before baking for 48 hr at
110°C. Testing of the insulation revealed infinite resistance up to
500 V. Two millimetres of the tip were bared and the end was lightly
sanded to allow easy passage through tissues. Routine maintenance
was ultrasonic cleaning and resharpening.
The thoracic electrodes were prone to noise of two origins, muscle
noise and ECG artifact. Good earthing and accurate and deep electrode
placement were the only solutions short of neuromuscular blockade and
synchronising the measurement cycle with the ECG cycle.
All electrode cables were Malco Microdot 75 ohm "Mini-Noise" coaxial
cable (275-3801-0000) which were led through the high pressure penetrator
in the chamber wall. The electrode connections were made through 5
cm of multistrand flexible copper wire ending in the matching connectors.
This arrangement permitted thoracic ventilation movement without working
the electrodes free. All screens came to a common earth.
2.7 EVOKED POTENTIAL PROCESSING
Up to five control sets of evoked potentials were collected from
each peripheral nerve input before the start of any experiment. The
EPs were recorded with the positive up convention and with a 2 ms delay
before stimulation. Figure 1 shows the form of peroneal and median
CEPs with three principal waves - and P^ - relating to near-
field cortical potentials. In addition, as many as 11 far-field potential
(FFP) relating to subcortical events were observed between the stimulus
and P^. The observed mean latencies for P^ , and P^ in the comparable
group of 11 dogs, from the median nerve were 10.2, 15.9 and 26.8 ms
respectively, and from the peroneal nerve, 14.0, 20.9 and 31.8 ms.
The SEPs (Fig. 2) produced complex polyphasic wave forms giving up
to 10 easily identifiable pairs of peaks. The more rostral to the
stimulus was the recording, the longer the latency, the greater the spread
and the smaller the amplitude. Records from close to the root input
were dominated by a large negative wave and a later slow positive wave
at 8 - 10 ms.
Analysis of these records took two forms. The CEPs were measured
primarily for amplitude. The OP^ and N^P^ amplitudes were also
measured as were the latencies of the primary peaks and the FFPs. Spinal
evoked potential records were also measured for the principal peak-to-
peak amplitude and for the amplitude of the late slow positive wave.
Initially, this was done by hand but eventually each trace was marked
for the peaks of interest and given an arbitrary baseline to compensate
for occasional wandering slow voltage changes. They were then entered
into a computer (PDP 11-70) using an Elographics Digitizer (Model E241
with an Orthoplex Coordinator Sensor Type 3825-1). Latency change was
of minor importance compared with amplitude so that the emphasis was
on the latter measurement. A simple numerical description of a record
was needed for statistical purposes and pilot studies showed that fine
discrimination techniques were not required for the gross changes that
occurred. An effective means of describing each SEP as a single value
was found to be the simple summing of peak-to-peak amplitudes (Pj^j
+ N-^P0 + ^2^2 etc-)" mean t'ie designated control values was
then calculated and all subsequent values were normalized by expressing
them as a percent of control. As a falling amplitude was sometimes
associated with an increasing peak-to-peak latency, it was thought that
sensitivity, would be increased by dividing the summed amplitude by
peak-to-peak latency. This was feasible so long as all peaks remained
visible. However, it contributed nothing to the overall results beyond
PERONEAL
110 ms.
Figure 1. Representative cortical evoked potentials. The principal
cortical peaks are marked Pj, etc., and the far-field





Figure 2. Representative spinal evoked potential. The records are
labelled with stimulus and recording site. The numerals
are placed by the positive peaks considered relevant. The
succeeding negative peaks would have the same number.
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the knowledge that latency shifts were also being considered, because
amplitude generally was markedly reduced before latency shifts occurred.
This analytic technique was therefore abandoned and cumulative peak-
to-peak amplitude retained as the index of measurement.
2.8 STIMULUS FREQUENCY AND DURATION
There was no change in SEP form, latency or amplitude at stimulus
rates up to 5 Hz in eight dogs. In the range 5 - 8 Hz there was a slight
tendency for the late slow P wave (n; 8 ms) to lose amplitude while the
principal early waves remained unchanged.
Fourteen dogs were tested at rates 0.9, 1.9, 2.9 and 3.9 Hz in
a randomised sequence with 2-3 CEP records to median nerve stimulation
made at each rate. Six dogs were anaesthetised with pentobarbital and
the remainder with chloralose. There was no difference between the
anaesthetic groups. There was a significant loss of amplitude when
the rate exceeded 2.9 Hz (P < 0.01) but no significant change in latency,
although P^ latency did tend to increase (Table 3). For all other studies
the stimulus rate used was between 2.0 and 2.5 Hz.
The optimal stimulus duration was found to be 0.3 ms which produced
a larger amplitude than shorter times but did not lead to distortion
of early waves by the stimulus artifact.
TABLE 3
THE EFFECT OF STIMULUS RATE ON CORTICAL EVOKES POTENTIAL (x ± SE N = 14)
FREQUENCY (Hz)
019 119 2^9 3.9
P1 Latency (ms) 13.8 ± 0.36 14.0 ± 0.41 14.3 ± 0.40 14.4 ± 0.39
Nj Latency (ms) 28.0 ± 2.96 29.2 ± 3.11 28.7 ± 2.30 28.6 ± 1.76




100 103.4 + 2.87 97.6 + 3.32 86.3 + 3.95
of
0.9 Hz N P
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Reducing the bandpass -3db points from 1-8000 Hz to 30-3000 Hz
had a pronounced effect on CEP amplitude but little effect on latency.
The combined effect of narrowed band pass and indifferent electrode
position can be seen in comparing Chlor (1) 30-3000 Hz and nasal
reference with Chlor (2) 1-8000 Hz and frontal sinus reference in
Table 4 and 5 (amplitude) and Figures 3 and 4 (voltage effect).
Studies on eight dogs showed that there was little apparent
difference between a 8000 and 3000 Hz limit except for the reduction
of high frequency noise. Reducing the limit to 1500 Hz blunted all
peaks in the SEPs and FFPs.
Changing the lower limit from 1 to 5 Hz had little effect but
moving it to 30 Hz caused a profound drop in amplitude. In the CEP,
OPj, and were reduced 45 and 20% respectively. However, this
did clarify the presence of which was otherwise barely identifiable.
The effects on SEP waves were less impressive and were most
noticeable in the later slow positive wave. There was a small reduc¬
tion in peak amplitude as a result of dropping the top limit from
8000 to 3000 Hz.
2.10 ANAESTHESIA
Prior to this study the maintenance regimen for pentobarbital
or ot-chloralose anaesthesia was guided by indications of a lightening
plane of anaesthesia. Any regimen which depended on shifting planes
of anaesthesia could well have a variable effect upon evoked potentials
(Pimmel et al., 1976; Parker, 1978a; Arezzo et al., 1979) but might
also destroy an experiment through undue movement should an animal
become light. There were practical problems over infusing large
volumes of «x-chloralose from outside a chamber pressurised to as
much as 10 bar. Anaesthesia by continuous infusion would also have
been a problem. Pentobarbital was chosen for the chamber studies
for this reason.
A retrospective analysis of the anaesthetic regimens of 24 dogs
used in other studies showed that with an initial pentobarbital dose
of 12.5 mg kg ^ (iv) the intervals for the maintenance dose of 25 mg
TABLE4










































































































































































































Stimulus Strength at 10 mA at 2.5 Hz with 0.3 ms Duration
Figure 3. The influence of recording method and two anaesthetics
on somatosensory cortical evoked potentials: P latency
and OP^ amplitude.
Points are mean of 10 - 95 percent confidence
limits of averages of 64 CEPs
□ c Pentobarbital 4 mg kg hr -'
Bandpass 30 3000 Hz
Nasal Reference
z>—c oc -Chloralose 40 mg kg-' hr-'
Bandpass 30 3000 Hz
Nasal Reference
» « oc -Chloralose 40 mg kg-' hrH




















20 40 60 BO 100 120 140 Volts
STIMULUS STRENGTH AT 10 mA at 2.5 HZ with 0.3 ms Duration
The influence of recording method and two anaesthetics
on somatosensory cortical evoked potentials: latency
and amplitude.
Amplitude
Points are mean ot 10 - 95 percent contidence
limits of averages of 64 CEPs
o—c Pentobarbital 4 mg kg hr
Band Pass 30-3000 Hz
Nasal Reference
a—a oc - Chkxalose 40 mg kg-' hr*'
Band Pass 30 3000 Hz
Nasal Reference
•—• a -Chloralose 40 mg kg-1 hr"
Band Pass 1-8000 Hz
Frontal Sinus Reference
varied between 1 and 155 minutes. Plotting the cumulative anaesthesia
given to each dog, showed that the dose required in unit time was linear
after about 40 minutes and was much less than the amount given during
the first 40 minutes. The mean interval between doses after 40 minutes
was 22 minutes. The dose-time slope was 4 mg kg * hr *. To arrive
at the 40 minute point the initial dose was increased to 13.5 mg kg ^
and half that dose was repeated at 20 minutes, being injected slowly
and diluted with saline. The maintenance dose was then given at 20 minute
intervals unless two successive 20 minute checks failed to elicit a
corneal reflex, then a dose was withheld. By the time the dog was
placed in the chamber it was usually clear whether or not the maintenance
dose should be changed. A need to deviate from this schedule was uncommon.
In six dogs studied over 5 hr, the direction of change of SEP
and CEP amplitude was observed from both median and peroneal nerve
stimulation, with relationship to maintenance doses of pentobarbital.
There was no clear indication that EPs decreased following anaesthesia
or increased during pre-anaesthesia intervals. Only the late slow positive
wave at 8 ms in the median-cervical SEP showed a tendency to decrease
after pentobarbital (P < 0.05 chi-square).
The margin of safety with pentobarbital was seen when two dogs,
on completion of other experiments, were given increasing doses at shorter
intervals. Blood pressure remained depressed when the dose reached
16 mg kg * hr at this point EEG amplitude also fell. Peroneal
CEP only lost amplitude when the dose reached 33 mg kg ^ hr ^.
The comparison of CEPs obtained under the two anaesthetics showed
that those recorded under pentobarbital had 50 to 60% less amplitude
than those recorded under chloralose (Table 4). However, with increasing
stimulus strength, an asymptote was approached earlier with pentobarbital.
2.11 STIMULUS VOLTAGE AND ANAESTHESIA
Ten dogs were studied under each anaesthetic regimen at the start
of various experiments. Stimulus voltage was varied in 20 V steps between
20 and 140 V in either ascending or descending sequence. The CEP from
from the median nerve input was recorded. The latencies of
and the peak-to-peak amplitudes were measured. The results are
presented in Table 4 and 5 as "Pento" and "Chlor (1)", and Figs. 3 and 4.
By 60-80 V the latency was fixed under pentobarbital and the peak-
to-peak amplitudes exceeded 90% of the maximum obtained at 140 V.
Under both regimens the visible motor threshold was between 30 and 40 V
although SEP and CEP were clearly identifiable before then. A reasonable
working voltage where the response was asymptotic and the latency fixed
would be about three times motor threshold at 100 to 120 V. Recording
without a stimulus or by stimulating the tip of the tail resulted in
essentially flat recordings except for the stimulus artifact in the
latter.
Median and peroneal CEP and SEP at the three sites were recorded
in a further seven dogs to see how SEP amplitude and CEP related under
pentobarbital anaesthesia. The amplitude grew proportionally in both
SEP and CEP, the best relationship being between the early (3-6 ms)
lumbar SEP waves and the peroneal CEP. The same applied for the comparabl
waves (1-4 ms) with the median - cervical SEP and CEP.
All SEP waves were usually present by 60 V and in only 3/13 cases
did SEP continue to increase when CEP was maximal. It was not possible
to identify one particular SEP wave as being associated with the CEP
primary waves. The SEP waves had a fixed latency within ± 0.1 ms by
80 V, this coincided with the presence and fixed latency of all the
cortical FFPs in most series. With the exception of the occasionally
observed first SEP wave (standing wave) which had a fixed latency at
all spinal sites, and the same latency as the earliest cortical FFP,
no temporal coincidence between the SEP waves and the cortical FFPS
was seen.
2.12 CORTICAL ELECTRODE POSITIONS
Prior to this work the placing of the active electrode for median
CEP had been to go 10 mm lateral to the bregma (Fig. 5) and just behind
the coronal suture. This led too frequently to repositioning of the
electrodes, and was of course no use in the occasional dog which had
no visible suture lines.
Prospectively, dogs were studied by taking the measurements shown
in Figure 5 designated as - IB, BN, BL, and LE. As both peroneal and
median CEPs were to be studied, BL had to be less than 10 mm in order
to move between median and peroneal areas. Control EPs were recorded
and on completion of the experiment, a needle dipped in indian ink was
pushed through the inner table of the skull into the brain. The vault
of the skull was cut, and before removal, was photographed from a fixed
position. The bone was then removed and the meninges cleared so that
a second photograph could be taken of the underlying brain. Where brain
marking was unsuccessful the overlaying of the two photographs allowed
the location of the electrode to be fixed with reference to the sensory
cortex in the post-central gyrus (Hamuy et al., 1956 ). Ten dogs with
equally good median and peroneal CEPs were selected to find the best
measurement system. In these mongrel dogs, weighing 9 - 17 kg, the
ratio of IB + BN to IB + LE was 2.97 ± 0.07 (SE), about one third of
the PA distance between inion and nasal bones. In larger dogs with
extensive frontal sinuses, it was necessary to go less than that distance
in practice. The lateral measurment (BL) proved satisfactory at 6 to
7 mm.
Initially, the indifferent electrode was placed in the frontal
sinus but increasing the distance between the two electrodes enhanced
the cortically recorded FFPs. Placing the indifferent electrode near
the anterior end of the nasal bones reveals the FFPs but at a cost of
about 10% decrement in amplitude of the CEP. The effect of this, in
addition to the decrement caused by the narrowed bandpass, is shown
in Chlor (2) in Tables 4 and 5, and in Figures 3 and 4. The fixed sub¬
cortical origins of the FFPs are demonstrated in Figure 6 where
simultaneous bilateral CEP recordings were made. The FFPs have the
same latencies on both sides indicating volume conduction from a fixed
point. The earliest FFP is the only one sometimes also seen in the
SEP records. The remainder clearly have their origin between the
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2.13 SPINAL ELECTRODE POSITIONS
Several electrode types and arrays were tried before adopting the
steel wires placed into the posterior spinal arch as pairs in adjacent
interspinous spaces. Examples of the SEP obtained from this bipolar
configuration are given in Figures 7 and 8. The recordings around the
relevant root entry zones were dominated by the large negative and late
slow positive intermediary potentials. As the recording site moved
rostrally these faded to leave the axonal volleys or travelling waves
which gradually lost amplitude and increased in latency.
Replacing the indifferent electrodes with a common reference removed
much of the fine detail in the polyphasic waveform but greatly increased
the amplitude of some of the remaining waves. Increasing the distance
between the monopolar electrode and the reference electrode, increased
the noise and made recording susceptible to ECG breakthrough which would
have necessitated tying the stimulus to a silent point in the ECG cycle.
Electrodes placed in the posterior spinous processes produced SEPs
of smaller amplitude. The amplitude was related to distance from the
cord. When studying left and right peroneal nerve inputs there was
an impression that electrode placement away from the mid-line could
be detected by the difference in SEP amplitude from the two inputs.
2.14 MOVEMENT AND NEURO-MUSCULAR BLOCKADE
Rigid fixing of a stimulated limb caused no alteration in CEP
or SEP records. However, in three dogs in which pancuronium bromide
(dose 0.1 to 0.3 mg kg was used to remove an outbreak of noise in
the thoracic electrodes, changes were seen in SEP but not in CEP. When
the initial effect wore off, the SEPs returned to their original form
and reverted again with a later repeated dose. The change seen in the
median-cervical SEP was a reduction of the late slow positive SEP.
There were also changes in form of the antidromic SEPs.
2.13 EFFECT OF TIME
A remaining question involved the stability of the preparation
with regard to time. Six dogs were prepared for the full range of EP
Pi
Figure 6. Cortical evoked potentials with far field potentials.
Simultaneous ipsilateral and contralateral records from
the same stimulus are shown. The far field potentials









bipolar SEPs are shown
from unilateral peroneal
nerve stimulation at the
neck of the fibula.
Observe the large negative
and late, slow positive
waves that dominate the
root entry zones. Latency
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Figure 8- Median nerve
-spinal cord evoked
potentials. Sequent¬
ial bipolar SEPS are
shown for unilateral
median nerve stimula¬
tion at the distal
end of the humerus.
The SEPs show classical
cord dorsum recordings
for a root entry-zone
evoked potential.
-is
recording. Recording was carried out over 5 hr. No change in latency
was seen. The amplitude results are given in Table 6. The overall
trend was one of a progressive fall in mean amplitude of between 1 and
2% hr * and an increase in variance with time.
TABLE 6
EFFECT OF TIME ON EVOKED POTENTIALS
(Expressed as a percentage of control)
(N = 6 2-6 measurements per dog per period)
Range of












































































































































In two dogs, temperature was altered above and below the normal
mean of 38°C by 2°C without apparent effect upon evoked potentials.
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THE EFFECTS OF GAS PRESSURE ON EVOKED POTENTIALS
3.1 PREAMBLE
Visual and auditory evoked responses (VER, AER) have been widely
used as measures of inert gas narcosis (Fowler andAckles, 1977).
Somatosensory cortical evoked potentials have been applied in this condition
less commonly (Langley, 1976; Langley and Hamilton, 1975). Whether
or not evoked potentials provide a true measure of narcosis continues
to be debated because they do not necessarily correlate well with
independent measures of cortical performance (Fowler and Ackles, 1977).
The effect of narcosis is thought to be one of interference with synaptic
transmission primarily in the brain (Bartus and Kinney, 1975, Bennett,
1966). It is interesting, however, that although in any given group
the overall effect on evoked responses is one of depression, the range
of effect can often be very wide, even showing a slight increase above
baseline values at pressures of up to 11 bar in some individuals (Bartus
and Kinney, 1975). The narcotic effect has also been attributed to
oxygen as well as to nitrogen (Bennettet al., 1969; Hesser, 1963).
As the objective of this project was to study the treatment of
DCS at pressure and there was a parallel study into the treatment of
arterial gas embolism, it was considered to be essential to know the
full range of possible effects of the expected hyperbaric conditions
upon the variables to be measured. Most of the observations reported
were made during the preparatory phases of DCS experiments but a small
number were made during specifically dedicated experiments.
The questions asked were:
a) How much of a depressing effect did various pressures of air
have on measurements made at pressure?
b) Is there an equilibration time for the expected changes in
EPs following a step change in pressure?
c) Does hyperbaric oxygen have any effect upon Elfe ?
d) Does prolonged exposure to high pressure air or oxygen have
any progressive effect?
e) For comparative purposes how do 20% oxygen-helium mixed affect
EPs over the same pressure range as air?
f) Are SEPs and CEPs equally affected or are any components more
affected than others?
3.2 METHOD
The results from 61 dogs weighing between 9 and 21 kg were used
in this study. The dogs were prepared in the standard fashion, previously
described. The primary measurements were peak-to-peak amplitudes of
P^Nj and N^P^ in the CEPs, and of in the SEPs. The last 16 studies
were also assessed using the peak-to-peak summation method adopted
in the final experiments.
When the animal was placed in the compression chamber, and was
stable within the desired range of physiological measurements, between
four and six sets of control evoked potentials were obtained for each
stimulus site. The chamber was then closed and with the appropriate
breathing gas on line to the ventilator, compression with air at a rate
of 75 ft. min * was begun. The ventilator exhaust was connected to
a 100 litre Douglas bag. This was vented outside the chamber to remove
oxygen and so reduce the fire hazard. Modifications to the ventilator
allowed control of cycle rate and inspiratory flow rate from outside
the chamber so that F CO was maintained at 3.5 - 4.5% surface equivalent
ET
as measured by a Beckman LB2 C02 analyser. The animals were subjected to
the dive profiles shown in Table 7.
About 2 minutes after each pressure change, EP recording was begun.
All records weremade in pairs. Results are expressed as a percent of
mean control EP amplitude values for each dog. One way analysis of
variance was performed where a significant difference between groups
was sought.
3.3 RESULTS
Examples of actual recordings taken from one dog are shown in
Figure 9 where the effect of breathing air at 300 ft (10 bar) may be
seen. All animals were maintained within the normal range for rectal
temperature, acid-base state and blood gases.
The results from each profile were first studied separately.
TABLE7
DIVEESCRIPTIONSFORNARC SISTUDY
PROFILENDIVEPROFILE(fswGAS)xmin.) 11160(02)xl0;165(A)xl0;23 )xA527230(A)xA5 317300(A)xl5 A360(02)xl0;165(A)x10;6 (02)x10;O( A ;165(A)x10;6 (02)x125360(A)xl0;60 02) 120;165(A)x10;0(A)xAO;60(A)x10;165( )x10;60(0 )x1 .6360(A)xl0;165(A)x2060(A)xl .7960(02)x20;165(A)x2060(02)x .88165(A)x20;0(02)x20. 93230(He)xl0;0(He)xl0;165(He)xl0;0 l0;60(02)xl0.10260(He)xl0;165(He)xl0;230(He)xl0;0( )xl .1160(A)x300 Allprofi esprecededby60-100min.ontrolperiod.Profi eoll w dprofile5,andprofile6followedprofile9inthesamed gswith60insurfaceinterval.Timesarapproximate.Breathinggaseswere(02)-100%;(A-ir(He)-20 /80%.TotalN=61.Inprofi es7andnlyMedianCEPw srecorded.
X>
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This revealed that regardless of profile, the effect of any given
condition with the same breathing gas, was the same. Therefore, the
results from all profiles using the same gas were pooled. At no time
was any effect on latency seen which could be attributed to gas, pressure
or time. The data used in the air and oxygen study were drawn from
the first 20 minutes of any given exposure.
While breathing oxygen at 60 ft (2.8 bar) there was a marginal
but insignificant depression of P^N^ in peroneal and median CEP, which
tended to be restored on returning to air breathing at the surface.
The effects of the various pressures on CEP and SEP in air breathing
dogs are shown in Table 8 and Figures 10 and 11. There was a significant
depression of both P^N^ and in CEPs proportional to pressure up to 230
ft (8 bar). It appeared that by 300 ft (10 bar) after a linear response
to pressure, there was at least a levelling off of the effect if not
an actual reversal. When breathing 20% oxyhelium instead of air no
effect of pressure was seen (Table 9). In those profiles (4, 5, 7 and
8 in Table 7) where dogs were returned to surface free from risk of
decompression sickness CEPs returned towards control values upon surfacing.
No significant depression of P-^N^ waa seen in the SEPs. The SEPs
measured in air and oxyhelium were almost the same (Table 8, Figure
11, and Table 9). However, the amplitude of the cervical SEP late P
wave was significantly reduced while breathing air, although to a lesser
extent than were the CEP's (Table 8, and Figure 11).
The effects of continuous exposure to pressure for up to 2 h are
shown in Table 10. Neither with continuous oxygen at 60 ft (2.8 bar)
nor air at 165 ft (8 bar) was there any evidence of an accelerated
deterioration beyond that due to time alone as seen at atmospheric pressure.
The actual changes seen were comparable with acute changes shown in
the pooled data presented in Table 8. On return from 2 h of oxygen
breathing at 60 ft (2.8 bar) to air breathing at atmospheric pressure,
there was no change in CEP amplitude so that the final level was comparable
with what time alone might produce (Table 6).
Figure9.Theffectsofnarcosisnpero ealdmedianCEPS so ed g.Stimulationat 100V,mAat2.5Hz(n=128).Thefirstecordofachpairw stcontrolre o d andthesecondwast300ft(1bar).
amplitude peroneal cep peroneal cep peroneal-lumbar sep
as percent 140 p.n, n.ft p.n.
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Figure 10. Effect of air pressure on peroneal and median CEPs and
SEPs. The shaded area represents the range of results.
The level of significance of the difference between
groups by ANOVAR is given on each graph.
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DEPTH • FEET OF SEAWATER
Figure 11. Effect of air pressure on
cervical SEP. The shaded
results.
late positive wave of median-
area indicates the range of
TABLE 8
EFFECT OF PRESSURE ON EVOKED POTENTIALS WHILE BREATHING AIR OR OXYGEN.
































































































































































Percent of mean surface control ± SEM. The pooled results from dive profile
1-6 but excluding the last 80 min of the 120 min studies at 60 ft (02) and
165 ft (A). Control data has ^ 5 replicates per dog and all other entries
{ 2 replicates.
An attempt was made to detect an effect of inert gas wash-in from the
data given in Table 11. Routinely after every step change in pressure, two
peroneal CEPs were recorded followed by two median CEPs. If the exposure
was longer than 15 min the cycle was repeated. Table 11 contains the
results from all three gases at all pressures tested. Firstly, the
direction of change between the first and second recordings (peroneal) and
third and fourth recordings (median) was tested by chi-square. There
were significantly more reductions from first to second recordings than
from third to fourth recordings (P < 0.01). This effect was apparent
over approximately the first 6 min after a step change of pressure while
breathing air. It was not apparent when breathing oxygen or oxy-helium.
There appeared to be a further reduction between the second and
third recordings although its significance was not tested because this
would have entailed crossing between peroneal and median recordings.
This suggests an asymptote for narcotic effect at about 10 min.
TABLE 9
EFFECT OF PRESSURE ON EVOKED POTENTIALS WHILE BREATHING 20% OXYGEN IN
HELIUM
Depth (fsw) Surface 60 165 230 300
Peroneal P N x 100.0 104.6 101.8 98.5 96.7
CEP SE 3.0 6.1 5.1 5.0 3.8
Peroneal N P x 100.0 104.0 102.7 101.3 97.5
CEP SE 3.0 3.4 5.3 5.9 3.9
Lumbar x 100.0 95.7 94.6 96.0 95.0
SEP SE 1.4 1.3 2.6 1.5 1.6
Median FN x 100.0 96.3 95.7 93.4 98.0
CEP SE 2.1 3.5 4.3 3.5 5.0
Median N P x 100.0 98.5 98.7 98.6 99.1
CEP SE 2.9 4.1 7.2 4.3 4.8
Cervical P N x 100.0 97.2 96.3 98.1 96.0
SEP SE 0.3 2.2 2.3 1.8 1.9
Cervical Late P x 100.0 97.2 96.3 98.1 96.0
SEP SE 0.3 2.2 2.3 1.8 1.8
Percent of mean surface control ± SEM N = 5. Control data has four
replicates per dog and other entries, two replicates.
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In the 230 ft (8 bar)air breathing group, which followed the trend
already outlined, it is noteworthy that the next pair of peroneal
recordings (No. 3 and 6) were the same (70.8%) as the preceding median
recordings (70.5%) and also the final pair of medians (No. 7 and 8)
(69.6%), indicating a plateau.
TABLE 10
THE EFFECT OF TWO HOURS EXPOSURE TO 2.8 BAR OF OXYGEN AND & BAR OF


































































































Results expressed as a percent of surface control values ± SD.
In a group in which only median CEPs were measured the same observations
were made. There was no consistent change seen with oxygen at 60 ft
(2.8 bar). Mean values for four consecutive measurements (n = 17)
were 96.8 ± 4.1, 96.2 ± 4.6, 89.9 ± 4.6, and 94.7 ± 5.6. With air
breathing at 165 ft (6 bar) there was again a significant difference
for the direction of change by chi-square (P < 0.001) between the first
and second pairs of recordings. This was also evident by paired "t"
test (P < 0.01). The mean values for the four consecutive measurements
(n = 17) were 86.5 ± 3.4, 79.5 ± 3.4, 77.3 ± 4.6, and 78.1 ± 4.5.
Evidence for wash-out was sought in the dogs which went from 165 ft
(6 bar) on air to 60 ft (2.8 bar) on oxygen (profiles 4, 5, 7 and 8
in Table 7). There was an insignificant increase in the group means
between first and second recordings of from 1 to 3% following arrival
at 60 ft (2.8 bar).
TABLE 11


















































































A +0.4 -0.9 -0.5 +2.2 +0.5 -2.9 -1.0 +2.0 -1.4
Results expressed as percent of mean control value ± SEM. The first
pair of CEPs (Peroneal) v/ere recorded between 1 and 6 min after arrival
at the stated pressure. The second pair ofCEPs (Median) were recorded
between 6 and 12 min after arrival at the stated pressure. The mean
values at 230 ft (Air) for a second pair of peroneal CEPs taken at
20 - 30 min were 70.7 ± 3.29 and 71.0 ± 3.50.
In assessing SEP, the study began by using the first of the travel¬
ling waves, • Later a summation of amplitude was used. P^^
and the summed amplitude ( S amp) were compared in 48 sets of SEP
measurements from the 16 dogs entered into the new system. A linear
correlation was performed on the data plotting 2 amp against P^N-^ •
This produced the relationship Samp = 22.12 ± 0.733 (P^N^) with
r2 = 0.6686. At about 79% the 2 amp and P-^N^ regressi°n lines crossed.
The two variables were not significantly different by paired "t" test
(t = 2.00 with 47 df).
3.4 DISCUSSION
Two facts emerge from the literature regarding evoked potential
measurement at pressure. One is that experimental numbers are commonly
very small and the other is that reported results are widely divergent
even within the same experimental group. Only one group has reported
5*
the use of somatosensory cortical evoked potentials in studies of the
effects of nitrogen. They reported the effects to be similar to those
on other EPs (Langley, 1976; Langley and Hamilton, 1975). All other
groups have relied on auditory or visual evoked potentials. Another
variable involves the subjects, which have included man, awake animals
and anaesthetised animals. Breathing gases from masks in contrast
to ventilation through an endotracheal tube, is also a potential
source of variability. The surrounding gas can leak through poor seals;
a problem well recognised in older mask designs. Masks are also prone
to cause some C02 build-up because of the increased dead space, a factor
known to exacerbate narcosis (Bennett, 1976). Clearly, breathing
chamber atmosphere or gas supplied through a cuffed endotracheal tube
are the only reliable ways of supplying a precisely known breathing
gas. Any circumstances where an animal breathes one gas while surrounded
by another will result in some cutaneous transfer, although the effect
will undoubtedly be trivial.
In both the median and peroneal CEP results, an approach to an
asymptote is suggested between 230 and 300 ft while air breathing.
Bennettet al. (1969) saw a similar effect but regarded it as experi¬
mental variation. Kinney et al. (1977) refer to an asymptote for
nitrogen in the region of 300 to 400 ft. There are no clear reasons
why this should occur. The possibility of a saturation of the effect
of nitrogen seems unlikely at this pressure as behavioural changes
continue to increase at greater pressures. If it were not that oxygen
is also alleged to be narcotic and should therefore have a synergistic
effect (Bennettet al., 1969; Hesser, 1963), the possibility of a
stimulating effect from the oxygen with a partial pressure approaching
2 bar might be considered as having some reversal effect on the EP
suppression by nitrogen. However, the short time scale excludes a
mechanism associated with classical acute cerebral oxygen toxicity.
The range of individual responses seen in these data was similar
to that reported by Bartus et al. (1975) where even at a pressure of
about 11 bar some records were greater than controls. The degree of
mean suppression of groups was also widely variable. Air breathing
at 200 to 300 ft has produced EP suppressions ranging from levels similar
5 5
to these (Ackles and Fowler, 1971) to twice as great as these (Bennett
et al . , 1969; Schatte and Bennett, 1973). It can be confirmed that
the effect of air at pressure on somatosensory CEP is similar to that
on auditory and visual CEP. The only report of a latency shift by
Kinney et al (1974) is at odds with these findings and those of Ackles
and Fowler, (1971), Bennettet al. (1969), and Hesser (1963).
The reported work on EPs while breathing oxyhelium in the pressure
range of interest here has largely been done with awake men and animals
(Bennett et al., 1969; Schatte and Bennett, 1973). They report a
depression of about 30% in AER at 300 ft and about 20% at 200 ft where
no apparent change was seen here. It may be that the anaesthesia in
these animals has already caused that amount of suppression. Certainly
if one deducts 30% from those results and also the air results reported
by the same authors then the findings are the same. This might suggest
a synergistic effect of narcosis with pentobarbital. It may also be
that the many extraneous effects of compression of which the conscious
man/animal is aware could also have an adverse influence upon EP measure¬
ment .
Bennett (1963) reported a reduction in cat spinal reflex activity
during air breathing at pressures of 7 to 9 bar. He likened the effect
to the asphyxia effects on the segmental SEPs recorded from the cord
dorsum described by Gelfan and Tarlov, (1955). Looking at the initial
travelling wave as opposed to the static wave of the root entry in
the SEPs and also the summed amplitude of the principal early waves,
showed a slight downward trend in amplitude which was not significant.
However, the late slow P wave in the median - cervical SEP showed
a significant change inversely related to air pressure. The depression
was considerably less than that seen in the CEP at the same pressures,
this wave may be related to interneuronal activity and possibly to
local reflexes (Gelfan and Tarlov, 1955). These findings would there¬
fore tend to corroborate those of Bennett(1963). The relationship
between the three types of EPs; SEP long tract travelling waves (mostly
non-synaptic), SEP late P waves (interneuronal local events), and CEP
(multiple synaptic transmission) and the relative effects of narcosis,
lend support to the idea that the inert gas effect is the result of
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interference with synaptic transmission (Bennett, 1966). The effect
is evidently mostly in the brain as suggested by Bartus and Kinney
(1975) where the density of synapses is greater.
The literature appears to contain no references to the ability
to detect the effect of inert gas wash-in upon the EPs. The appearance
of a plateau by about 8 to 10 min is compatible with opinion regarding
the time for inert gas exchange in the brain (Jones, 1951; Weathersby
et al., 1981). With much smaller pressure changes in the decompression
phase a similar but insignificant reverse trend was observed.
After reaching equilibrium following a step pressure change, there
was no indication that the additional pressure caused an acceleration
of the small deterioration expected as a result of time alone.
Although Bennett et al. (1969) and Hesser (1963) have stated that
oxygen has a narcotic effect comparable with that of nitrogen this
was not confirmed. A slight reversible effect was seen in the 10 min
exposures, but was not seen in the 20 and 120 min exposures. Ray and
Hawgood (1977) also failed to find the effect, although the late effects
of acute toxicity caused a progressive loss of EP amplitude after between
60 and 100 min breathing 5.76 bar of oxygen. Their animals like these
were anaesthetised. The possibility of the surrounding influences
contributing to the effect in alert men or animals must again be considered
as an alternative to an effect attributable to the gases breathed.
For this reason in the clinical area, efforts are made to remove all
extraneous influences when measuring CEPs (Cracco, 1972; Goff et al,
1962). In compression experiments this is well nigh impossible.
The discrepancy between the observations of no significant change
in EP while breathing oxygen or oxyhelium at pressure, and the observa¬
tions of Bennett et al. (1969) that a decrement occurs, although without
any observable loss of performance, clearly supports Fowler and Ackles'
(1977) doubts concerning EPs as measures of narcosis. This study allowed
the calculation of a correction factor for CEPs measured at pressure
particularly inother studies. This was not necessary for the SEPs.
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SECTION A




HOW DO SPINAL CORD EVOKED POTENTIALS CHANGE?
4.1 ASPHYXIA
There was 110 local experience of how SEPs might change with DCS
or with the systemic changes that occur with DCS. During the develop¬
ment of the method some guidelines were required to prepare the author
for what changes might be seen. At the end of some control studies
continuous peroneal SEP recordings were made after death. In others
the anaesthesia was maintained after the ventilator was disconnected
and the endotracheal tube occluded. Figure 12 shows the sequence of
changes in two dogs correlated with mean blood pressure.
The first major point is that latency is not noticeably affected
until amplitude is much reduced. Secondly, in a generalised hypoxaemia,
the later slower waves are reduced first. Dog No. 916 showed an
occasionally observed phenomena when the timing of recording was right.
There may be a generalised increase in amplitude before the reduction
begins.
4.2 BLOOD PRESSURE
In a separate study into developing a means of monitoring spinal
cord function during paediatric spinal cord surgery, which would avoid
the need to wake children in mid operation, the effect of lowered blood
pressure was studied in several dogs. Some examples of the changes
in SEP correlated with mean blood pressure are shown in Figures 13,
14 and 15. There was an infinitely variable response to hypotension
with a significant loss of amplitude when mean blood pressure fell
into the range below 60 to 30 mm Hg. This being the range below which
cord blood flow autoregulation fails (Sandler and Tator, 1976). There
was again a tendency for the later travelling waves to lose amplitude
first. Dog No. 922 (Fig. 13) in the left median SEP shows the relative
sensitivity of the local functions with most of the amplitude loss
occurring in the late slow positive wave.
The last SEP in Dog No. 923 (Figure 14) shows how subsidiary waves




A series of partial cordotomies confirmed that most of the SEPs
recorded by this method were transmitted through the dorsal columns.
However there were contributions from the ventral and lateral columns.
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Figure 12. The sequence of SEP changes in asphyxia. Mean arterial
blood pressure and summated SEP amplitude as a percentage















13. Changes in SEPs related to blood pressure. Dog. No. 922.
Mean blood pressure, experiment time and summated amplitude






























Figure 14. Changes in SEPs related to blood pressure. Dog. No. 923.
67

















Changes in SEPs related to blood pressure. Dog No. 925.
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SECTION 5





THE DEVELOPMENT OF THE ELECTROPHYSIOLOGICAL MODEL AND THE DIVE
5.1 PREAMBLE
The objective of this phase was to develop a reliable means of
remotely monitoring anaesthetised dogs for signs of spinal cord DCS.
The means of monitoring had to be quantifiable to enable statistical
analysis to be made of the severity of, and recovery from DCS. The
ability to at least roughly localise the sites of lesions was also
sought.
Decompression sickness is a notoriously unpredictable and difficult
disease to develop and control. This meant that any dive used to
produce the desired spinal cord lesions would have a fairly high
attrition rate. As the objective was to study delayed treatment a
further complication was added to the model.
There were several dog models of DCS, some of which were known
to produce spinal cord problems (Behnke and Shaw, 1937; Mclver and
Leverett, 1964; Wells et al., 1971). A modified version of that
described by Bove et al. (1974) was selected for use.
There were,however, certain constraintswhich had to be imposed
on the model. The model had to be capable of surviving without
chemotherapy on the surface for long enough to allow the cord lesion,
once diagnosed, to consolidate and thus assume the characteristics
of the delayed treatment case. Furthermore, as perfusion pressure in
the neuraxis could reasonably be assumed to be relevant in treatment,
severe hypotension had to be avoided. It is well recognised that fluid
loss from the vascular space can be a major problem (Arturson and Grotte,
1971; Bove et al., 1974; Cockett et al., 1965), and liberal fluid
administration is generally recommended in decompression sickness treat¬
ment (Davis, 1979). Therefore, hypotension and haemoconcentration
could reasonably be corrected by infusion of Ringers Lactate. This
and correction of acidosis were the only additional therapies permitted.
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5.2 METHOD
Dogs weighing between 6 and 22 kg were prepared in the prescribed
fashion as required. Full control data wereacquired before the start
of the dive.
All initial dives were carried out breathing air with a compression
rate of 75 ft min Bottom times refer to time spent at maximum
pressure. Decompression was at 60 ft min * to 60 ft and slower from
there to the surface. If a first dive failed to produce DCS within
30 - AO min, animals were redived but for a shorter period. The Bove
et al. (197A) model required a "controlling recompression" after the
first signs of cardiopulmonary involvement to prevent complete cardio¬
vascular collapse. This return to 70 ft stabilized the condition and
was followed by a long decompression to prevent recurrence of cardio¬
pulmonary collapse.
The development is reported in four parts. The early dives were
to 230 ft (8 bar) and initially only CEPs were monitored. Once measure¬
ment of SEPs became reliable, the 230 ft dive and subsequent manipula¬
tions were modified in an effort to produce a treatable model of
decompression sickness. The second phase ended with similar dives
to 230 ft but without having producedaphysiologically stable animal
model of cord DCS. The third phase will only be mentioned in the
discussion and entailed searching for a way to produce cord DCS in
an only moderately sick animal. The final phase covered the exploration
of a short dive to 300 ft (10 bar) which produced the required model
of cord DCS.
Initially the dives and acquisition of EPs were developed in parallel.
The first major change in design resulted from the observation of a
high incidence of cerebral DCS as indicated by a loss of EEG amplitude.
This unexpected event removed the ability to monitor cord function
via the cortex, and forced the development of a technique for directly
measuring cord function using SEPs. Cortical evoked potentials continued
to be measured because the far field potentials provided some indications
of upper cord and brain stem involvement.
5.3 RESULTS
The initial phase began with dives as long as 61 min at 230 ft
(8 bar). Dives were shortened by amounts related to three groups of
body weight. The following bottom times produced DCS: < 10.0 kg,
50 - 61 min; 10.0 - 13.0 kg, 39 - 59 min; > 13.0 kg, 37 - 60 min.
In the larger group of 10.0 - 13.0 kg weight, there was a tendency
for onset time to be inversely related to bottom time. For dives of
51 min. and longer, mean onset time was 3.0 min (n = 4) and for shorter
dives mean onset time was 7.3 min (n = 7). In this first group of
17 dogs the onset of DCS took various forms, some of which occurred
simultaneously (form of DCS - No. of dogs): elevation of RVP and
CSFP - 7; loss of EEG amplitude - 9; elevation of CSFP and depression of
EEC - 3; loss of EEG only - 3; elevation of CSFP only - 2; loss of
CEP only - 1; hypotension (systolic AoP < 100 mm Hg) - 2; hypertension - 1.
Loss of EEG amplitude invariably reduced CEP. These dives resulted
in 15 controlling dives to stabilise the animal. Decompression from
70 ft lasting 18 to 41 min only reached the surface occasionally and
the majority were held at pressures between 10 and 30 ft to arrest
the development of hypotension.
The second group of animals dived to 230 ft (8 bar) were observed
specifically for cord DCS using SEPs. The dive details are shown in
Table 12. The 10.1 - 13.0 kg group had similar onset times to the
first group with 3 min for dives > 51 min and 9 min for shorter dives.
Experience with severity and controlling dives was the same.
The inability to return to the surface within a short time demon¬
strated a wide variation in the severity of the systemic DCS, so a
dive profile producing less variance in severity of DCS was sought.
TABLE 12
FORM AND OUTCOME OF FIRST DIVES TO 230 FSW (8 bar)
Wt group x bottom time (range) Ascent Rate Controlling Cord
(kg) n to give DCS (min) ft min~l Dives DCS DCS
<10 3 61.0 (57-65) 51 222
10.1-13 5 50.6 (47-55) 60 414
>13 8 46.9 (37-50) 56 556
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TABLE 13
FORM AND OUTCOME OF FIRST DIVES TO 300 FSW (10 bar)
Time group x weight Ascent Rate Controlling Cord
(min) n (kg) ft min Dives DCS DCS
6 5 10.8 55 2 3 4
10 - 15 8 13.0 57 2 5 6
> 17 2 14.3 57 0 0 2
The final model was a short air dive to 300 ft (Table 13). The
derivation of this is described in the discussion. The first dives
were for 6 min but bottom times up to 22 min were expbred. Bottom
times of between 10 and 15 min for dogs of all weights, resulted
in more moderate DCS which allowed the dogs to be kept on the surface
for a period preceding the start of treatment. Twelve out of 15 dogs
developed DCS and eight of these went on to develop cord DCS after
one dive. Three out of four dogs redived for shorter times developed
cord DCS. Only four dogs were given controlling dives with decompressions
of 10 min or less. They were all successfully returned to atmospheric
pressure before treatment. Only one of these was recompressed because
of major cardiovascular pressure changes. The remainder were recompressed
to stop ECG abnormalities (2) and to stop a precipitous reduction in
EEG amplitude (1).
The nature and timing of the onset of DCS from the two dives was
remarkably similar (Table 14). However, the degree of severity was
markedly different because, unlike the 300 ft (10 bar) dives, most
of the 230 ft (8 bar) dives resulted in a controlling recompression
to halt the development of the disease process. This frequently resulted
in the dogs being held at pressure to prevent further deterioration.
Notable differences in the results of the two dives are that the
300 ft (10 bar) dives, even without a controlling recompression, did
not usually cause uncontrollable hypotension (systolic AoP < 100 mg Hg)
and the degree of EEG amplitude loss was very much less. There was
a similar incidence of cord DCS from both dives.
The principal feature of the onset of DCS following both dives
TABLE14
THEOCCURRENCEANDO S TTIM SFANG SIME SUREPARAME ERS 230ft300ft 12/12(+3redived)12/15(+redived)
































































































































(1)AoPtwhenitoccurssalwayassociatedwithfRVPandCSFP (2)CSFPfsometimespreced sRVPtbutCSFPialwaystRVs (3)EEG4,in300ftdiveswamuchlesseveret an230ftdi s Onecaseofhok sie chgroup.W ntdenominatoril t anf rhegroup,ti di tes thaterelevantdatw reonlyavailab efthenum rshown,t snumb sr p es ntwhare consideredtbmajorantheref epathologicalchan es.
was a loss of EEG amplitude and a rise in CSFP in at least 75% of cases.
A rise in RVP was often seen a little later in about half of the cases.
A rise in RVP resulted in a simultaneous rise in CSFP. When aortic
pressure increased significantly RVP was usually already elevated.
Such an increase in AoP was never sustained and the subsequent fall
sometimes dropped systolic AoP below 100 mm Hg. The elevation of RVP
and CSFP generally fell towards pre-onset levels within 20 min of their
peak. Of all dogs with indications of DCS those with cord DCS were
indistinguishable from those without. Two dogs had a rise in CSFP
without changes in SEP becoming evident. Occasional ECG changes were
seen. These included arrhythmias, conduction defects, and signs of
myocardial ischaemia. Repeat dives of shorter duration than first
dives generally resulted in earlier changes of greater severity but
were no guarantee of cord DCS. The extent of physiological changes
is shown in Table 15. In thosecases were arterial blood could be taken
during DCS, evidence of hypoxaemia, hypercapnic acidosis and plasma
loss (packed cell volume increased by up to 12%) were seen. It became
routine to correct an assumed plasma volume loss of 8% with Ringers
Lactate.
Two examples of the diagnosis of spinal cord DCS using evoked
potentials are shown in Figure 16. Initial changes were commonly
amplitude losses in the late small waves. This progressed to affect
the earlier large waves and could reach the stage of reducing the SEP
to an isoelectric voltage. Sometimes there was a generalised attenuation
affecting all the travelling waves in the affected cord region. With
few exceptions, changes in SEP amplitude were detected by eye well
before they reached a decrement in cumulative amplitude of 10 percent.
The anatomic distribution of the cord lesions was the same in
both groups and overall 16 lumbar cord lesions and sevei cervical
cord lesions were identified.
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TABLE 15
CONTROL DATA AND MAXIMUM DEVIATIONS FROM CONTROL VALUES
DURING THE PRETREATMENT PHASE OF DECOMPRESSION SICKNESS
RESULTING FROM SINGLE DIVES TO THE DEPTHS SHOWN
DIVE DEPTH 230 fsw 300 fsw
CONTROL x ± SD (Systolic/Diastolic)
AoP mm Hg 136 ± 12/110 ± 10 136 ± 22/106 ± 16
RVP mm Hg 25 ± 8/ 0 ± 1 16 ± 6/ 0 ± 1
CSFP mm He 7±3/6±3 5 ± 4/ 3 ± 3
HR min"^ 128 ± 27 118 ± 17
MAXIMUM CHANGE x t SD (range) n
AoP T Systolic 52 + 44 (10 - 110)4 60 + 39 (15 - 95)4
Diastolic 41 + 29 ( 5 - 70)4 31 + 23 ( o - 55)4
AoP i, Systolic 24 + 12 (10 - 50)8 27 + 14 (14 - 45)8
Diastolic 18 + 16 ( 0 - 25)8 24 + 7 (15 - 35)8
RVP t Systolic 16 + 9 ( 6 - 28)4 15 + 7 ( 8 - 25)4
Diastolic 6 + 7 ( 0 - 13)4 5 + 10 (-1 - 20)4
CSFP t 19 + 12 ( 4 - 36)9 12 + 9 ( 5 - 37)10
HR t 15 + 9 ( 6 - 30)6 20 + 10 ( 8 - 32)5
HR I 22 + 12 (15 - 36)3 11 + 5( 8 - 15)2
The data are drawn only from those dogs in which the parameter changed
beyond normal variation.
5. 4 DISCUSSION
There are other dive profiles which have been shown to cause DCS
in dogs. The original discovery of the double dive method, where the
cardiopulmonary DCS caused by the first dive (146 ft (5.4 bar) for
105 min with decompression in 6 s) was treated by a second shallower
dive and commonly resulted in cord DCS, was made by Behnke et al.
(1937). This also entailed a long decompression. Mclver and Leverett
(1964) and Cockett et al. (1967) used a 165 ft (6 bar) dive for 60
min with decompression at 16 ft min This produced classical cardio¬
pulmonary DCS which could be controlled by recompression to 66 ft
(3 bar) (Mclver and Leverett. 1964) and had a high mortality rate
with brain and cord pathology if untreated (Cockett et al., 1967).
























Figure 16. Spinal evoked potentials in decompression sickness.
Three examples of SEP changes at the stages shown.
A and B are from the same dog, which had been dived to
300 ft. Sample C came from a 300 ft-dive dog.
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The same or longer dives with decompression of 2.25 to 5.25 min resulted
in paralysis and shock. There was one instance of probable cerebral
DCS and all animals had to be sacrificed inside 10 to 15 min
(Wolkiewlez et al., 1979). A 50 min oxy-nitrogen dive with an equivalent
air depth of 240 ft (8.3 bar) ending in a decompression lasting
10 min, resulted in death in 10/18 dogs within minutes of surfacing
(Wells et al. 1971). Arturson and Grotte (1971) lost 2/7 dogs after
60 min dives to 200 ft (7 bar) with a bleed decompression lasting
about 12 min. All of these dives created the conditions which might
lead to cord DCS, but all resulted in very severe systemic involvement
with a high risk of circulatory collapse.
Bove et al. (1974) reported a dog decompression sickness model
which entailed a 220 ft (7.7 bar) dive of 40 min. With the standard
compression and decompresssion rates, these dives commonly led to
severe cardiopulmonary embarrassment. This was usually associated
with signs of pulmonary vascular obstruction. Rapid recompression
to 70 ft allowed the condition to stabilise before a decompression
lasting up to 45 min returned the dogs to the surface. During this
phase cord DCS became evident. There were several variations on
the basic theme including longer dives, a 5 min stop at 40 ft, and
a slow decompression from there to the surface.
That dive schedule was modified by rounding it to 8 bar (230
ft), and refined by reducing the bottom time in inverse relation
to weight group, to a duration just exceeding that which would give
around a 90% chance of cord DCS within about 20 min of surfacing.
Almost every case produced by these dives required a controlling
dive to prevent cardiopulmonary collapse. Initially it was planned
to allow the cord DCS to consolidate for an hour before starting
treatment. However, experience showed that after 20 min from the
time of diagnosis very little SEP amplitude would be recovered.
Generally, it was not possible to return dogs to atmospheric pressure within
20 min of the onset which resulted in their being held at any pressure
between 2 and 40 ft. This indicated a wide range of severity, clearly
not a good position from which to try and compare the efficacy of
different treatments.
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An additional complication with this model was a very high incidence
of cerebral DCS as indicated by the loss of EEG. It seems unlikely
that the small difference between the 230 ft (8 bar) dive and that
reported by Hallenbeck et al. (1975) could account for the latter's
failure to observe cerebral DCS. The principal difference may have
been posture. Their animals were all lying down either prone or
on their sides while the dogs in this study were all prone but with
head held erect. The EEG loss was one of the earliest signs, often
preceding any indications of pulmonary vascular obstruction seen
as a rise in RVP. It often occurred without a significant rise in
CSFP which would indicate venous obstruction in the drainage from
the neuraxis. Two dogs were dived on their sides and while they
both developed DCS neither experienced a loss of EEG. This postural
difference in outcome suggests that bouyancy might be aiding the
distribution of arterial bubbles in a cerebral direction as in arterial
gas embolism. It appears therefore, that the most common first signs
of DCS in this model might result from arterial gas. This is not
to say that the gas did not originate in the venous return and pass
through the pulmonary vasculature. Sufficient!/ small bubbles may
well traverse the pulmonary filter (Butler and Hills, 1979). Extravascular
bubble formation is also a possibility.
While there was the possibility of avoiding EEG loss by a change
in posture, the practical problems such a change created in securing
of the cord electrodes, prevented that route being taken.
It was possible to produce changes in the SEPs by artificially
causing the epidural vertebral venous system (EVVS) to be obstructed
by bubbles. Taking an anaesthetised dog to 20 ft and inflating a
balloon in the inferior vena cava caused venous return to shunt through
the azygous system and the EVVS. Injecting 20 ml (at 1 bar) or air
into a femoral vein during the decompression and then deflating the
balloon caused some air to be trapped in the EVVS and shortly after
surfacing gave rise to SEP changes similar to those seen in DCS.
A similar effect was produced by retrograde injection of air into
the azygous vein during decompression. At autopsy there was air
in the EVVS and associated haemorrhage. The disadvantage of such a
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model, which was developed for other purposes, was that there was
no reservoir of inert gas in solution in the tissues.
In studies of the treatment of arterial gas embolism (AGE) it
had been observed that certain combinations of air pressure and time,
led to impairment of cord blood flow on decompression from dives
which would not normally be expected to cause cord DCS in dogs (Leitch
et al., 1984). This suggested that a small volume of gas, injected
into a femoral artery before a short deep dive might, by either seeding
or redistributing, lead to cord DCS without such severe systemic
disturbances as a longer dive would cause. It needed not less than
5 ml of air, given within 5 min of the start of a dive of 15 to 20
min at 230 ft, to cause changes after decompression. There were
few systemic disturbances and out of six dogs a loss of EEG was seen
in two, a severe loss of SEP in one and small changes in SEP in four.
The injection of air into the femoral artery before diving had two
possible routes to the neuraxis. On compression it would be cleared
through the limb into the venous drainage. Being bouyant some of
the bubbles could enter the venous anastomoses and reach the EVVS,
there to later expand and also take up dissolved gas on decompression.
Other bubbles would return to the heart and those not caught in the
lungs would then be free to enter the arterial distribution. At
this point, bubbles would be small enough to pass freely through
capillaries. It would therefore be possible for some to end up in
the relatively sluggish blood pools of the EVVS (Batson, 1940) only
to grow on decompression. This model was discarded because of its
unnatural origins and high rate of cerebral involvement.
The source of the problem of severe systemic involvement lay
in the volume of gas released into the circulation. Theoretically,
if the critical tissues could be saturated quickly, i.e. the neuraxis
and epidural fat, with sufficient gas to cause DCS, the tissues with
longer half times would contribute proportionately less gas on decom¬
pression. Thus, the systemic problem might diminish. Therefore
deeper and shorter dives were tried at a 300 ft (10 bar) dive and
a range of bottom times between 6 and 22 min was explored. There was
a high incidence of cord DCS but systemic disturbances were much
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less severe than with the 230 ft (8 bar) dives, as indicated by the
fact that all 300 ft dogs were returned to the surface and kept there
prior to treatment. The onset times and form of DCS were the same
as in the earlier dives, but a much more economical and controllable
model of cord DCS which was suitable for the comparison of treatments
was available. All subsequent work was done with dives of between
12 and 15 min duration. A dive to 300 ft, breathing air, with descent
time of 4 min and an ascent rate of 60 ft min * to 60 ft and 45 ft min ^
from 60 ft to the surface can be expected to have at least a 75%
success rate in producing cord DCS. A repeated dive of 9 + min generally
caused cord DCS in the remainder. Interestingly, comparing the human
decompression schedules for the two types of dives, shows that the
decompression time from a 230 ft (70 m) for 45 min dive is two to
three times that from a 300 ft (90 m) for 15 min dive (Royal Navy,
1972; US Navy, 1973). The 230 ft dives, because of their severity,
should perhaps be considered more akin to "blow-up", the uncontrolled
surfacing from a dive requiring decompression stops. This type of









PRELIMINARY STUDIES OF FACTORS IN TREATMENT
6.1 PREAMBLE
Prior to starting the main study the experimental scheme was
tested using for the most part two of the commonly used standard
treatments . The objective was to ensure that some recovery would
occur, and that it could be monitored through the SEPs. This led
to the establishment of an appropriate time interval between the
diagnosis of cord DCS and the start of treatment.
6.2 METHOD
Sixteen of the dogs previously described, which remained physio¬
logically stable and had unequivocal cord DCS (4 cervical and 15
lumbar lesions) according to the evoked potential (EP) observations,
were treated by recompression. Delays between the diagnosis of cord
DCS and treatment were not less than 9 min but could have been as
much as 25 min. The maximum time is uncertain because of varying
intervals between the last normal and first abnormal SEP.
The treatments used were thestandard options of 60 ft (2.8 bar)
with oxygen, or 165 ft (6 bar) with air, but 165 ft with 47% oxygen
(P02 2.8 bar) and 230 ft with air were also included. The appropriate
gases were supplied to the ventilator before recompression. The
earlier studies having shown that EPs were unaffected by continuous
exposure to 2.8 bar of oxygen in dogs without DCS, the treatments
using increased concentrations of oxygen were given without break
for two hours.
Compression rate to the treatment depth was between 60 and 80 ft
min The experiment was terminated after 120 min at the treatment
depth. Each experiment was based for time on the first cord lesion
diagnosed. Evoked potential recording was repeated continuously
until the start of compression. Each series of EPs was repeated twice
in the first 15 min atrpressure and thereafter at 15 min intervals for
each series observing a lesion, and at 30 min intervals in series
observing normal cord. For example, a lesion in the lumbar cord
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would be observed with the peroneal inputs every 15 min, while the
normal median-cervical cord would be checked at 30 min intervals
with the median input.
The last pretreatment observation was made close to the time
of leaving the surface for treatment. This result was converted
to express it as the percent lost of mean control SEP amplitude. If
there was a further reduction in SEP at the start of treatment this
SEP was used instead of the pretreatment SEP. Because the severity
of the lesions was both unpredictable and uncontrollable, it was
considered that some normalising procedure should be applied. This
was done by expressing all recovery as a percentage of what was lost.
This did not alter the trends observed when looking at straight
percentages of control but did reduce the variance of the groups.
This system was used for all subsequent experiments.
All results are expressed as the mean ± 1 standard deviation
and statistical analysis was by one way analysis of variance.
The method for producing global CNS ischaemia described by Hallenbeck
and Bradley (1977) was used to study the effects of acute cord ischaemia
and the restoration of blood flow on SEPs. The three dogs studied
were prepared as previously described. The ischaemia was caused
by raising the hydrostatic pressure of the CSF space by means of
a bottle of Elliotts solution B (Elliott and Jasper, 1949) suspended
at a variable height sufficient to exceed mean arterial BP. The
solution was heated to 38°C before reaching the adaptor attached
between the cisternal needle and the pressure transducer. The hyper¬
tensive Cushing response was blocked by phentolamine (10 mg i.v.)
and BP was controlled by the removal and return of blood. The CSFP
was raised for various periods between 13 and 20 min and then restored
to normal while SEP recovery was observed.
6.3 RESULTS
Of the 16 dogs used in this study, nine were exposed to 230
ft (8 bar) and seven to 300 ft (10 bar) dives; of these 4+3 respect¬
ively were treated with oxygen at 60 ft (2.8 bar) and 3+3 with
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air at 165 ft (6 bar). Two of the 230 ft dogs were treated with
air at 230 ft and the remaining 300 ft dog with 47% oxygen in nitrogen
at 165 ft. Three dogs from the 230 ft dives each had two distinct
sites of cord DCS which were observed separately. These dogs were
distributed one to each treatment.
Eight dogs from the 230 ft dives were held at pressures between
5 and 40 ft before treatment (mean pressure 25 ft). All other dogs
were held at surface pressure. There was a variable interval between
the last recorded normal SEP and the observation leading to recognition
of a lesion. This led to some uncertainty about the duration of
lesions before treatment. Possible ranges of duration began with
a known minimum and a possible maximum. They were 12.5 ± S.D. 5.8
to 18.7 ± 3.9 min for the 230 ft dogs and 15.0 ± 7.0 to 21.9 ± 7.4
min for the 300 ft dogs.
The principal physiological measurements are shown in Table
16. There was a tendency for mean BP and cerebral perfusion pressure
(CPP) to be higher in the 300 ft dogs than the 230 ft dogs. This
may reflect the different amounts of Ringers Lactate and bicarbonate
solutions given between the onset of DCS and the completion of treatment.
These were 287 ± 126 ml and 204 ± 61 ml respectively. In general,
right ventricular pressure (RVP) and CSFP were a little lower than
their early DCS peaks by the start of treatment and changed little
thereafter. No differences were observed between treatments or between
original dives. The previously mentioned ECG changes were generally
reversed by recompression butEEG never recovered.
Two examples of the response of lumbar SEPs to treatment with
oxygen at 60 ft are shown in Fig. 17. The causative dives were both
to 300 ft. Dog 103 required a controlling dive. By the start of
treatment they had lost 92% and 84% of their control amplitude,
respectively. Of this loss dog 102 progressively recovered 44% by
114 min of treatment. Dog 103 quickly recovered 48% by 16 min and
then steadily deteriorated until by 88 min the SEP was smaller than
the pretreatment level.
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The change in summed EP amplitude permitted before a diagnosis
was made, ranged from 0 to 16%. The mean change allowed to pass,
for the 230 ft dogs was 0.6 ± 1.6% and for the 300 ft dogs was A.8
± 7.2%.
TABLE 16
PHYSIOLOGICAL MEASUREMENTS BY CAUSATIVE DIVE AND TREATMENT
DIVE 230 ft 300 ft
Parameter BP ' RVP CSFP CPP BP RVP CSFP CPP
sy sy sy sy
R Phase
60 ft Pre R 104 28 15 89 114 27 16 99
±28 ±9 ±4 ±25 ± 4 ±15 ±3 ±7
02 5 80 26 15 65 105 28 23 85
±13 ±2 ±6 ±9 ± 3 ±29 ±2 ±42
60 83 13 14 68 108 22 17 90
±14 ±2 ±8 ±14 ±15 ±15 ±8 ±13
120 77 14 14 63 111 43 13 101
±17 ±1 ±10 ±18 ±17 ±24 ±8 ±14
165 ft Pre R 106 10 16 90 94 11 6 88
Air ± 5 ±0 ±3 ±6 ±14 ±2 ±2 ±16
5 89 11 17 73 107 36 17 89
±16 ±1 ±10 ±22 ± 9 ±14 ±7 ±9
60 90 10 15 74 113 19 22 88
± 3 ±2 ±11 ±12 ±18 ±12 ±13 ±43
120 86 14 15 71 109 23 21 88
± 8 ±5 ±9 ±14 ±34 ±10 ±9 ±43
Other* Pre R 89 25 11 78 70 8 8 62
±32 ±8 ±1 ±33 - - - -
5 90 30 30 59 128 14 17 Ill
±28 - ±22 ±50 - - - -
60 90 12 27 62 92 22 22 70
±42 - ±26 ±69 - - - -
120 70 12 25 46 95 20 18 77
±56 - ±12 ±66 - - - -
Mean ± 1 SD for mean arterial pressure: (BP) , systolic RVP , systolic CSFP
and cerebro-spinal perfusion pressure (CPP) . .Values given for the stated
times before and during treatment. * 'Other ' includes 2 dogs in the 230
ft group which were treated at 230 ft with air and 1 dog in the 300 ft
group which was trfeated with 47% 02 at 165 ft.
TABLE 17
SEP LOSS AND RECOVERY BY CAUSATIVE DIVE AND TREATMENT
DIVE (ft) 230 300 230 + 300
Treatment
and Phase
60 ft 02 Loss(n) 51.0116.7 (5) 77.1123.7 (3) 60.6122.A
B 15 min 18.A125.8 36.2117.0 25.1123.A
AO 3A.01A5.2 19.2122.0 28.A137.0
80 39.3139.A 25.1123.9 33.9133.3
120 25.313A.7 2A.0122.A 2A.8128.8
165 ft A Loss(n) 53.9112.9 (A) 77.6111.1 (3) 6A.1116.9
R 15 min OO.OiOO.O 39.1116.1 16.7122.9
AO 13.2121.1 30.Al19 • 7 20.6120.9
80 16.0120.8 30.7118.3 22.3119.7
120 18.6121.5 32.8113.2 2A.7118.6
Other Loss(n) 56.1121.9 (3) 68.7 - (1) 59.3118.9
R 15 min 28.A1A9.2 1A. 6 - 2A.91A0.7
AO 35.21AA.A 6.A - 28.0139.0
80 A5.7151.2 0 - 3A.21A7.6
120 A3.11A7.0 0 - 32.31AA.0
All Loss 53.2115.A 76.1115.3




Mean ± SD. Percent lost before treatment and percent of loss recovei
at the stated times during treatment.
The SEPs deteriorated between the last surface measurement and early
treatment in seven of the 230 ft dogs and one of the 300 ft dogs.
The two dogs in the 230 ft groups which did not show a fall in SEP
at this stage included the one dog not held at pressure. A similar
proportion of SEPs in both groups deteriorated by more than 5% from
their best recovery; nine out of 19 SEPs overall. There was no
recovery at any stage in four of the 230 ft group SEPs. By the end
of treatment 6/12 and 2/7 SEPs showed no recovery in the 230 and
300 ft groups respectively.


















The effect of treatment on spinal evoked potentials lost
during decompression sickness. Treatment was with oxygen
at 60 ft. Dog A lost 92% of its SEP before treatment.
It recovered 17% by 15 min and 44% of its loss by 114 min.
Do g B lost 84% of its SEP before treatment. It recovered
48% of its loss by 16 min before deteriorating to a
condition worse than its pretreatment state.
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Recovery ranged as high as 100% transiently in two SEPs. The
severity of the lesions and their recovery are shown by dive and treat¬
ment in Table 17. The severity of SEP loss from the two dives at
53.2% and 76.1% respectively, was significantly different P < 0.01.
However there was no difference in recovery either in treatments
or dives in this study. Overall mean recovery was around 25%, most
of which was attained within about 15 min.
There was an insignificant difference in mean delay time between
those with zero recovery at 15 min and the rest: 17.10 ± 5.39 min
and 15.50 ± 6.02 min respectively. Similar times were seen for the
same comparison at 120 min: 17.75 ± 2.49 min and 15.33 ± 6.87 min
respectively. However, when SEP recovery at 120 min was compared
between groups with a maximum possible delay to treatment of < 19
and > 20 min, a significant difference was found (P < 0.05) with
SEP recoveries of 40.6 ± 28.2% and 16.4 ± 19.9% respectively.
No predictors for a greater likelihood of recovery were seen
in the physiological observations or treatments. Only the interval
to treatment appeared to be of importance.
Three dogs were subjected to a total of four episodes of global
CNS ischaemia. It was observed that the cortical EPs were lost within
one minute of the step increase in CSFP. Thereafter sub-cortical
FFPs were progressively lost in a centrifugal fashion until nothing
remained after about 15 min. With ischaemia as long as 13 min no
restoration of the cortical waves was seen in a 30 min recovery period,
although most FFPs returned, even after 17 min of ischaemia.
The SEPs sometimes exhibited a sudden transient increase in
amplitude in the first minute of ischaemia. Some loss of amplitude
in the travelling waves occurred between 4 and 5 min and progressed
until the early root entry potential was all that remained by 7 to
12 min. This too was lost after 15 to 17 min.
Restoration of blood flow after 13 - 20 min of ischaemia allowed
varing degrees of SEP recovery in 25 to 30 min of observation. The
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majority of the return had occurred after 5 min of reflow. After
ischaemia of 15 or more minutes duration, SEP recovery in the observa¬
tion period ranged from 50 to 90% of pre-ischaemia amplitude.
6.4 DISCUSSION
The only physiological difference between either groups or
treatments was the higher mean BP in the 300 ft group. This was
probably the result of a greater infusion of fluid.
There was a surprisingly high incidence of continued SEP deterior¬
ation into the first few minutes of treatment in the 230 ft group.
Some of these were doubtless due to an unduly long interval between
the last record and the start of treatment, so weie artifacts. However,
the remainder were seen where the interval was brief. These findings
may reflect the fact that many animals in the group were held at
pressure and so on treatment, particularly at 60 ft, experienced
less compression than the 300 ft group, and therefore, initially
less effective treatment with the result that the lesions continued
to develop. Six of the eight SEPs which showed no improvement by
the end of treatment were also held at pressure before treatment.
The holding at pressure of the 230 ft group was probably also respon¬
sible for the smaller SEP loss seen in this group.
Only three SEPs showed better than 50% recovery, eight better
than 30%, and eleven better than 20%. Overall recovery was in the
region of 25%. Late deterioration was commonly seen. No treatment
produced better results than any other. These findings indicate
that this series contained conditions suitable for the study of delayed
therapy. The frequency of secondary deterioration suggests that
chemotherapy might be an appropriate additional measure. The key
factor to recovery lay in the length of delay before treatment. With
an interval of 15 to 18 min between diagnosis and recompression,
there was little chance of achieving complete restoration of the
SEP. The frequency of secondary deterioration in the short time of
120 min without associated decompression strongly suggests vascular
involvement in the mechanism.
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The global ischaemia studies indicated that, following a sudden
cessation of cord blood flow, except for a sudden transient increase
in amplitude, the travelling waves of the SEPs remained unchanged
for between 4 and 5 min. Thereafter, function rapidly faded until
totally absent in 15 to 17 min. If flow was restored after 20 min
of ischaemia then a large part but not all of SEP amplitude returned
inside 30 min. The continued function lasting 4+ min after the onset
of ischaemia would suggest that in this model of DCS a diagnosis
was made not less than 5 min after flow had been compromised. Therefore,
if the cessation of function is the result of vascular obstruction
and there is a 15 min delay it would mean an ischaemic episode of
20 min duration.
The results of delayed treatment of cord DCS appear to be exactly
in keeping with what would be anticipated from studies of cord
ischaemia where the insult was present for about 20 min. It was
concluded that an appropriate interval between the diagnosis of cord
DCS and the start of treatment would be about 15 min. This would
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THE RELATIONSHIP BETWEEN SPINAL CORD BLOOD FLOW AND
EVOKED POTENTIALS IN DECOMPRESSION SICKNESS
7.1 PREAMBLE
An experimental model of a condition largely attributed to vascular
obstruction, which was to be diagnosed and monitored by means of
evoked potentials, necessitated the establishing of a correlation
between cord blood flow and changes in SEPs. The requirement was
to demonstrate that SEP changes only occurred after changes in cord
blood flow. Such a demonstration would be the definitive validation
of a method using evoked potentials as a means of diagnosis in this
model of DCS.
7.2 METHOD
Seven dogs weighing 7 - 15 kg were prepared in the standard
fashion and with the additional arterial catheter required for the
flow study.
One dog was prepared and maintained in the prescribed fashion
for about 2 hr, during which time it was stimulated for EP recording.
A 1-min autoradiographic flow study performed on this undived dog
served as a control. Three dogs (80J, 86J, 88J) were used in EP
control studies at 60 and 165 ft, en route to 230 ft. They remained
at 230 ft for 45 - 60 min before decompression to the surface. The
other three dogs (38R, 86P, 88P) were used in a different set of
EP control studies of helium breathing as deep as 300 ft. They were
decompressed from these dives without incident. After a surface
interval they were dived to 165 ft breathing air via a 15-min stage
at 60 ft. After 120 min at 165 ft they were decompressed to 60 ft,
where they remained for 10 min before returning to the surface.
After surfacing the SEPs were continuously recorded until various
14
degrees of DCS were observed. A one minute C-iodoantipyrine
autoradiographic flow study was then performed. The observations
sought were low cord blood flove where white and grey matter flows
were less than 6 and 15 ml 100 gm ^ min , respectively, flows that
are considered to be "neuron-disabling" in the brain (Branston et
al., 1974, Hallenb^ck et al., 19 82).
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7.3 RESULTS
The six dived dogs developed DCS of varying severity. Four
showed a rise in CSFP of between 8 and 70 mm Hg, and three showed
a rise in RVP of between 24 and 60 mm Hg. Four showed gross SEP
changes and two showed small variable changes. Only two showed gross
EEG changes, one of which (88J) became isoelectric.
The mean cord blood flows in the control dog were 11 and 38
ml 100 gm * min ^ for white and grey matter, respectively, with ranges
of 6 - 16 and 29 - 46 ml 100 gm * min . This compared with previously
observed control values for lumbar white and grey matter flows of
8 and 21 ml 100 gm ^ min \ with ranges of 6 - 11 and 15 - 26, respectively,
in dogs not experiencing peroneal nerve stimulation (Leitch et al.,
1984b).
Relevant autoradiographs of cortical blood flows are shown in
Figure 18, where the top half of 88P may be regarded as normal.
Examples of cord flows in cervical, upper and lower thoracic , and
lumbar regions are shown in Figure 19, together with details of high
and low flows in grey and white matter, and amplitude of SEP.
80J (Figures 20 and 21).
There were few systemic changes, with only a small increase
in CSFP, a stable BP and no gross changes in EEG. Transient lumbar
SEP changes showing alternating increases and reductions of amplitude
occurred between 9 and 67 min post-dive (Figure 20). No change in
median-cervical SEP was seen at 58 min post-dive. A correspondence
between SEP and CEP (Figure 21) amplitudes was seen at 28 and 36
min. The cord flow study done 13 min after the last EP recording
showed no evidence of "neuron-disabling" flows, but several instances
of abnormally high flows, particularly in the lumbar region (Figure
19). The cortical autoradiograms (Figure 18) revealed no clear evidence
of low flows, but again, evidence in some areas of high flows. Overall,
the section does not appear normal when compared with the upper sections
of 86P.
86J (Figure 22)
CSFP was elevated shortly after surfacing and cycled throughout
50 min of observation, reaching 90 mm Hg at its highest point. There
80J86J88J8 P
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was a sharp fall in BP at 37 min post-dive. Saline infusion and
Levophed corrected this fall after 14 min. Local lumbar SEP changes
were seen by 3 min (Figure 22). These progressed steadily until the
last observation 6 min before the flow study. The peroneal-thoracic
SEP disappeared between 36 and 44 min, indicating total conduction
block in the upper lumbar-lower thoracic region. No median-cervical
SEP changes were evident at 31 min. The flow study (Figure 19) at 50
min showed an almost complete absence of flow in the lower thoracic
region, and gross asymmetry and heterogeneity in other segments.
There were some areas of abnormally low flow in the cortex (Figure 18).
88J
After 5 min on the surface, CSFP began a small rise and EEG
amplitude fell. By 13 min the EEG was almost isoelectric. Lumbar
SEP remained unchanged throughout the observation period, but after
10 min no peroneal-thoracic SEP was visible. The flow study revealed
a generalised reduction in blood flow, with very low flows evident
in the whole of the thoracic cord (Figure 19). The cortical flow
study showed marked flow deficits compatible with the EEG loss.
38R
Seven minutes post-dive there was a small rise in RVP and CSFP.
EEG remained unchanged, but BP was elevated by about 50 mm Hg. At
this point there were transient lumbar SEP changes. The median-cervical
SEP was not observed within 10 min of the flow study. The flow study
showed flows generally in the low end of the observed range, although
none were in the neuron-disabling range (Figure 19). No abnormalities
of cortical blood flow were seen.
86P (Figures 23 and 24)
There was a sharp rise in both RVP and CSFP after 2 min. They
eventually rose by 52 and 34 mm Hg, respectively. There was a brief
fall in BP to 70/50 mm Hg at 6 min. No change was seen in the EEG.
Lumbar SEP changed at 6 min (Figure 23). The thoracic recording
was destroyed by noise, not an uncommon finding in acute DCS. At
the time of the flow study there was little left of the lumbar SEP
and consequently nothing in the peroneal-cervical SEP. Two minutes
before the flow study the median-cervical SEP was normal. The CEP





























Figure24.No86P-Cortical evokedpotentialsfr m peronealnerve.
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the median CEP remained unchanged. The flow study showed a marked
flow deficit in the distal half of the cord, while the rostral part
appeared relatively normal (Figure 19).
88P (Figures 25 and 26)
Two minutes post-dive there was a generalised moderate increase
in BP, RVP and CSFP. By 6 min, changes in the lumbar SEP were evident
(Figure 25). Concurrently, the thoracic and cervical SEPs may have
shown changes greater than those due to the lumbar changes alone.
At 10 min there were local changes in the median-cervical SEP. The
lumbar SEP changes were reflected in the CEP (Figure 26). The flow
study done at 10 min showed a marked reduction in cord blood flow,
particularly caudal to the cervical cord (Figure 19). There was
some reduction in cortical flow in the inferior parts, remote from
the subelectrode region (Figure 18).
7.4 DISCUSSION
The results from this study demonstrated that where there were
clear SEP changes, there were also neuron-disabling low flows in
the cord. Where there were transient SEP changes, the subsequent
observation of hyperaemia suggested that these too might have been
associated with transiently reduced blood flow. The appearance of
patchy hyperaemia during recovery from gas embolism has been reported
before (Hallenbeck et al., 1982; Leitch, et al., 1984). The observa¬
tions of occasional spontaneous recovery conform with clinical
experience. There was a good correlation between EEG changes and
cortical blood flow. The two dogs showing EEG changes had flow deficits
in the subelectrode regions. The approximate localisation provided
by the EPs conformed to zones of impaired perfusion in cord and brain
14
so that the electrical recordings were substantiated by the C-
iodoantipyrineautoradiographic flow studies.
An overall impression was that the degree and extent of neuron-
disabling low blood flow was greater than the SEPs might have led
one to expect. However, the intervals between the last peroneal SEP
observations and the flow study ranged from 0-13 min, with a median
of 5 min. It has already been shown that there is a lag time of
about 4 min between cessation of blood flow and change in SEP travelling
i
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waves. Similar observations have been made previously by others
(Bernhard and Koll, 1953; Gelfan and Tarlov, 1955). Therefore, in a
deteriorating situation, even when the flow study and last SEP observation
are simultaneous, apparent function will probably be greater than
the flow rate might predict. At no time were significant SEP changes
seen that were not associated with a reduction in spinal cord blood
flow to neuron-disabling levels. Therefore the validity of using
evoked potentials to monitor spinal cord DCS was demonstrated.
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SECTION 8





CONSISTENCY IN THE PRINCIPAL EXPERIMENTS
8.1 PREAMBLE
As the experiments were spread over a two year period, a check
on the consistency of the electrophysiological model was maintained
by comparing the effect of narcosis in each experiment. The principal
experiments were the studies of oxygen and pressure as factors in
treatment. The results from all other studies were incorporated
into the first assessment of narcotic effect.
8.2 OXYGEN STUDY
The control data of the 25 dogs used in thecxygen study are given
in Table 18 and 19. The amplitudes and latencies of the CEPs were
as seen earlier. The same narcotic effect was also seen. The summated
amplitudes for left and right peroneal to lumbar SEPs, and for median
to cervical SEPs, were not affected by 10 bar of air being 98% (SE 2)
and 99% (SE 2), and 99% (SE 1) respectively of controls.
Conduction velocities were calculated from interelectrode
distances and peak latencies. The peroneal first travelling wave
had a conduction velocity between stimulus and lumbar sites of 65 m ^
(SE 3). In the cord, velocity between lumbar-thoracic and thoracic-
cervical sites was similar at 71 m s ^ (SE 5)and 69 m s * (SE 5) respectively.
The median stimulus-cervical velocity was 79 ms ^ (SE 4). The velocities
from cervical site to cortex were 18 m s^ (SE 1) and 16 m s^ (SE 1).
A later identified travelling wave had a much slower conduction velocity
of 36 m s* (SE 2)and 32 m s* (SE l)in the stimulus to first electrode
segment for peroneal and median SEPs. In the peroneal SEPs this was
reflected by a widening interval between the two waves as they passed
rostrally. At the lumbar, thoracic and cervical sites the peak to
peak intervals were 3.14 ms (SEQ20), 3.86 ms (SEQ22) and 4.38 ms
(SEQ26) respectively.
8.3 PRESSURE STUDY
Tables 18 and 19 show the control amplitude and latency data
from the pressure study. The narcotic effect on CEPs at 10 bar was
as previously seen. The SEP summated amplitudes were insignificantly
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reduced by 10 bar of air, the left and right peroneal to lumbar,
and the median to cervical SEPs being 97% (SE2), 95% (SE2) and 95%
(SE2) respectively of their controls.
In summary, CEP amplitudes were generally suppressed by 10 bar
of air to about 80 percent of the control values. The latencies
tended to be marginally increased but this finding was not consistent.
The cord conduction velocities and CEP latencies were similar to
those reported elsewhere (Norrsel1, 1966; Parker 1978a; Parker, 1978b).
TABLE 18
CORTICAL EVOKED POTENTIAL AMPLITUDE.
Peak to Peak (pV x ± SE)
(% of control)
Oxygen Study


























CORTICAL EVOKED POTENTIAL LATENCY
Peak (ms x ± SE) fl P.>
Oxygen Study
Peroneal at 1 bar 16.9 + 0. A 25.0 + 0.7 27.7 + 1.0
at 10 bar 17.2 + 0. A 25.6 + 0.7 38.2 + 1.0
Median at 1 bar 12.8 + 0.2 19.5 + 0.3 32.A + 0.8
at 10 bar 12.9 + 0.2 19.5 + 0. A 32.8 + 0.7
Pressure Study
Peroneal at 1 bar 15.8 + 0.5 22.8 + 0-5 3A.2 + 0.7
at 10 bar 15.8 + 0.5 23.1 + 0.5 3A.A + 1.0
Median at 1 bar 12.8 + 0.3 19.3 + 0. A 31.9 + 1.0

















The objective of this study was to find the lowest effective
P02 for the delayed treatment of spinal cord decompression sickness
(DCS) at pressure. The lowest practical P02 was considered to be
1.0 bar and the highest to be 3.0 bar. To avoid the potential problem
of giving dogs hypoxic mixtures, air with 20 - 21% oxygen was chosen
as the lowest oxygen gas. This selected the pressure for all treat¬
ments as 5.0 bar, which with air gave a P02 of 1.0 bar. The pressure
of 5.0 bar falls in the middle of the pressure range of treatments
in common use.
9.2 METHOD
Dogs weighing between 9.1 and 13.6 kg were prepared as described
before. However, the use of the intercostal stimulating site was
abandonned because of the unreliability of the resultant SEPs.
Dogs were assigned to one of the five treatment groups according
to their weight. This ensured that the group mean weights were similar
(range 11. 1 to 12.6 kg). All treatments were at a pressure of 5.0
bar (132 ft). Oxygen mixtures of 20, 30, 40, 50 and 60% in nitrogen
were supplied to the ventilator. These gave a P02 of 1.0, 1.5, 2.0,
2.5 and 3.0 bar respectively at 5.0 bar. The experiments were cycled
so that after each series of five treatments the next replication
began one place to the right. The plan was to continue until it
was clear that either there was no difference between treatments
or that a statistically significant difference was sustained over
two replications. In the event the difference was significant in
the fourth and fifth replications. There are therefore five dogs
in each group.
After satisfactory control measurements were made the chamber
was compressed with air to a pressure of 10.0 bar (300 ft) at a rate
of 75 ft min At pressure, duplicate EP recordings of the left
peroneal and median nerve inputs were made. After a bottom time
of 15 min (the first 4 dogs had shorter dives, 3 had 12 min and 1
did 14 min in a final adjustment to the dive) the chamber was decompressed
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at a rate of 60 ft min * to 60 ft and at about 45 ft min * from 60 ft
to the surface. This resulted in ascent times between 5.0 and 6.0
min. In practice the chamber was held with 1 to 2 ft of pressure
at the surface in order to make the ventilator oxygen dump bag vent
from the chamber.
Continuous EP recordings were made after arrival at the surface.
Left and right peroneal recordings were alternated on a 3 to 4 min
cycle. This allowed observation of the whole length of the cord.
As soon as a minor change was observed which was seen to progress
on the next recording, the diagnosis of DCS was made. Compression
for treatment began 14 to 17 min after the diagnosis was made. If
a lesion was identified in the cervical region during a peroneal
recording the next interrogation would be the median. The SEP for
the affected region was used for the control and assessment of the
subsequent experiment.
If after a 30 to 40 min surface interval no SEP changes were
seen the dog was given another dive with a bottom time of 9 to 13
min. This was necessary in seven of the 25 dogs. When any dog with
DCS developed hypotension during the surface interval this was correct
with lactated Ringers solution. Additional fluid was given to correct
the haemoconcentration commonly seen. Hypotension and haemoconcentra-
tion were usually associated with an acidosis which was corrected
with 8% sodium bicarbonate. Fluid balance was recorded over the
period beginning with the dive until the end of treatment.
There were six criteria used to eliminate dogs from the study
group, the criteria were:
a. A missed diagnosis resulting in the pre-treatment interval
being too long.
b. Insufficient loss of SEP amplitude (< 10% loss).
c. Hypotension resulting in systolic blood pressure being below
100 mm Hg for more than 5 min.
d. Failure to show more than 5% recovery at any stage in the
treatment.
e. Any degree of spontaneous recovery during the pre-treatment
interval.
11-3
f. Sudden cardiovascular collapse during treatment.
Immediately before compression for treatment a last record of the
controlling SEP was made. The correct gas was switched to the ventilator
and the chamber compressed to 5.0 bar at 75 ft min The treatment
gas was breathed without break thereafter. A repeat of the controlling
SEP plus the remainder was made on arrival at pressure. The SEP
recordings were repeated at 15 min. Thereafter all SEPs demonstrating
lesions were checked every 15 min and the rest at 30 min until 120
min of treatment were completed.
The final pretreatment SEP was expressed as the percent of control
which was lost. If there was a further loss of SEP amplitude during
compression the lower value was taken as the loss. All recovery
was then expressed as a percent of what was lost as a normalising
procedure. The reported treatment data were reduced to the nearest
recording to the 15, 40, 80 and 120 min points. All results are
expressed as the mean ± one standard error. The basic statistical
analysis was a one way analysis of variance.
After the experiments were terminated the spinal cords were
removed from 11 dogs and fixed in phosphate-buffered 10 percent
formalin (4% W/V formaldehyde). These were sectioned and stained
with haemotoxylin and eosin for light microscopy. The cord was
cut into seven gross segments and three or more specimen sections
from each segment were observed for frequency of haemorrhage. The
objective was to see whether there was any correspondence between
SEP recovery and the frequency of haemorrhage in the cord.
9.3 SYSTEMIC CHANGES
The earliest change indicating DCS in this model was a reduction
in EEG amplitude. The reduction ranged from about 15 percent to
the EEG being isoelectric. Eighty percent of dogs were affected
(Table 20). This occurred 1 to 16 min after surfacing. Cerebrospinal
fluid pressure rose in most dogs to levels shown in Table 21. The
rise in CSFP began from 1 to 16 min after surfacing. These times
were not coincident with the EEG changes. However the two dogs which
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did not show a rise in CSFP did not experience a reduction in EEG
amplitude. Fifteen dogs experienced a rise in RVP to as high as
120/20 mm Hg (Table 21). In 8 this rise occurred later than the
CSFP rise. Towards the end of the pretreatment period, the raised
RVP began to fall in 20 dogs and the raised CSFP began to fall in
15 dogs. In the remainder it remained constant or rose further,
compression therapy caused random changes in CSFP but generally caused
RVP to stabilise at around control levels (Table 21).
During the pretreatment interval 9 dogs had an increase in systolic
blood pressure of more than 20 mm Hg above any pre-diagnosis pressure
(Tables 20 and 21). In three cases this exceeded 300 mm Hg. In
most cases of hypertension there was a precipitate fall in pressure
within a few minutes. When pressure rose rapidly and levelled off,
infusion of lactated Ringers solution was started to prevent the
rebound hypotension where systolic blood pressure fell below 100
mm Hg. Of the five dogs in the final data pool which were transiently
(< 5 min) hypotensive only three had been hypertensive. Cerebral
perfusion pressure calculated as the difference between CSFP and
mean blood pressure is shown in Table 21. Heart rate generally increased
at some stage before treatment then returned to pre-DCS levels. Ventila¬
tion rate was controlled completely in most dogs. During the DCS
there were occasional episodes of tachypnea attributable to "chokes".
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TABLE 20
EVENT TIMES DURING DECOMPRESSION SICKNESS
P02 (Bar) 1.0 1.5 2.0 2.5 3.0 F-ratio
EVENT
Surfacing to D 12 15 19 17 12
±3 ±3 ±2 ±3 ±3
D-l to D 4 5 5 8 5
±1 ±1 ±1 ±3 ±1
Last SEP to TR 2 1 2 3 3
±2 ±1 ±1 ±1 ±2
RVP T (5)9 (4)9 (3)12 (2)5 (3)5
CSFP t (5)4 (5)6 (4)8 (4)5 (5)4
EEG 4- (4)2 (4)3 (3)11 (3)4 (4)5
BP t (2)11 (4)14 (0)- (1)13 (2)14
BP 4* (0)- (2)18 (0)- (1)6 (2)10
Times in minutes shown as mean ± 1 standard error. Figures in parenthesis
indicate numbers of dogs. D - diagnosis of DCS in the SEP, D-l - last
normal SEP, TR - start of treatment.
In spite of the volumes of fluid given before treatment began,
only 10 dogs had an increase in haematocrit of 3 percent or less
(Table 22). The greatest increase seen was 16 percent. Overall
the increase was significant (P < 0.05) for both the increase and
the absolute level. The group mean increases were 6, 12, 8, 3 and
4 percent respectively. The urine outputs in Table 22 were from
the start of the dive until the end of treatment, a period of about
3 hours.
A marked respiratory acidaemia occurred during the pretreatment
phase (Table 23). Nine dogs had an arterial pH of less than 7.3
which was caused by an elevation in arterial PC02. In 12 dogs PaC02
exceeded 39 mm Hg and in four of these PaC02 exceeded 45 mm Hg.
There was no independent change in bicarbonate ion concentration
coincident with this. There was however a slight hypoxaemia when
12 dogs had an arterial P02 of less than 85 mm Hg. This resolved




P02 (bar) 1.0 1.5 2.0 2.5 3.0 F-ratio
MEAN BLOOD PRESURE (mm Hg)
Post-dive 11414 11616 126+5 10814 11419 1.08
Interval range 77-220 70-257 87-150 70-152 70-147 -
Pre-treatment
Change on
8913 103114 11218 10019 9218 1.02
Compression -26(5) -18(4) -12(4) -17(5) -12(4) 0.49
Tr 15 min 127111 137124 116110 11314 12519 0.53
Tr 120 min 110116 10819 11813 105110 1201113 0.34
RIGHT VENTRICULAR PRESSURE (mm Hg)
Post-dive 18/1 25/0 18/1 25/5 20/0 1.73
Interval range
(Syst) 6-120 20-105 14-60 18-85 16-60 _
Pre-treatment 33/7 40/4 29/1 31/6 27/0 0.92
Tr 15 min 21/3 34/1 21/1 27/5 30/1 3.23*
Tr 120 min 16/0 20/0 16/1 23/4 21/1 0.93
CEREBROSPINAL FLUID PRESSURE(mm Hg)
Post-dive 1112 1013 511 1616 1313 1.07
Interval range 5-36 1-82 2-28 2-38 4-32 -
Pre-treatment 1813 2318 1214 1314 1815 0.68
Tr 15 min 2718 2015 913 21+4 2416 1.15
Tr 120 min 1918 2118 613 2216 1813 1.21
CEREBRAL PERFUSIONS PRESSURE (mm Hg)
Post-dive 10415 10617 12015 9217 10118 2.32
Pre-treatment 7114 79112 10017 8719 7419 2.12
Tr 15 min 10118 117122 10818 9217 102+10 0.55
Tr 120 min 92116 87+10 115+8 83113 102113 1.01
Pressures in mm Hg shown as mean ± 1 standard error. Mean blood pressure
= diastolic BP +2/3 pulse pressure. Figures in parentheses indicate
numbers of dogs. * Under F-ratio column shows significance at P < 0.05.
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It can be seen that except for CSFP all the pressures stabilised
at a level a little below control values, during treatment. The
haematocrit, arterial pH and PC02 all returned to levels not greatly
different from the controls. There were only two instances where the
groups were statistically different: the pretreatment haematocrit
and the RVP after AO min of treatment (P < 0.05). Compression caused
an at least transient drop in mean blood pressure. The two dogs
which showed a rise in pressure were both hypotensive at the start
of compression (Table 21).
TABLE 22
HAEMATOCRIT AND FLUID BALANCE
P02 (bar) 1.0 1.5 2.0 2.5 3.0 F-ratio
Hct Control (%) A6 A5 A3 A6 A5 0.98
±1 ±1 ±2 ±1 ±1 .
Pre-Treatment 52 57 A8 A6 A9 3.81*
±3 ±3 ±2 ±1 ±2
Tr AO min 51 A7 AA AA A8 2.76
±2 ±3 ±1 ±1 ±2
Tr 80 min 50 A6 AA A5 A8 1.85
±1 ±2 ±1 ±3 ±2
Overall Fluid 261 20A 9A 155 216 0.92
Balance (ml) ±A8 ±8 ±56 ±6A ±78
Fluid-in in Tr 230 252 196 109 19A 0.57
(ml) ±89 ±79 ±38 ±23 ±A7
Urine output 126 195 170 103 1AA 1.11
(ml) ±22 ±60 ±31 ±18 ±22
Data given as mean ± 1 standard error . Tr- treatment .* under F-ratio
indicates a significance of P < 0.05.
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TABLE 23
ACID-BASE AND GAS ANALYSIS
P02 (Bar) 1.0 1.5 2.0 2.5 3.0 F-ratio
ARTERIAL pH
Control 7.39±0.02 7.39±0.02 7.38±0.02 7.4110.02 7.3910.02 0.56
Pre-Tr 7.3110.04 7.3H0.01 7.3410.02 7.3110.03 7.3210.03 0.29
Tr 40 min 7.3510.01 7.3910.03 7.3810.02 7.38+0.01 7.3810.02 0.25
Tr 80 min 7.3910.02 7.3910.02 7.3610.01 7.3910.02 7.3910.03 0.38
ARTERIAL PC02 (mm Hg)
Control 3412 3412 3512 3211 3411 0.55
Pre-Tr 4215 3811 4013 3913 4013 0.22
Tr 40 min 3511 3512 3716 36+3 3412 0.07
Tr 80 min 3812 3814 3913 3412 3614 0.33
END TIDAL PCO2 (Percent)
Control 3.910.2 3.710.1 4.010.1 3.610.2 4.1+0.1 1.81
Pre-Tr range 2.6-4.7 2.6-5.0 3.2-4.9 2.9-4.4 2.5-5.2 -
Pre-Tr 2.810.2 4.010.3 4.110.3 3.910.3 4.110.3 0.32
Tr 40 min 4.710.3 4.610.3 4.510.4 4.410.3 4.4+0.2 0.18
Tr 80 min 4.410.5 4.610.2 4.510.1 4.210.4 4.5+0.3 0.27
ARTERIAL P02 (mm Hg)
Control 9412 9213 9211 9513 9412 0.27
Pre-Tr 80111 8016 9015 9416 8916 0.71
Data shown as mean 1 1 standard error . Tr - ■treatment.
9.4 SPINAL EVOKED POTENTIALS
Examples of SEP changes during two experiments are shown in Figures
27 and 28. The first identified SEP lesions in the 25 dogs in the
final data pool included, 16 left lumbar, 6 right lumbar, 1 right
thoracic and 2 left cervical lesions (Table 26). These SEPs were
used for diagnosis and assessment of recovery. The loss of SEP amplitude
ranged between 15 and 100 percent by the start of treatment. At
the start of treatment there was no significant difference in severity
between the groups (Table 24 and 26).
The time from surfacing at which SEP change was identified ranged
between 4 and 25 min. There was no difference between the group
means (Table 20). The extent of the change leading to diagnosis
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(D— 1 to D) ranged between 2 and 60 percent (Table 2A). With the
exception of one dog in the 2.5 bar group which had a 20 min interval
between the last normal and diagnostic SEPs, most intervals were A
to 5 min (Table 20). Inspite of the long interval in that case the
SEP loss at diagnosis was only A percent. As a check on diagnostic
perception the penultimate normal SEP (D-2) was checked against the
last presumed normal SEP (D-l) and no difference between the groups
was seen (Table 2A), nor was any large change found. Where the time
to onset was short there were 9 cases where D-2 was measured at pressure
in the dive.
TABLE 2A
CHANGES IN SPINAL EVOKED POTENTIALS
P02 (bar) 1.0 1.5 2.0 2.5 3.0 F-ratio
TIME PERIOD
D-2 to D-l -1 -1 +3 -1 -2 0.9A
±2 ±3 ±5 ±2 ±A
D1 - D -2A -11 -25 -25 -21 0.59
±5 ±A ±11 ±11 ±2
D to Pre-Tr -AA -28 -A 7 -A1 -A9 0.52
±13 ±8 ±12 ±15 ±9
Pre-Tr loss 67 52 69 68 65 0.52
±11 ±13 ±9 ±16 ±11
Change in SEP as a percent of control shown as mean ± 1 standard error.
D-2 - penultimate normal SEP, D-l - last normal SEP, D ■- diagnostic
SEP, Tr - treatment.
The progression of the SEP amplitude loss between diagnosis and
start of treatment (D to Pre Tr) is shown in Table 2A. The cord lesions
were not stable at the start of treatment. All SEPs were continuing
to deteriorate at varying rates. The interval between the last pre-
treatment SEP and the start of compression therapy varied between
0 and 8 min (Table 20). Two dogs showed a further loss of SEP during
compression. One lost another 31 percent and the other 8 percent. They
respectively had a 0 and 7 min interval between the last SEP and the
start of treatment.
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Recovery of SEP amplitude was rapid in the first 15 min of treatment
(Table 25) and ranged between 5 and 100 percent. Although the 2.0
bar group led the recovery at 15 min there was no significant difference
between groups. In the three groups with a P02 of 2.0 bar or more,
mean group recovery continued out to AO min. In the two lower P02
groups, deterioration occurred between 15 and AO min (7/10 cases)
and the SEP amplitude stabilised for the remainder of the 2 hours
of treatment. The differences between the groups at AO, 80 and 120
min were significant (P < 0.05) with the 2.0 and 2.5 bar oxygen treat¬
ment groups having the same mean recovery at 70 and 66 percent. Two
dogs, one in each of the 1.0 and 1.5 bar groups ended with no recovery,
in fact with even a further SEP loss, having shown 7A and 53 percent
recovery at 15 min. The peak recovery times covered the entire treat¬
ment period. Using all the available SEP data showed the group mean
peak recovery times to be 60, 32, 5A, 65 and 58 mins (F ratio 0.AA).
the mean SEP recovery at these times was 63, 79, 91, 80 and 58 percent
(SE 6 to 13, and F ratio 1.A3).
The extent of CNS involvement as far as it was possible to assess
it is shown in Table 26. This includes the onset times for EEG changes
as well as the pretreatment SEP amplitude loss. As travelling
waves are recorded more rostrally the reducing amplitude must lead
to a greater error and therefore possible inconsistency in SEP loss.
TABLE 25
SEP RECOVERY AS PERCENT OF LOSS
P02 (bar) 1.0 1.5 2.0 2.5 3.0 F-ratio
TIME PERIOD
at 15 min A2 55 70 52 AA 0.8A
±13 ±15 ±11 ±11 ±11
at AO min 29 33 79 69 53 3.92*
±10 ±10 ±9 ±12 ±13
at 80 min 29 30 68 71 39 3.79*
±1A ±11 ±6 ±11 ±8
at 120 min 22 3A 70 66 A2 3.53*
±10 ±10 ±12 ±1A ±8
Recovery of SEP during treatment expressed as percent of loss shown as
mean ± 1 standard prror. * Under F-ratio column shows significance at
P < 0.05.
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However some local activity is included in the peroneal-lumbar SEPs
so it would be possible to see the local loss without affecting the
travelling waves rostrally as possibly shown in dog 174. If the lumbar
SEP loss is total then no assessment of thoracic cord can be made.
Expressing the number of affected SEPs as a percent of available
recordings showed the proportion of affected cord segments in each
group to be about 55, 59, 56, 39 and 67 percent respectively. Taking
only the left and right lumbar and the left cervical segments, those
with large reliable SEPs, the figures were 87, 80, 71 53 and 60 percent
respectively. There was no consistent pattern of involvement related
to recovery.
9.5 DISCARDED DATA
Eight dogs were lost for various technical reasons. Another
four completed treatment without any recovery of SEP at any time.
Of these, two had a missed diagnosis which led to a pretreatment phase
of more than 35 min. One experienced 9 min of profound hypotension
(Systolic BP 70 mmHg). The other developed an uncontrollable respiratory
and acid-base problem which resulted in 80 min with a pH between 7.20
and 7.29 and a PaC02 of 80 mm Hg. These dogs were replaced in the
data pool.
9.6 PATHOLOGY
A few petechial subarachnoid haemorrhages were seen in some
dogs when the cords were removed. A major subarachnoid haemorrhage
was present in the lumbar-thoracic cord of dog No. 184. There was
poor SEP recovery in this case with a slow improvement reaching 12
percent at 120 min.
Many cord segments showed varying degrees of haemorrhage and
occasional vascular congestion. There were microscopic petechiae
in either or both of the grey and white matter. Most appeared in
the central grey matter. The haemorrhages consisted of small clusters
of red cells surrounding capillaries and venules to larger though
still microscopic foci of bleeding. The appearance was compatible
with hypoxia or embolic episodes. There was no other evident tissue
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damage, inflammatory infiltration or oedema. There was no detectable
relationship between frequency of severity of haemorrhage and extent
of SEP loss, its recovery, or subsequent deterioration. However the
one case (No. 174) with the least SEP loss and the least cord involvement
(left lumbar only) also had the smallest number of haemorrhages.
TABLE 26
EXTENT AND SEVERITY OF CNS DECOMPRESSION SICKNESS
EVOKED
POTENTIAL LPL LPT LPC RPL RPT RPC LMC EEG (Time)
DOG
140 79 ? 86* 82* 7 100* 11 —
141 28 k ?* 54* 11* ?* 33* 48* 1
142 92 100 100 90 100* 100* 65 4
143 75 100 100 20* 25 55 0 1
144 19 23 49 62 22* 37* 0 3
150 18 ?* 7 14 7 100 0 —
151 61 47 57 47* 7 40* 0 3
152 17* ?* 0* 29 * 26* 27 0 4
153 62 100 100 59 100 100 89 1
154 8* ?* 32* 41* 41* 100 <?3 6
160 72\ 56 7 86 7 7 0 —
161 59 7 7 71 ? 7 7 -
162 0 0 0 49 31 48 0 16
163 100 7 ? 100 7 7 0 7
164 54 100 100 66 100 100 58 11
170 1 38 64 11 m 100 27 3
171 100 100 100 100 100 ? 0 -
172 91 80 100 81 100 100 0 6
173 53 36 7 0 0 7 0 -
174 15 0 7 0 7 7 0 2
180 58| 78 100 0 0 0 33 1
181 68 70 100 77 64 7 0 -
182 44 28* 43 0 23 30 0 13
183 100 100 100 84 77 53 0 3
184 86 100* 100*+ , 97 ?* 100*+ 0+ 3
Data are presented as percent of control SEP lost at the start of
treatment.□ -principal and controlling SEP, ? - no record,
* - no recovery at 120 min, + - cord haemorrhage at post mortem.
Evoked potentials are LPL - left peroneal _lumbar, thoracic and cervical,
RPL - right peroneal 2.UTnt>ar, thoracic and cervical, LMC - left median
cervical. Figures in EEG column are onset times in minutes.
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9.7 DISCUSSION
At the start of treatment the physiological condition of the five
groups of dogs was similar except for the mean haematocrit in the 1.5
bar group which was higher than the rest. All groups had cord DCS
of similar severity and similar development. During treatment a large
proportion of the mean SEP recovery had occurred in all groups by
15 min. This was not sustained in the 1.0 and 1.5 bar groups. The
higher P02 groups recovered further by 40 min before stabilising at
a lower level between 40 and 120 min. Throughout the later part
of treatment there was a significant difference between the groups
with the 2.0 and 2.5 bar groups showing the best mean recovery of 70
and 66 percent respectively.
The choice of 15 min for the interval between diagnosis and the
start of treatment seems to have been correct. Only four dogs achieved
a complete recovery but two of these failed to sustain it. The
preliminary studies showed that complete recovery was unlikely after
total ischaemia lasting 15 min. There was a risk, if additional
pressure was more effective than oxygen in treating DCS, that 5.0
bar could mask any oxygen effect. This did not occur.
There was a strong indication of peripheral vascular obstruction
by gas in that 22 dogs (88%) showed a transient step reduction in
mean blood pressure during the compression phase of treatment.
C ompression of intra- or extravascular obstructing gas would lead
to a sudden drop in peripheral resistance and a transient fall in
blood pressure. There was no apparent reason why the SEPs of 2 dogs
should have deteriorated transiently on compression. The finding
is similar to occasional clinical experience. It might result from
vessel collapse on compressed bubbles or gas redistribution transiently
worsening a local problem. There was no association with higher oxygen
which would implicate oxygen uptake in the bubbles. If the efficacy
of specific treatments and speed of treatment are disregarded there
are two major factors which may govern the extent of recovery; first
the severity and extent of cord involvement, and secondly aspects
of systemic disturbance which will influence microcirculatory perfusion,
such as perfusion pressure, haematocrit and acid-base state.
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When monitoring function using EPs it is possible to obtain a
crude estimate of the extent of cord involvement by differentiating
between left and right and by having several interrogation points.
There were five cases of unilateral lumbar SEP loss. The median-cervical
SEP showed the left cervical cord to be unaffected in 16 cases where
the lumbar cord was affected. Separating the cases into those showing
generalised cord involvement and those only 'locally' affected gave
respective mean recoveries at 120 min of 41 and 50 percent ('t' test
0. 1 > p > 0.05). This could have influenced the treatment group
means as only 3 of the 8 cases affecting cervical cord occurred in
the three high oxygen groups (Table 26). There was a smaller difference
when unilaterally and bilaterally affected lumbar SEPs were compared
(p <0. 6). Within the treatment group means there was no difference
between the losses in the primary SEPs. When all the primary SEP
losses were divided between generalised and local cord DCS the SEP
losses were the same with 68 and 65 percent respectively. So severity
of SEP loss does not seem to be related to extent of cord involvement
but greater extent may reduce recovery.
Although there was no significant difference in mean onset times
between groups, the two best groups had longer onset times than the
remainder. There was no relationship between onset time of SEP loss
and the amount lost. However, there was a relationship between onset
time and amount of recovery. The least squares regression equation was:
Y = 12.92 + 2.18t
where Y was the percent recovered and t the onset time in minutes
(R = 0.48, p < 0.02). Separating recovery into those with less than
40 percent and those with more than 60 percent gave mean onset times
of 13.5 and 19.0 min ('t' test p < 0.001). Thus speed of onset may
indicate a poorer chance of recovery. There was no difference between
these two groupings for percent of SEP loss, 59 and 62 percent
respectively so recovery was not related to severity.
There was an indication of brainstem involvement in possibly
nine cases. Such lesions could arise from any one of three possible
mechanisms, arterial gas emboli, venous obstruction or autochthonous
bubble formation. The transient hypertension which in three cases
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reached very high levels could have been caused by a mechanism similar
to that described in cats receiving arterial gas emboli to the brainstem
as described by Evans et al. (1981). Lesser rises may also result
from increased peripheral resistance caused by vascular obstruction.
The subsequent hypotension seen in some of these and other dogs may
reflect a loss of peripheral sympathetic tone in association with
the cord DCS or a reduction in cardiac output. Several cases showed
ECG changes compatible with ischaemia.
The fall in blood pressure and haemoconcentration reflects the
severity of systemic disturbance. Fluid infusion is the essential
method for correcting the haemoconcentration (Cockett et al.,1979);
this incidentally corrects the blood pressure. The fluid supplements
over the period following onset of DCS were similar in each group
but failed to completely correct the haematocrit in the 1.0 bar group.
A markedly elevated haematocrit with the consequently increased viscosity
must impair tissue perfusion.
As far as possible the physiological variables whlc h could influence
recovery were controlled. However there was a tendency for factors
such as blood pressure and thus cerebral perfusion pressure, haematocrit
and arterial P02» during the pretreatment and early treatment phases
to favour perfusion and oxygenation in the higher oxygen treatment
groups. The pretreatment group mean haematocrit was the only relevant
variable significantly different between treatments. However, neither
group means nor individual haematocrit correlated with recovery at
15 or 120 min (Recovery at 120 min = 163.4 - 2.3 Hct with R = 0.24
(p > 0.1)). With the exception of pretreatment haematocrit, analysis
of covariance using various combinations of the physiological variables
failed to alter the level of significance of between group differences
for SEP recovery. Pretreatment haematocrit reduced the level of signifi¬
cance to p < 0.1. It may be that the therapeutic measures taken during
the surface interval and early treatment plus the exclusion criteria
were effective in removing any clear association with lack of recovery.
Continuous exposure to high partial pressures of oxygen will
lead to oxygen toxicity. If these were having a detrimental effect
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on the recovery of damaged cord tissue it should show as an increased
deterioration in the high oxygen groups as exposure continued. The
mean deteriorations for the 1.5 to 3.0 bar groups were: 11, 13, 11
and 11 percent respectively (SE2 - 5). The mean for the 1.0 bar group
was distorted by one case with a 58 percent deterioration otherwise
the mean would have been the same as the others. Therefore there
was no indication of oxygen toxicity. It is noteworthy that the only
5 dogs to experience no deterioration during treatment were in the
groups treated with 2.0 bar oxygen or greater.
Interpretation of findings in the spinal cord sections was confounded
by the history preceding their fixation. While changes could be
attributed to the initial decompression insult it might be modified
by the subseqeunt compression treatment; the fact of their final
decompression also subjected them to a second insult. Two hours of
air breathing at 5 bar (1.0 bar P02 group) could result in DCS, but
breathing 60 percent oxygen (3.0 bar P02 group) makes DCS less likely.
Therefore without knowing the event which caused the lesions, no differen¬
tiation between groups would be valid because of the varied risk of













From earlier work by Leitch et al. (1984a) it had been shown that
pressures greater tha 2.8 bar did not improve the treatment of cerebral
arterial gas embolism. Similarly Barnard and Hanson (1973) had found
an optimal treatment pressure for mice with DCS, between 3.0 and 3.5
bar. It was now planned to see whether with P02 of 2.0 bar, additional
pressure beyond the presumed threshold would improve the outcome of
treatment.
10.2 METHOD
Dogs weighing between 10.0 and 14.5 kg were used in the final data
pool. They were assigned to one of four treatment groups according to
their weight. This ensured that the group mean weights were similar
(range 11.3 to 12.1 kg). The treatments included three with P02 of
2.0 bar and ambient pressures of 3,5 and 7 bar and a fourth group breath¬
ing oxygen at 2.8 bar. The last group was included to provide a compari¬
son with the generally accepted standard treatment. The desired P02
was obtained by providing 66, 40, 29 or 100 percent oxygen in nitrogen
mixtures to the ventilator. The experiments were cycled so that after
each series of four treatments the next replication began one place to
the right.
The dive protocol was streamlined and all dogs were compressed
to 10.0 bar (300 ft) at a rate of 75 ft min * while breathing air.
They remained at 10 bar for 15 min before being decompressed at 60 ft
min ^ to 60 ft and at about 45 ft min ^ from there to the surface.
Dogs which did not show SEP changes within 30 min of surfacing were
given a further 9 min at 10 bar. One dog in each group required a second
dive. Mean ascent time was about 5.5 min (range 5.0 - 5.7 min).
Recompression for treatment began 15 to 17 min after the diagnosis of
spinal cord DCS was made.
The maintenance of dogs developing hypotension during the pre-
treatment surface interval was improved by giving 8 percent sodium
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bicarbonate to correct the acidaemia before giving the lactated Ringers
solution. The same six exclusion criteria were applied in this experi¬
ment and led to the elimination of 12 cases from the final data pool.
After the dogs were decompressed at the end of the experiment
the spinal cords were removed within 30 min of death from those dogs
in the low pressure groups. The cords from the 3 and 2.8 bar groups
were fixed in 10 percent phosphate buffered formalin (4% W/V formaldehyde).
The low pressure groups alone were used because there was little risk
of DCS from the final decompression. Thus any changes could reasonably
be attributed to the initial decompression and have some bearing on
recovery during treatment.
The cords were cut into 7 segments, cervical, 4 thoracic and 2
lumbar segments. These in turn were sectioned and 3 or 4 sections stained
with haematoxylin and eosin. The sections were scrutinised for gross
changes and for extent of haemorrhage. Each section was scored by
the number and size of haemorrhages. Each haemorrhage was approximately
graded 1 to 4: 1 - < 10 RBC, 2 - 10 to 20 RBC, 3 - 20 to 40 RBC and
4 - > 40 RBC. Each section was then scored for grey and white matter
by multiplying each grade by its frequency. The mean section score
was then calculated for the four main cord segments: cervical, upper
thoracic, lower thoracic and lumbar.
10.3 SYSTEMIC CHANGES
The earliest change indicating DCS was qgain a reduction in EEG
amplitude. However only 50 percent of cases were affected in this
series (Table 27). The range of onset times was 2 to 17 min after
surfacing. Cerebrospinal fluid pressure (CSFP) rose in 13 cases to
levels shown in Table 28. There were 5 cases where CSFP rose in the
absence of EEG changes and 2 cases where-EEG changed without a CSFP
rise. In only one case did the CSFP rise begin before the EEG change.
The onset time for the CSFP rise was 3 to 18 min. There was no systematic
association between CSFP rise and reduction in SEP amplitude.
Thirteen cases showed a rise in right ventricular pressure (RVP)
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to as high as 170/0. In no cases did this precede the CSFP rise, in
4 cases the rises were coincident and in 4 cases the RVP rise was later.
The remaining 5 were not associated with a significant CSFP rise.
The pattern of change in RVP and CSFP during the pretreatment interval
and treatment were similar to that seen previously (Table 28).
During the pretreatment interval only 4 dogs had an increase in
systolic blood pressure of more than 20 mm Hg above any pre-diagnosis
pressure (Tables 27 and 28). They all developed pressures in excess
of 200 mm Hg but none reached 300 mm Hg. While these pressures were
transient, in no case did the systolic pressure in these or the other
cases fall even transiently below 100 mm Hg during the pretreatment
interval. Compression caused a transient fall in mean blood pressure
of up to 70 mm Hg in 13 cases.
TABLE 27
EVENT TIMES DURING DECOMPRESSION SICKNESS
Pressure (bar) 3.0 5.0 7.0 2.8 F-ratio
EVENT
Surfacing to D 15 18 10 16 0.80
±3 ±5 ±3 ±4
D-l to D 4 4 4 5 0.86
±1 ±1 ±1 ±1
Last SEP to Tr 1 2 2 2 0.22
±1 ±1 ±1 ±1
RVP t (3)11 (3)9 (2)14 (5)12 -
CSFP T (4)15 (2)8 (4) 9 (3) 8 -
EEG (3)10 (1)8 (4) 6 (2) 3 -
BP T (3)23 (0)- (0)- (2)24 -
BP 4- (0)- (0)- (0)- (0)- -
Times in minutes shown as mean ± 1 standard error. Figures in paren¬
thesis indicate numbers of dogs. D - diagnosis of DCS in the SEP,
D-l - last normal SEP. Tr - start of treatment.
Cerebral perfusion pressure calculated as the difference between
CSFP and mean bl ood pressure is shown in Table 28. Heart rate increased
up to 45 beats min ^ in 13 cases and was unchanged in 7 during the
pretreatment phase. It returned to control levels during treatment.




Pressure (bar) 3.0 5.0 7.0 2.8 F-ratii
MEAN BLOOD PRESSURE (mm Hg)
Post-dive 118±5 122110 11215 12018 0.39
Interval range 88-185 82-162 80-127 90-203 -
Pre-treatment 132±16 11218 10317 11714 1.41
Change on Tr -36(5) -11(2) -9(2) -29(4) 1.39
Tr 15 min 130±8 144112 13314 121111 1.16
Tr 120 min 11414 11915 12317 11517 0.53
RIGHT VENTRICULAR PRESURE (mm Hg)
Post-dive 43/0 18/2 48/2 29/0 1.72
Interval range (syst) 20-170 12-34 10-110 18-115 -
Pre-treatment 61/4 25/1 54/1 53/1 0.81
Tr 15 min 72/1 20/2 50/3 31/2 1.37
Tr 120 min 29/4 19/3 42/2 24/0 1 70
CEREBROSPINAL FLUID PRESSURE i(mm Hg)
Post-dive 1214 1413 1115 1915 0.72
Interval range 1-22 2-22 1-28 5-56 -
Pre-treatment 1014 1114 1013 2014 1-50
Tr 15 min 1013 1115 2118 1717 0.80
Tr 120 min 1013 1819 2318 1817 0.67
CEREBRAL PERFUSION PRESSURE (mm Hg)
Post-dive 10617 10819 10111 10115 0.27
Pre-treatment 122113 10116 9318 9816 2.00
Tr 15 min 12017 13318 11218 104114 1.76
Tr 120 min 10416 101112 10018 9713 0.08
Mean blood pressure = diastolic BP + 2/3 pulse pressure. Figures in
parenthesis indicate numbers of dogs.
Variable amounts of fluid were given after the diagnosis of DCS
(Table 29). They were effective in maintaining blood pressure and
reducing the expected rise in haematocrit to a mean of 2.2 percent
(Table 29). In only three cases did the increase exceed 5 percent
and 15 cases showed a rise of only 3 percent or less.
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A marked respiratory acidaemia occurred during the pretreatment
phase (Table 30). Five dogs had an arterial pH of less than 7.3 which
was caused by an elevation in arterial PC02• In 6 dogs PaC02 exceeded
39 mm Hg and in 3 of these it was 45 mm Hg or more. The 6 hypercapnic
dogs were also hypoxaemic with a Pa02 less than 85 mm Hg before treat¬
ment. The infusion of bicarbonate and compression resolved these
conditions.
Up to the start of treatment the only variables which were
significantly different between the group means were the arterial PC02
and P02. This indicated a significant pulmonary gas exchange probli
in the 2.8 bar treatment group.
TABLE; 29
HAEMATOCRIT AND FLUID BALANCE
Pressure (bar) 3.0 5.0 7.0 2.8 F-ratio
Hct Control (%) 44 44 43 45 0.66
±2 ±1 ±1 ±1
Pre-Tr 47 47 43 47 1.02
±3 ±2 ±2 ±1
Tr 40 min 49 47 43 45 1.36
±3 ±2 ±1 ±2
Tr 80 min 46 45 44 45 0.26
±2 ±2 ±1 ±2
Overall Fluid 77 140 108 4 1.27
Balance (ml) ±71 ±51 ±26 ±48
Fluid-in in Tr 190 186 96 100 2.15
(ml) ±46 ±42 ±20 ±27
Urine Output 178 104 146 140 0.65
(ml) ±55 ±12 ±40 ±30
Data given as mean ± 1 standard error. Tr - treatment.
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TABLE 30
ACID-BASE AND GAS ANALYSIS
Pressure 3.0 5 0 7.0 2.8 F-ratio
ARTERIAL pH
Control 7.39±0.01 7.3710.01 7.3910.02 7.3810.01 0.62
Pre-Tr 7.3510.02 7.3A10.02 7.3A10.03 7.3110.03 0.A9
Tr AO min 7.3A10.02 7.A110.02 7.3810.05 7.3810.02 0.9A
Tr 80 min 7.3710.02 7.A010.02 7.3710.OA 7.3710.01 0.A7
ARTERIAL PC02 (mm Hg)
Control 3311 3A11 3312 3511 0.92
Pre-Tr 3212 3812 3813 A3l3 3.32*
Tr AO min 3613 3A12 A015 3812 0.72
Tr 80 min 3713 3513 AHA 3611 0.6A
END -TIDAL FC02 (Percent)
Control 3.A10.3 3.810.A 3.310.3 3.710.3 0.30
Pre-Tr range 2.2-A.l 2.1-5.3 1.8-A.l 2.51A.6 -
Pre-Tr 3.710.1 3.610.A 3.A10.A 3.710.3 0.22
Tr AO min A.AiO.3 A.Ai0.3 A.710.3 A.610.2 0.31
Tr 80 min A.510.3 A.610.1 A.510.3 A.210.1 0.61
ARTERIAL P02 (mm Hg)
Control 9A13 9612 9213 9013 1.02
Pre-Tr 108110 9916 891A 7Al9 3.33*
Data shown as mean 1 1 standard error. Tr- treatment. * Under F-ratio
indicates a significance of P < 0.05.
10.A SPINAL EVOKED POTENTIALS
Examples of EP changes in two dogs are given in Figures 29 and
30. The first identified SEP lesions in the 20 dogs in the final data
pool included 13 left lumbar and 7 right lumbar lesions (Table 33).
These SEPs were used for diagnosis and assessment of recovery. The
loss of SEP amplitude ranged between 29 and 100 percent by the start
of treatment. At the start of treatment there was no significant
difference in severity between the groups (Table 31 and 33).
The time from surfacing at which SEP change was identified ranged
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between 2 and 30 min. There was no significant difference between
the group means inspite of the shorter mean onset time in the 7 bar
group (Table 27). The extent of the change leading to diagnosis (D-l
to D) ranged between +8 and -45 percent of control (Table 31). Occasion¬
ally an increase in amplitude was seen as inhibitory fibres ceased
to function before there was a generalised loss of amplitude. The
interval between the last normal SEP and the diagnostic SEP was less
than 5 min in all cases (Table 27). The check on diagnostic perception
of comparing the penultimate normal SEP (D-2) with the last presumed
normal SEP (D-l) showed no difference between the group means (Table
31). In 2 cases in the 7 bar group onset time was very short so the
prediagnostic SEPs were recorded at pressure.
The progression of the SEP amplitude loss between diagnosis and
start of treatment (D to Pre Tr) is shown in Table 31. Three cases
showed a stable SEP loss prior to treatment; one in the 3 bar group
and two in the 7 bar group. The remainder were showing a progressive
deterioration. The interval between the last pretreatment SEP and
the start of compression therapy varied between 0 and 6 min (Table
27). Four dogs showed a further SEP loss over compression. The additional
losses were 36% (3 bar), 21% (5 bar), 2% and 11 (2.8 bar) with respective
intervals before compression of 1, 6, 2 and 2 min.
Recovery of SEP amplitude was rapid in the first 15 min of treat¬
ment (Table 32) and ranged between 1 and 100 percent. Although the
3 bar group led recovery at 15 min there was no significant difference
between the group means. The 3 and 2.8 bar groups showed a further
improvement in group means by 40 min. This led to a significant differ¬
ence between the group means (P < 0.05). The significant difference
was preserved at 80 min but lost by 120 min, as the 3 bar group entered
a slow deterioration while the 5 bar group continued to improve.
The 7 and 2.8 bar groups remained stable. The decline in the 3 bar
group was largely due to one case which lost 70 percent of its 100
percent peak at 15 min. The rest of the group all showed a small
reduction in amplitude. Two dogs contributed to the continued improvement
of the 5 bar group, and one dog to the late fall in the 2.8 bar group.
Ten dogs did not show more than a 4 percent deterioration from their
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peak recovery. The 120 min of treatment ended with no significant
difference between the groups.
The individual peak recovery times covered the entire treatment
period. Using all the available SEP data showed the group mean peak
recovery times to be 54, 46, 60 and 81 min (F ratio 1.31). The mean
SEP recovery at these times was 91, 80, 54 and 63 percent (SE 6 to
12 and F ratio 3.46*). The subsequent deterioration was similar in
the four groups at 24, 18, 25 and 20 percent.
TABLE 31
CHANGES IN SPINAL EVOKED POTENTIALS
Pressure (bar) 3.0 5.0 7.0 2.8 F-ratio
TIME PERIOD
D-2 to D-l +3 +3 -1 -4 1.42
±4 ±2 ±1 ±3
D-l to D -27 -7 -17 -4 2.08
±7 ±5 ±3 ±11
D to Pre-Tr -54 -47 -60 -65 0.29
±15 ±14 ±15 ±14
Pre-Tr loss 86 70 84 81 0.45
±7 ±13 ±12 ±8
Change in SEP as a percent of control shown as mean ± 1 standard error.
D-2 - penultimate normal SEP, D-l - last normal SEP, D - diagnostic
SEP, Tr - treatment.
TABLE 32
SEP RECOVERY AS PERCENT OF LOSS
Pressure (bar) 3.0 5.0 7.0 2.8 F-ratio
TIME PERIOD
at 15 min 75 55 31 32 3.11
±11 ±12 ±13 ±9
at 40 min 89 53 31 46 4.20*
±10 ±14 ±13 ±8
at 80 min 80 58 27 50 3.89*
±10 ±13 ±11 ±9
at 120 min 67 62 29 42 2.39
±13 ±13 ±8 ±12
Recovery of SEP during treatment expressed as percent of loss shown
as mean ± 1 standard error. *Under F-ratio column shows significance
at P < 0.05.
140
The extent of CNS involvement as far as it can be assessed is shown
in Table 33. This includes the onset times for EEG changes as well
as the pretreatment SEP amplitude loss. Expressing the number of left
and right lumbar, and left cervical SEPs affected as a percentage of
the available recordings gave group means of 50, 40, 50 and 60 percent.
10.5 DISCARDED DATA
Twelve dogs were discarded because they did not satisfy the criteria
for inclusion. Three required second dives and four required controlling
dives to prevent cardiovascular collapse. The diagnosis was missed
in 4 cases which resulted in excess delay to treatment, 4 cases showed
no recovery, the remainder experienced one each of prolonged hypotension
as low as 50/34 for 13 min, physiological instability, spontaneous
recovery and random SEP changes. This large loss was in part due to
the learning needs of potential successors to the author.
10.6 PATHOLOGY
Three dogs had macroscopic haemorrhages in the cord. Number 202
had gross haemorrhage over the left lateral column in the cervical cord,
No. 204 had petechial haemorrhages over the thoracic cord and No. 234
had gross haemorrhage over the cervical cord and petechial haemorrhages
over the lumbar cord (Table 33 and 34).
Cords were removed from 9 dogs in the experiment. A control
dog which was prepared in the same way for a control study but was not
dived was added, as was the cord from a case of untreated DCS.
Sections showed a spectrum of haemorrhages from nil to frequent
and macroscopic, as seen in No. 204 (Table 34). Additional changes
seen were instances of vascular congestion and a teased appearance.
An estimate of the extent of haemorrhage is shown in Table 34.
A small number of haemorrhages were seen in the thoracic cord
of the control dog. This suggests a need for a greater number than
2 or 3 per section to indicate pathology. For the most part the majority
of haemorrhages occurred in the grey matter except in dogs 204 and 234.
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TABLE 33
THE EXTENT AND SEVERITY OF CNS DECOMPRESSION SICKNESS
EEG
EP LPL LPT LPC RPL RPT RPC LMC (Time)
DOG
200 100 ? 100 100 7 100 0 -
201 100 100 100 52 7 7 0 14
202 65 >41 >29* 0 24 14* >20*+ 9
203 75 69 47 L_76| 7 7 0 8
204 1' 90 100+ 100 86 >67+ 100 0 -
211 ["98 85 100 11 >23 7 66 7
213 0 0 ? 31 58 7 0 -
216 95 ? 96 85 100 100 0 -
217 77 68 50 0 0 7 0 -
218 29 100 100 0 100 100 0 9
220 24 13 27* 36 35* 36 0 3
221 90 83 82 100 7 7 0 -
222 99 ? 100* 89 7 7 0 17
224 90 100 95 76* 71* 100 0 2
225 84 97 100 93 100 100 0 3
231 [loo 100 100 85 7 7 0 —
232 >69 ? >46 90 7 100 0 -
233 65 ? 55 37 7 >58 >20* 4
234 59 + ? 68 74+ 7 7 95*+ 2
235 93 ? 100 89 7 100 0 -
Data are presented as percent of control SEP lost at the start of treatment.
□ -principle and controlling SEP, ? - no record, * - no recovery at
120 min, + - cord haemorrhage at post mortem. Evoked potentials are LPL -
left peroneal _lumbar, thoracic and c:ervical, RPL - right peroneal _lumbar,
thoracic and cervical, LMC - left median cervical. Figures in the EEG
column are onset times in minutes.
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TABLE 34
FREQUENCY AND DISTRIBUTION OF HAEMORRHAGE
LOWER UPPER
SITE LUMBAR THORACIC THORACIC CERVICAL
DISTRIBUTION G W G W G W G W
DOG
CONTROL 0 0 1 0 3 0 0 0
DCS No Tr 0 0 5 5 2 20 37 3
201 3 0 7 0 0 0 0 0
202 0 0 10 7 6 1 1 3 0+
203 4 0 9 1 11 0 12 * 4 *
204 41 43 13 41 + 12 9+ 16 153
231 1 0 1 0 4 1 0 0
232 1 2 1 0 2 0 0 0
233 1 0 2 0 8 0 33 2
234 3 11 + 1 3 3 7 14 41
235 0 1 0 5 4 0 2 0
Mean section haemorrhage expressed as the product of frequency and grade
for each main cord segment, divided into grey (G) and white (W) matter.
Dogs were; undived control, untreated DCS, 4 dogs from the 3 bar group
and 5 dogs from the 2.8 bar group. + - macroscopic subarachnoid haemorrhages.
* Unilateral haemorrhage.
TABLE 35
INDIVIDUAL SEP RECOVERY AT 120 MIN
3 Bar Treatment
DOG 201 202 203 204
SEP SITE LPL LPL RPL LPL
% RECOVERED 84 97 82 44
2.8 Bar Treatment
DOG 231 232 233 234 235
SEP SITE LPL RPL LPL LPL LPL
% RECOVERED 55 18 68 10 60
Data shown as percent of SEP loss recovered at 120 min. LPL - left
peroneal lumbar, RPL - right peroneal lumbar.
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Three dogs (202, 233, 234) experienced a loss of cervical SEP which
did not return during treatment. The cervical cords of 202 and 234
showed extensive subarachnoid haemorrhage, while those of 233 and 234
showed extensive microscopic haemorrhages. Comparing the amount of
lumbar SEP recovery at 120 min (Table 33) with the extent of lumbar
cord haemorrhage shows only a correlation between the poorest recovery
in each group and the greatest amount of haemorrhage.
10.7 DISCUSSION
At the start of treatment the four treatment groups were physiologically
similar except that the 2.8 bar group displayed a respiratory acidosis
with hypoxaemia. This was indicative of a pulmonary perfusion problem
although it was not particularly reflected in the pretreatment RVP.
The groups had similar degrees of spinal cord DCS. During treatment
a large proportion of the recovery had occurred by 15 min with a peak
of recovery at around 60 min. Twenty minutes either side of this peak
the groups were significantly different from one another. By 120 min
the difference was no longer significant. The hypothesis that additional
pressure would not improve recovery once a pressure threshold had been
passed and an optimum P02 established was proven. The appearance was
also given that the rate of recovery when using a P02 greater than 2.0
bar might be slower although the same end point might be reached.
Only three dogs recovered their SEP loss completely but none of
the recovery was sustained. Comparisons of this and the prevous study
suggested that better control had been established over the model.
The systemic DCS now seemed less severe. The rate of EEG loss fell
from 72 to 55 percent, and the rate of principal SEP loss fell from
71 to 50 percent. However the mean SEP loss rose from 64 to 80 percent.
There was a lower incidence of hypertension, down from 36 to 25 percent,
and none of these approached a systolic pressure of 300 mm Hg where
previously 3 dogs had exceeded that pressure. There was less acid-base
disturbance, the haematocrits were largely contained, and there were
no cases of hypotension in the pretreatment period inspite of a smaller
volume of fluid being infused. The number of instances of transiently
reduced blood pressure during compression fell from 88 to 65 percent
possibly indicating less free systemic gas. The level of recovery gained
by the best groups in each study was similar inspite of a greater SEP
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loss in this study and more severe systemic disturbance in the former
study. The fact that ten dogs did not show more than 4 percent reduction
from peak recovery coincides with the observation in the previous study
that those which did not deteriorate were confined to the 2.0 bar or
higher oxygen groups. The reduction from peak amplitude was similar
in the 4 groups but was twice that seen in the previous study.
Although there was no significant difference between the group
mean onset times, it is notable that the 7 bar group with the shortest
onset time had the lowest recovery. There was again a correlation between
onset time and recovery. The least squares regression equation was
Y = 15.50 + 2.35t
where Y was the percent recovered and t was onset time in minutes (R
= 0.51, P < 0.001). Separating recovery into those achieving less than
40 percent and those achieving more than 60 percent at 120 min gave mean
onset times of 6.7 and 20.2 min ('t' test P < 0.001). So in this study
where all treatments are expected to be equally effective it was confirmed
that early onset time militates against good recovery where there is
at least a 15 min delay before recompression. Again there was no difference
in the percent of SEP loss at 75 and 78 percent respectively. There
was no identifiable association with systemic changes, cerebral DCS,
haemorrhages or extent of cord DCS to account for this relationship.
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SECTION 11






ELECTROCARDIOGRAPHIC CHANGES IN DECOMPRESSION SICKNESS
11.1 PREAMBLE
Electrocardiograph changes have only rarely been reported in divers
suffering from decompression sickness (DCS) (Burch, 1979; Halpern and
Greenstein, 1981; Kizer, 1980). This probably reflects the infrequency
of ECG recording in sick divers. Such changes have been seen in compressed
air workers (McCallum, 1968; Zannini, 1967). McCallum listed amongst
serious signs and symptoms, angina and irregular pulse. While Zannini
reported a wide spectrum of ECG findings: pulmonary P waves, notched
P waves, depression of the S-T segment, flattening or inversion of T
waves, lengthening of P-R interval, right axis deviation, bundle branch
block and A-V blocks. Changes suggesting early myocardial injury suggested
by S-T segment and T wave changes have also been reported by Burch,
(1979). Animal studies of venous gas emboli have been reported to cause
diaphasic T waves and flattening or inversion of T waves (Butler and
Hills, 1979). Bubbles have also been seen post-mortem in coronary arteries
(Behnke et al. 1936). First degree A-V block and premature ventricular
contractions were seen in two divers with DCS (Halpern and Greenstein,
1981; Kizer, 1980).
11.2 METHOD
The 21 cases described were drawn from a total of 77 dogs reported
in previous studies. The ECG was recorded from four limb leads and
a thoracic electrode at the V,. position. The electrodes were stainless
steel 21 guage needles placed subcutaneously. Lead II was recorded
continuously except when the 7 other possible leads were recorded at
intervals.
The ECGs were analysed using Ettinger and Suter (1970) as a guide
to interpretation. The 21 cases selected had unequivocal changes
associated with systemic and neurological DCS. These were are least
partially reversible with compression. The changes were correlated
with the simultaneously observed systemic observation.
Four categories of change were sought. Evidence of right or left
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atrial strain: P wave amplitude more than 0.4 mV or an increase in P
wave amplitude, P-R segment depression, P wave prolonged and notched,
S wave enlarged. Evidence of supraventricular conduction defects: P-R
interval exceeding 0.13s, dropped beats. Evidence of myocardial ischaenia:
QT
prolonged QT^ interval (QT^, = ^ ), deep or absent Q wave, small R,
widening or slurring ofQRS, S-T depression exceeding 0.1 mV or elevation
of more than 0.15 mV, flattening or inversion of T wave, tall or notched
T wave exceeding 25 percent of R. Evidence of arily thmias: premature
A-V nodal liythmn, A-V dissociation, irregular P waves, ventricular
tachycardia, bigeminal or trigeminal riythmn, unifocal or multifocal
premature ventricular contractions.
11.3 RESULTS
The 21 cases with ECG changes had DCS of varying degrees of severity
Ten could be classed as having severe DCS based on gross cardiovascular
changes. These were a systolic BP exceeding 250 mm Hg or hypotension
with a systolic BP below 100 mm Hg, or a rise in right ventricular sytolic
pressure (RVP) of more than 20 mm Hg. All 10 dogs had a rise in RVP
of at least 10 mm Hg, 5 had a rise of more than 20 mm Hg and two of
these reached 115 and 144 mm Hg, both fourfold increases. Three each
were hypertensive or hypotensive. Eight of these 10 dogs also had a
severe irreversible loss of EEG amplitude as a result of DCS.
All cases showed an elevation of cerebrospinal fluid pressure.
Half the cases showed between none and relatively small changes in BP
and at least 6 of these showed no real change in RVP. Fourteen dogs
showed a loss of EEG amplitude. Of the 7 which retained a normal EEG,
2 were classed as having severe DCS. Arterial blood samples taken during
the acute DCS phase showed an increase in haematocrit of at least 5
percent in 6 dogs (maximum increase 16 percent), a pH of less than 7.3
in 6 dogs (3 also had raised haematocrits), and an arterial P02 below
65 mm Hg in 4 dogs. Ringers lactate solution and bicarbonate were
given to correct haemoconcentration and acidosis. Examples of ECG
changes are shown in the figures. The legends give the times and
materially altered physiological variables for each ECG shown. All
traces were Lead II unless otherwise shown. Increases in P wave voltage
of between 0.15 and 0.26 mV raised P wave amplitude to over 0.4 mV in
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5 cases (Figure 31). In two of these there was no indication of an
increased RVP. There were smaller amplitude increases in 5 other dogs,
and 3 instances of P-R depression (0.05 to 0.10 mV) (Figure 31).
There were no instances of prolongation of the P-R interval in
excess of 0.13s. However there were 2 cases of apparently dropped
beats arising one as a result of an irregular P wave (Figure 32) and
the other as a result of a wandering pacemaker (Figure 33). Both occurred
in association with changes suggestive of myocardial ischaemia and both
episodes were brief and reverted spontaneously to normal dythmn. In
Figure 33 the heart rate was precisely halved 14 min after the onset
of systemic DCS.
Examples of ECGs suggestive of myocardial ischaemia are shown in
Figure 34. Corrected QT interval was prolonged between 0.02 and 0.07s
in 15 cases, the R wave was attenuated by 0.15 to 0.6 mV in 5 cases
and the S-T segment was depressed by 0.15 mV in 2 cases and elevated
by 0.20 and 0.40 mV in 2 cases. The T waves were flattened or inverted
in 15 cases and were increased by up to 0.6 mV in 3 cases to be at least
25 percent of the R wave amplitude.
There were only 2 instances of ardythmias arising without other
ECG changes. Ten dogs showed ventricular ardythmias. These included
2 cases of ventricular tachycardia, 4 cases of bigeminal dythmn, 3 or
multifocal and 2 of unifocal premature ventricular contractions
(Figure 35). Two different ardythmias occurred in the same dog.
It should be noted that by the end of each study 8 ECGs had not
returned completely to the control ECGs.
11.4 DISCUSSION
Electrocardiographic changes suggestive of right heart strain,
myocardial ischaemia and functional derangement were seen. All cases
had DCS identifiable by systemic changes as well as spinal cord DCS.
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Figure 31. ECG changes in decompression sickness. S-T, T and P wave
changes. A1 to 4 shows a sequence of changes including
S-T depression in A2 and A3. There is P wave peaking in
A3. After recompression all was restored to normal in A4.
A1 - Control BP 130/100 HR 118 PCV 43 pH 7.35
A2 - 12 min post-DCS 350/180 148 61 7.28
A3 - 2 min post-recompression 125/ 90 148 48 7.38
A4 - 88 min post-recompression 125/ 90 94 - -
B2 shows peaking of P and S-T elevation with a reduction in
R and an increase in S suggestive of right axis deviation.
B1 - control BP 150/120 HR 84 PCV 39 pH 7.37
B2 - 10 min post-DCS 112/ 65 100 50 7.28
B3 - 17 min post-recompression 130/ 94 91 37 7.29
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Figure 32. ECG changes in decompression sickness. S-T, T and P
wave changes. B and C show S-T segment and T wave changes
which continued after recompression in D. There is P-R
depression in B and E. E shows a slightly irregular
P wave with 2 prolonged recovery intervals. The P waves
look similar and not ectopic. The 4 regular negative
peaks are stimulus artifacts.
A - control BP 180/145
B/E-15/12 min post DCS 235/120
C - 29 min post recompression. 148/120
D - 58 min post-recompression 140/120






Figure 33. ECG changes in decompression sickness. S-T and P wave
changes. B shows P wave peaking and S-T segment changes.
D shows a transient bradycardia with a regularly
occurring ectopic P wave followed by a prolonged recovery
period.
A - control BP 144/108
B/D - 14 min post-DCS 200/120








ECG changes in decompression sickness. S-T and T wave







13 min post-DCS 108/ 78
2 min post-recompression 68/ 46





B2 and 3 show two stages of T wave changes which were
reversed in B4 on recompression.
B1 - control BP 135/110 HR 115
B2 - 14 min post-DCS 130/108 106
B3 - 4 min post-recompression 105/ 85 104
B4 - 33 min post-recompression 150/130 116
C2 shows S-T elevation with T wave inversion which
recovered on recompression in C3.
CI - control BP 120/ 90 RVP 26/0
C2 - 17 min post-DCS 90/ 45 38/0








Figure 35. ECG changes in decompression sickness. Arxtythmias.
A shows a period of unifocal premature ventricular
contractions with bigeminal dythmn, B shows a period of
multifocal premature ventricular contraction (Lead III)
and C shows a period of ventricular tachycardia.
A - 5 min post-DCS
B - 16 min post-DCS









The ECG indications of right heart strain were not necessarily-
associated with significantly increased right ventricular pressure or
hypoxaemia. There were 4 such cases. There were another 5 cases with
pulmonary hypertension or hypoxaemia which did not show ECG changes
associated with right heart strain.
Indications of the compromising of myocardial oxygenation may
result from severe hypoxaemia of which there were 4 instances. It seems
unlikely that in situ myocardial bubble formation would occur in such
a highly perfused organ. However coronary artery bubble embolism would
be a possibility. There was abundant evidence of intravascular bubbling
not least in the level of haemoconcentration seen in several cases
inspite of intravenous fluids and in the pulmonary hypertension. These
conditions may also cause cardiac arriythmias.
Evans et al. (1980, 1981) point to three other possible sources
of ECG changes resulting from central nervous system injury and
activation by the autonomic nervous system. These include head injury,
spinal cord compression and brainstem embolisation. Similar responses
could also follow brainstem, cerebral and spinal cord DCS. Studies
of acute cord compression produced sinus or nodal bradycardia, massive
hypertension, premature AV nodal or ventricular beats with AV dissociation,
ventricular tachycardia, bigeminal and trigeminal dythmns.In the DCS
cases there was one case of nodal bradycardia. All cases were prepared
with a low dose of atropine which might in some cases have blocked the
bradycardia as was reported by Evans et al., (1980) using higher doses,
there were several cases of transient hypertension, of which six out
of seven had ventricular ariiythmias.
Air embolisation of the brainstem through the vertebral artery
has been shown to produce a similar range of cardiovascular and ECG
changes (Evans et al., 1981). There were three cases in this series
where EEG amplitude loss was closely associated with ECG changes although
this did not include an ar&ythmia in one case. Only one of the three
cases developed hypertension.
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Evans et al. (1980) attribute the bradycardia to afferent nerve
injury creating vagal activity through the medullary reflex pathway.
They suggest that spinal afferent sympathetic nerve injury might cause
diffuse stimulation of the heart and vasculature. This results in
increased heart rate, contractile force and blood pressure causing a
reactive vagal hyperactivity. The resulting sympathetic-parasympathetic
imbalance causes arikythmias. In the study of brainstem mechanisms they
found that complete surgical and pharmacological autonomic blockade
failed to stop the tachycardia and hypertension (Evans et al., 1981).
As the catecholamine effects should have been blocked they postulated
an unidentified humoral agent released from the brainstem. As no such
blockade was present in the DCS cases an increase of stress released
catecholamines could also have contributed to the changes seen.
The occasional clinical cases of ECG changes associated with DCS
reported were not immediately reversed by compression treatment. In
this series of animal observations 8 out of 21 cases did not return
completely to normal after up to 2 hours of compression therapy. Very
few ECGs are recorded from cases of DCS and there would seem to be valid
reasons for increasing the frequency of such recording. Particularly
as there was about a 27 percent incidence of ECG changes in this series
covering a wide range of systemic derangement, and about 40 percent





12.3 The Pathological Mechanism of Decompression Sickness
12.4 Factors in recovery





The method developed for studying spinal cord DCS by means of
multiple evoked potentials proved effective in allowing diagnosis, a
degree of localisation and quantification of the lesions without
invasion of the spinal canal or neuraxis. The observations on the effects
of varying stimulus and recording parameters largely corroborated those
of earlier investigators. The comparison of the effects of chloralose
and pentobarbital on CEP revealed a considerable depression in amplitude
attributable to pentobarbital.
The comparison of anaesthetics did not include unanaesthetised
animals so no comment can be made on how CEP or SEPs deviated from
normal. In comparing these two anaesthetics Harding et al. (1979) observed
that pentobarbital reduced the number of active cortical neurons when
compared with chloralose. It has also been observed that barbiturate
anaesthesia in low doses tends to facilitate CEP but that higher (surgical
anaesthesia level) doses tend to depress CEP (Pimmel et al., 1976;
Dafny, 1978; Nordwall et al.,1979). Dafny attributes this to an effect
upon the reticular system. Abrahamian et al. (1963) also point to
an extralemniscal influence but on the later waves. Other authors
observed that in general only the late non-specific parts of the CEP
were depressed (Clark and Rosner, 1973; Allison et al., 1963). These
slightly conflicting observations may result from the maintenance of
different levels of anaesthesia and the fact that all those observations
which suggested that the early waves (< 100 ms) were unaffected, were
made in man. The tentative observation that the late positive wave
in the SEP recorded close to the root of entry might be affected by
anaesthesia, may be supported by Robson's (1971) observation that
presynaptic inhibition is potentiated by barbiturates leading to mono¬
synaptic reflex depression. No dogs in the choralose experiments were
prepared for SEP measurement. However, it seems probable that relative
to the unanaesthetised state and to chloralose anaesthesia, the SEPs
were also depressed by pentobarbital as seen by Nordwall et al. (1979).
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Rosner and Clark (1973) observed that pentobarbital caused a reduction
in excitatory activity in cord and suppression of transmission in small
fibres (cutaneous) in the antero-1ateral columns at moderate doses.
These findings are all largely in accord with those of Albe-Fessard
et al. (1970) who compared these two anaesthetic agents.
Pimmel et al. (1976) also found that increasing stimulus and its
duration increased CEP amplitude and that it was reduced by increasing
rate. They found that durations greater than 5 ms and rates greater
than 3 Hz distorted the CEP. Cracco and Bickford (1968) observed in
awake humans that CEP amplitude plateaued beyond 0.1 ms stimulus duration,
although they experimented with a duration of 0.3 ms and rates of 1
- 3 Hz. Matthews et al. (1974) saw that CEP amplitude continued to
grow and latency to shorten, as stimulus increased up to about three
times motor threshold- The cervical SEP was unaltered by rates up
to 10 Hz although CEP was reduced. The findings in this study were
generally in accord with these, although beyond 5 Hz there was a slight
tendency for the late P wave amplitude in SEP to fall. Nordwall et
al. (1979) successfully recorded the travelling waves at rates up to
30 Hz.
The effect of bandpass limits has been investigated by Desmedt
et al. (1974). It was confirmed that the upper limit should not be
less than 3 KHz. The lower limit used was 30 Hz which cost some CEP
amplitude reduction but was necessary in order to view P2 (latency
25 - 33 ms). This bandpass had little effect upon the SEP.
The key to revealing the cortical FFPs was the increased separation
of the reference electrode from the active cortical electrode by placing
it in the distal end of the nasal bones. Iragui-Madoz and Weiderholt
(1977) also found this. They also observed that a large distance between
active and reference electrode which crossed the cardiogenic electrcal
field made EPs prone to ECG breakthrough. The problem of episodic
ECG breakthrough was never entirely solved, although many approaches
to earthing it with multiple needle earths and a chest plate earth
were tried.
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It was necessary to avoid tying the EP average to the ECG QRS
complex because the decompression sickness sometimes caused severe
arfiythmias which could prevent EPs being observed altogether. The
alternative of increasing the numbers averaged would have entailed
an unacceptable time penalty.
The increased complexity of the SEP seen with the bipolar configura¬
tion was preferred to the larger amplitude but less detailed SEP
obtained with monopolar electrodes by others (Cracco, 1973 and Ertekin,
1978). As in this study, Ertekin (1978) and Sarnowski et al. (1975)
observed that SEP amplitude and definition depended upon the proximity
of the electrode to the cord. The driving of the electrode into the
lamina essentially produced an epidural SEP. An additional advantage
was the anchoring of the electrode so eliminating the possibility of
movement artifact.
Complex analytical methods (John, 1974; Dill et al., 1976) were
considered but as the examples of EP during cord DCS show,fine
discrimination techniques were hardly necessary and the simple additive
method proved satisfactory.
The 2°C deviation from the mean rectal temperature of about 38°C
produced no observable change in the EP. Greater extremes do adversely
affect EPs (Aunon et al., 1977; Budnick et al., 1981; Dubois et al.,
1981).
The observation of the reduction of late slow P waves in SEPs
after neuromuscular blockade have been seen before with d-Tubocurarine
(Lindbolm and Ottosson, 1953). The late P waves clearly represent
local events and have been temporally linked to segmental reflexes
(Gelfan and Tarlov, 1955). In view of the failure to observe any change
as a result of rigid joint fixation and the changes seen with muscle
relaxation, it seems that the affected components may be muscle
afferents.
The first three primary cortical waves P^, and were observed
to the exclusion of the later waves which were more variable. The
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observed mean latencies in all groups studied were comparable with
those observed in dogs by Norrsell (1966), Parker (1978a), Parker (1978b),
Norrseli, in cord transection experiments, showed that the
components were transmitted ipsilaterally in the dorsal columns and
in the dorsal part of the lateral funiculus. He also observed that
waves with the latencies of P^ and later were transmitted through
both ipsilateral and contralateral ventral funiculi.
While remembering that species differences exist in the neuroanatomy
(Arezzo et al., 1979), similar findings were reported by Simpson et
al. (1981) in monkeys. Large diameter fibr-es in the dorsal columns
contributed to waves of latency less than AO ms and small diameter
fibres in the antero-lateral columns contributed to latencies greater
than 70 ms. The waves between 35 and 70 ms a contribution
from both columns. These findings are generally supported by human
work which shows that cord lesions which cause the greatest reduction
in the early CEP waves are associated with impairment of vibration
and position sense while the lesser impairment of the P2^2^3 waves
is associated with loss of pain and temperature sense (Sances et al.
1978; Yamada et al., 1979; Dorfman, et al., 1980).
Between four and seven FFPs were commonly observed in the CEP,
the majority preceded . They could be observed bilaterally with
a unilateral stimulus. They were most pronounced with median nerve
stimulation which on occasion showed as many as 11 FFPs. The earliest
observed was the stationary wave closest to the stimulus which was
sometimes also seen in the SEP and is attributed to the entry of the
dorsal root to the cord. There do not appear to be descriptions of
FFPs in dogs in the literature, and as their origin in the dog was
not investigated here, any conclusions regarding their site of origin
remain speculative. The fixed nature of their latency indicates that
they are volume conducted potentials arising from events fixed anatomically.
Wiederholt and Iragui-Madoz (1977) using rats, observed four FFPs
on the rising slope of P^. They attributed them in sequence to dorsal
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column, dorsal column nucleus and medial lemniscus, ventral posterior
thalamic nucleus and sensory radiation and possibly also cerebellar
pathways and cerebellum. Using cats allowed a better separation of
the FFPs and they were localised to dorsal column, dorsal column nucleus
and/or medial lemniscus, cerebellum and/or cerebellar pathways, ventral
posterior nucleus of thalamus, sensory radiation and with some thalamic
contribution (Iragui-Madoz and Weiderholt, 1977). Human work has
produced similar observations but with more complexity, including
observation of the peripheral nerve or dorsal root (Cracco and Cracco,
1976; Anziska and Cracco, 1980; Desmedt and Cheron, 1980; Pratt and
Star, 1981). Future work may produce more detailed knowledge of these
origins, as clearly if up to 11 FFPs can be seen in this study, those
smaller numbers reported by other authors may be broken into more
separate peaks.
Gasser and Graham (1933) reported cord dorsum potentials following
dorsal root stimulation in the same segment which produced a short
latency spike compatible with A fibre transmission. This was followed
by a large negative potential and a slow positive wave which were
labelled intermediary potentials and attributed to internuncial neurons.
This distribution was localised and attributed to the ascending and
descending branches of the dorsal root nerve which give collaterals
to the grey matter. The ascending branch, now smaller continues to
the dorsal column nucleus. Barron and Matthews (1938) considered that
the slow waves represented local reflex activities and that the spike
potentials in the cord were axon volleys whose latency increased with
distance from the stimulus. This interpretation has since been modified
by Bernhard (1953), Bernhard and Widen (1953), and Gelfan and Tarlov
(1955). They suggest that the large negative potential associated
with the root entry zones at and is post-synaptic and ipsilateral,
and represents converging interneuronal activity, some part of which
is associated with multisynaptic reflexes taking place in the posterior
horn of the grey matter (Lindblom and Ottosson, 1953; Ertekin, 1976).
they also observed that the distribution of amplitude of the positive
intermediary waves had a rostral skewness around the four or so segments
of the root entry zone. Opinion differs as to whether the positive
wave is related to reflex activity or to primary afferent depolarisation
of propriospinal neurons extending over several segments.
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The bipolar records generally showed more axonal volleys than
those authors single initial positive and axonal volley. This probably
reflects the use of supramaximal stimulation of a distant peripheral
nerve allowing time for separation of synchronous volleys in axons
of different sizes, and therefore, different conduction velocities.
The similarity of their root entry segment potentials recorded from
the cord dorsum and these records suggest the these records are
basically those which might be recorded from cord dorsum although the
activity seen is not necessarily confined to the dorsal columns. Others
using similar electrode placings but with monopolar recordings found
less complex waveforms than those seen in this study (Nordwall et al.
1979; Holliday et al., 1979).
It was observed that as the recording site moves rostrally,
additional peaks separated from those evident around the entry segment.
These progressively lost amplitude and increased in latency with a
wider separation of peaks as the distance increased. It is assumed
that the loss of amplitude is the result of the giving off of collaterals
so that neuronal bulk is reduced, and that the apparently different
conduction velocities represent axons of different sizes or synaptic
activity (Sarnowski et al., 1975). It would be fair to assume that
the variation in axonal size is a continuum. Therefore, in order to
account for the clear separation of peaks, it must be assumed that
different groups of similar sized axons are synchronous and are perhaps
grouped by modality, these need not be separated as discrete bundles
anatomically. It was not possible to correlate different SEP peaks
with cortical FFPs or with a particular anatomical position in the
cord but it is presumed that the earlier and larger peaks contribute
most to the CEP, and are therefore, mainly in the dorsal column.
Certainly the late peaks may be lost in DCS without apparent change
in the CEP, and the early peaks must change in order for CEP to change.
In dogs, dorsal column potentials recorded from light touch, hair,
joint movement, and deep pressure can also be produced by peripheral
electrical stimulation. However, the physical stimuli cannot be detected
in the antero lateral column (spinothalamic), although the electrical
stimulation produces a response commensurate with A/3 and AS fibres.
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the so-called "fast-pain fibres" (Illingworth and Molina-Negro, 1974).
Shimoji and Kano (1975) recording epidurally in man found that moving
from the posterior to the anterior space simply inverted the potentials
recorded dorsally which suggests that all cord activity can be observed
from the cord dorsum.
Clinical and experimental experience suggests that the use of
SEP and CEP has considerable potential in predicting outcome and in
monitoring cases of acute cord injury (Nash et al., 1977; Rowed et
al., 1978; and Parker, 1978b). In practice it has been found to be
a useful method for diagnosing and quantifying the DCS spinal cord
lesions in studies of treatment. It remains to be seen how the changes
observed would relate temporally to symptomatology in man. It would
be impractical to use SEPs in the diagnosis or quantification of DCS.
However the technique might have a place in post-treatment follow-up
in cases liable to residual damage.
The validity of the evoked potential method was demonstrated by
the finding that no major changes in SEPs were seen unless there was
severe disruption of blood flow. In practice this meant 'neuron-
disabling blood flows of less than 6 and 15 ml 100 g ^ min *
respectively for white and grey matter (Branston et al., 1974, Hallenbeck
et al., 1982).
12.2 THE DIVE
The development of the 10 bar (300 ft) dive produced a model of
moderate to severe decompression sickness. The systemic upset ranged
from mild, which needed little support, to severe enough for about
15 percent to be lost as a result of cardiovascular collapse. Of those
45 dogs included in the final studies only 25 percent required a second
dive to produce DCS with cord involvement. The spectrum of evoked
potential findings was similar to human clinical experience with occasional
occurrences of spontaneous recovery, transient worsening on compression
(6 cases) and extensive deterioration after some recovery,to levels
worse than before treatment (2 cases). While there is no doubt that
most cases were more severely affected than the average human case,
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localised unilateral cord involvement was seen with only minor systemic
changes. In view of the total unpredictability and inability to dictate
the nature of DCS the attrition rate in this model was surprisingly
low. Animals were maintained during the surface period with infusions
of lactated Ringers solution and bicarbonate. No additional therapy
was given.
In the search for the required model of DCS two other useful models
were found. Cerebral DCS which is an infrequent diving problem could
be studied using the 300 ft dive. Decompression in 5 min produces
a useful incidence of cerebral DCS without too frequent overwhelming
systemic disturbances. The frequency and severity of cerebral and
systemic problems can be controlled by slowing the ascent from 60 ft
to take up to 1.5 min. Even at this rate the frequency of cerebral
DCS did not fall below 50 percent. It is possible that a change in
posture by lowering the dogs heads would further reduce the incidence.
The earlier 230 ft (8 bar) dive produced severe DCS and was
probably more akin to 'blow-up' . Certainly that model could not be
contained to enable delayed treatment to be studied.
12.3 THE PATHOLOGICAL MECHANISM OF DECOMPRESSION SICKNESS
The most widely accepted explanation of the mechanism of spinal
cord DCS is probably the venous obstruction model of Hallenbeck et
al. (1975). Hills and James (1982) have argued against it not very
convincingly with a proposal of autochthonous bubble formation. While
Hennessy (1980) would suggest that all the arguments lie with arterial
obstruction. As with most ideas in diving none of these hypotheses
is: new (Boycott et al, 1908; Haymaker, 1957).
Although the objective in this study was to refine the ideas on
treatment, it proved impossible to avoid the issue of the mechanism
of cord DCS because of the conflicting observations.
At all phases in the study the same conflicts were seen. The
control of the animal model was continually refined so that at each
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phase the insult was less severe. For instance in the last two phases
cerebral DCS fell from 72 to 50 percent and the frequency of CSF
pressure rise, fell from 92 to 65 percent.
In general the systemic changes were in keeping with the venous
obstruction model. There was a high incidence of raised CSF pressure
compatible with EVVS obstruction which preceded by varying intervals,
changes in SEPs indicating cord DCS. Increases in RVP were also
frequent at about 66 percent in both groups. However, there were 9
cases where CSF pressure did not increase although cord lesions did
develop. This is theoretically possible with a very localised EVVS
obstruction and associated intramedullary circulatory block. However,
there can have been no gross venous obstruction. Hallenbeck et al.
(1975, 1976, 1978) repeatedly report that at no time did they observe
any evidence of cerebral DCS. However even in the final study reported
here there was a 50 percent incidence. This cannot be entirely
attributed to posture but must in part be attributed to the nature
of the DCS arising from two different dive models.
The blood flow studies produced additional conflicting findings.
Hallenbeck and Sokoloff (1978) observed that the cords in paretic dogs
usually had uniformly low flows of less than 5 ml 100 g ^ min ^ in
affected segments. They did not observe the unilateral disruption
seen in 86J and 86P (Fig. 19). They argued that the uniformity was
the result of bilateral epidural vertebral venous obstruction, stating
that "mottled" unilateral changes would need to be seen to support
the possibility that the cord ischaemia was due to circulating arterial
gas bubbles. These results therefore raise that possibility, particularly
when seen in association with discrete brain lesions (86J). The EEG
attenuation and foci of autoradiographic flow impairment in the brain
indicate the probability of circulating arterial bubbles in several
animals. Nevertheless, the observed unilateral cord ischaemia is also
compatible with subsequent local events such as increasing vascular
resistance and autochthonous bubble formation accompanying unilateral
epidural vein obstruction, as noted previously (Hallenbeck, 1976).
There is little doubt that intravascular gas was present. The
flow studies demonstrated vascular obstruction and of the 45 dogs in the
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final studies 35 showed a transient fall of blood pressure immediately
on compression. This is very suggestive of intravascular gas causing
increased peripheral resistance. No ready explanation is available
for the 6 cases of deterioration occurring during compression. There
was no particular association with pure or even a high P02• The cases
were randomly distributed. Transient vessel collapse on compressed
bubbles might reduce blood supply.
Venous obstruction cannot be applied as an explanation of cerebral
DCS. This must be either arterial in origin or the result of autoch¬
thonous bubble formation. In seven dogs in the last two studies there
was a rise in RVP before or coincident with the fall in EEG amplitude.
Such a rise in RVP with the associated respiratory acidosis and
hypoxaemia indicates pulmonary vascular bubble overload and the
probability of bubble break-through leading to arterial gas embolism
(Butler and Hills, 1979). There remain 21 other dogs with EEG losses
which were generally the first signs of DCS. There is therefore a
strong possibility that autochthonous bubble formation could be the
mechanism in these cases.
The distribution of haemorrhages in the cords of 9 dogs with DCS
showed partial grey matter sparing in only 8 out of 34 cord segments
showing any degree of haemorrhage (Table 34). Grey matter sparing
is said to be compatible with venous obstruction while arterial
occlusion affects grey matter particularly in the watershed regions
(Henson and Parsons, 1967). The cord sections presented a picture
apparently dominated by evidence of arterial obstruction with
haemorrhages concentrated in grey matter. However this presentation
is also compatible with general hypoxaemia.
Although systemically the presentation of DCS did not conflict
with the venous obstruction model of Hallenbeck et al. (1975), the
frequency of cerebral involvement and the dominance of cord grey matter
haemorrhages and unilateral SEP loss in 9 dogs is at variance with
that model. This reinforces the probability that arterial and autoch¬
thonous bubble formation have more than an incidental role in the
pathology of cord DCS in this model. Crockett et al. (1979)
reported examples both with and without grey matter sparing. Palmer
167
et al. (1978) saw extensive grey matter haemorrhages associated with
white matter infarction in goat cords. The question then arises as
to whether the different microscopic appearances represent cord DCS
arising from different dive profiles and therefore of different
severities.
Although a large number of clinical cases of cord DCS have been
reported few have been documented with even moderate systemic distur¬
bances (Barnard et al., 1966; Brunner et al., 1964; Moretti et al. ,
1973; Rivera, 1964; Saumarez et al., 1973; Slark, 1963; Van der Aue
et al., 1947). What human evidence exists for venous obstruction is
based on morbid pathology (Bauer, 1870; Hayashi, et al. , 1978; Kitano
et al., 1977). Other animal work has similarly resulted in near
moribund cases (Walkiewiecz et al., 1979). This lends support to the
idea that particular dive profiles may produce a particular form of
pathology. It would appear that the 10 bar dive for 15 min produces
a full spectrum of pathology.
12.4 FACTORS IN RECOVERY
Outside the factors of oxygen and pressure in treatment there
are undoubtedly uncontrolled factors related to the pathology which
influence the extent of recovery. There was no relationship between
the amplitude loss of the controlling SEP and the amount recovered.
There was also no relationship between the amount of SEP loss and
the number of cord divisions affected. The only clear relationship
indicated that earlier SEP loss led to less chance of recovery. This
experimentally corroborated Riveras (1963) observations that early
onset led to more residua. However there was no connection between
onset time and amount of SEP loss. There did not appear to be any
connection between the severity of systemic disturbance and recovery.
This latter observation probably arises from the efforts made to combat
systemic changes and the exclusion of those dogs which failed to meet
the inclusion criteria.
To simplify the discussion pure ischaemia will be considered
first. Cord and CNS survival has been studied using basically three
techniques; global and local ischaemia broadly as described earlier,
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interruption of blood supply by vessel clamping or by bleeding and
hypotension, and by asphyxia and anoxia. The effects of these insults
after restoration of blood flow or oxygenation have been followed using
blood flow studies, pathology, electrical function and clinical
recovery.
Cord neuronal survival has been investigated in a setting of
global or local ischaemia produced by rasing CSF pressure. This
method by emptying the neuraxis of blood appears to provide some
protection against secondary deterioration resulting from blood-
damaged tissue interaction (Hallenbeck, 1977). Neely and Youmans
(1963) found some degree of neuronal recovery following 25 min of
ischaemia, while Wolfe (1960) found a 100% mortality in animals
subjected to only 5 min of circulatory arrest where the neuraxis blood
was left in situ. Similarly, Van Harrevald and Marmont (1939) found
some survival and functional recovery following not more than 25 min
of localised cord pressure ischaemia ("bloodless ischaemia"). Longer
periods produced less recovery.
The relative vulnerability of the cord components has mostly been
observed in experiments with vessel clamping or hypotension, and has
been shown to be related to their capacity to recovery from anoxia.
Whatever the cause of the insult to the cord, the overall findings
are similar both in type and in timing, although asphyxia tends to
produce later effects (Gelfan and Tarlov, 1955).
The local events are the earliest to be affected, with a facili¬
tation of reflex related local potentials in the SEP and of reflexes
within the first minute (Bernhard and Roll, 1953; Brooks and Eccles,
1947; Gelflan and Tarlov, 1955; Porter et al., 1938). These may reflect
a loss of inhibitory activity. Thereafter, by 3 to 5 min, the reflexes
and segmental negative and positive SEP waves have disappeared (Wang,
1959).
Prolonging the insult progressively reduces the amplitude of the
travelling SEP waves, the intramedullary primary afferents, until no
activity is detectable by 8 to 20 min (Cracco and Evans, 1978; Gelfan
and Tarlov, 1955, 1956; Kobrine et al. , 1979, 1980). Motoneurons cease
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to function within 2 min of ischaemia or 3 to 5 min of asphyxia; inter-
neurons and afferent long tract fibres last about 1.5 and 2.5 times
as long respectively (Gelfan and Tarlov, 1956).
Removal of the insult within 5 min of the onset of the electrical
silence of the component will generally restore much of its function
(Brookes and Eccles, 1947; Kobrine et al., 1979, 1980). In terms of
overall ischaemia or asphyxia, a duration of the insult in excess of
15 min appears to result in some permanent loss of function and
detectable microscopic pathology (Gelfan and Tarlov, 1955, Tureen,
1936; Van Harreveld and Marmont, 1939). Restoration of blood flow
or oxygen after 4 to 15 min of absence seems to restore function
completely without permanent pathology, at a rate directly
related to the duration of the insult (Bernhard and Koll, 1953;
Brookes and Eccles, 1947; Gelfan and Tarlov, 1955; Tureen, 1936).
The most rapid recovery is in the large long tract neurons (Gelfan
and Tarlov, 1955).
It is now well established for cerebral blood flow that there is
a threshold of blood flow below which function ceases., the "ischaemic
penumbra" of "neuron-disabling" flow (Astrup et al., 1981), but where
increasing the flow will rapidly restore function (Branston et al.,
1974). It can therefore be assumed that some cord DCS is the result
not of complete microcirculatory arrest but of marginally adequate
perfusion. In view of the now defined survival limits of cord tissue
in total ischaemia, reduced blood flow remains the only alternative
explanation, besides the existance of the smallest discrete areas of
vascular obstruction, for the possibility of any degree of recovery
of function after long delays before treatment. A current unknown is how
long can "neuron-disabling" flows exist before the neurons become
irretrievably damaged or flow ceases altogether as a result of the
haematological events triggered by DCS? If neuron survival is prolonged
then all cases, no matter what delays occur, should be treated.
From the pathology the only indication of factors related to
recovery were that those with least haemorrhage tended to do better
than those with most. However the numbers were too few to be sure
that there was no association between onset time and numbers of
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haemorrhages. There was no correlation between frequency of haemorrhage
and previous hypertension. Discussion must come down to speculation
about events at a cellular level such as autochthonous bubble formation.
There is a lag time of about 5 min between onset of ischaemia and loss
of SEP, but tissue compression as might be caused by autochthonous
bubble formation would cause sudden SEP loss. In view of the number
of dogs in which such an event may have occurred in the brain this
becomes a strong possibility in the cord. In fact in the last two
studies, three dogs showed an SEP loss within 4 min of surfacing.
This might indicate autochthonous bubbles. The question of the relative
damage caused by autochthonous bubbles versus vascular obstruction
arises. If haemorrhage does not occur with vascular obstruction then
integrity is probably preserved. Recovery then becomes a matter of
the duration and degree of ischaemia.
Intuitively it seems likely that autochthonous bubbles formation
in neural tissues must disrupt neural integrity. If it damages cells
or axons then recovery is unlikely. However if the damage was
confined to myelin then the possibility of repairable damage might
exist. Such a propostion would allow for some of the long delayed
recovery now largely attributed to adaptation. Clearly severe myelin
disruption would damage axons thus causing permanent loss.
If vascular obstruction is a major mechanism in cord DCS then
a high perfusion pressure should be beneficial in treatment. However
in the normal cord, blood flow is constant within a range of mean blood
pressure of 45 to 135 mm Hg (Sandler and Tator, 1976). Precisely how
this affects fo cally damaged cord remains unclear. In stroke it is
believed that hypotension should be avoided in order to maintain
perfusion in the marginal areas (Astrup et al., 1981). Any influence
of blood pressure on recovery was removed. However the secondary
effect of haematocrit was not entirely eliminated during the oxygen
study.
In these studies the absolute level of recovery may have been
enhanced by the use of pentobarbital anaesthesia. This suppresses
neural metabolism so reducing oxygen demand (Feuslet et al., 1981;
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Astrup et al. , 1981). As this was common to all treatments it cannot
be considered to have influenced the outcome of the experiment.
12.5 TREATMENT WITH OXYGEN AND PRESSURE
Having demonstrated a difference in efficacy for a range of oxygen
partial pressures all at the same absolute pressure, it is necessary
to attribute the difference to some property of the oxygen. As there
were few systemic differences between the groups only the nature of
SEP recovery remains. The acute response to treatment suggested an
optimum treatment of 2.0 bar P02. Pressure was beneficial but a P02
between 1.0 and 1.5 bar did not produce much additional recovery,
1 and 2 dogs respectively showed further notable recovery with those
treatments. The initial poor response could be attributable to
inadequate tissue oxygenation because physically all groups received
the same compression. In addition inert gas clearance would be
slower in the low oxygen groups. These two factors could lead to
a longer early hypoxic period which would lead to further cell death
thus reducing longer term recovery.
At the higher P02 of 2.5 and 3.0 bar there would be vasocon¬
striction (Torbati et al., 1979) even in the damaged tissue (Ledingham,
1977). While the increased inert gas gradient would hasten the
clearance of bubbles, the vasoconstriction with reduced flow would
retard bubble clearance and restoration of flow. The extended capacity
for oxygen diffusion which probably meets the greatest need (Astrup,
et al. 1981) would preserve hypoxic tissues for sometime enabling
them to recover later when perfusion was restored. However the
vasoconstriction could reduce the oxygen supply. Certainly 5 and
4 dogs respectively showed further improvement during treatments.
Other factors play a part in secondary deterioration. Arterial
air emboli cause endothelial damage in less than 3 min with resultant
fluid and macromolecule leakage causing vasogenic oedema (Vise et
al., 1978). If the surrounding tissue has been ischaemic sufficiently
long then cytotoxic oedema will also develop. When flow is restored
within 60 min cytotoxic oedema lessens only to be replaced by vasogenic
oedema (Ito et al., 1979). The variable deterioration between cases
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may reflect such factors as the amount of intravascular gas and poss¬
ibly the duration of its presence.
Other possibilities are the development of secondary post-
ischaemic microcirculatory impairment,and tie'no-reflow' phenomenon.
These arise from blood-damaged tissue interaction (Hallenbeck et al.,
1982). There are also the products of blood-bubble interactions
(Philp et al., 1972). Flow is initially restored but is then reduced
as a form of local coagulopathy develops (Hallenbeck et al., 1982).
Either of these mechanisms may have caused the secondary
deterioration, which exceeded what would have been caused by time
alone in the model. The only indication that any of the treatments
had a better preventive action than any other is that the 5 dogs which
did not deteriorate noteably were breathing 2.0 or more bar of
oxygen. The main advantages of 2.0 to 2.5 bar of oxygen in treating
spinal cord DCS appear to have been effective in the early stages
of treatment. This implies that tissue oxygenation is probably the
mainstay of oxygen therapy in the initial treatment of DCS. However
if all the dogs treated with a P02 of 2.0 bar or more, are compared
with those treated with a lower P02 for the frequency of no signifi¬
cant secondary deterioration (< 5%). It is seen that there were 15
out of 35 dogs treated with higher oxygen and none out of 10 in the
lower oxygen groups.
Buckles (1968) observed that as DCS developed in hamsters small
bubbles coalesced as they arrived, first in the arteries and then
in the veins. Bubbles appearing in the veins also travelled distally
filling from large vessels. For arterial bubbles to enter arterioles
required an adequate perfusion pressure. Small bubbles became
sausage shaped as they coalesced. Film of bubbles in larger vessels
showed that they tended to remain spherical (Hallenbeck, 1976).
Interstitial bubbles would be unable to coalesce and would probably
be distorted by structures. However for practical purposes they may
be considered spherical. Compression caused arterial bubbles to move
distally and to break up while venous bubbles moved proximally and
broke up (Buckles, 1968). Some bubbles remained adherent to the
vessel wall and shrunk until they were reabsorbed in situ. Both
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venous and arterial bubbles were seen to be circulating for up to
10 min after recompression.
The use of Boyles Law to determine what would be an appropriate
treatment pressure founders on not knowing the nature and location
of the offending bubbles. In lozenge shaped bubbles volume must be
reduced before reduction in diameter can occur as it does in
spherical bubbles.
Compression to 3 bar reduces surface volume to 33 percent and
diameter to 69 percent. At 5 bar this is 20 percent and 58 percent
respectively and at 7 bar it is 14 percent and 52 percent. Evidently
the law of diminishing returns becomes relevant for diameter before
it does so for volume. Volume is dramatically reduced by moderate
compression but it takes much greater pressures to similarly reduce
diameter.
Kunkle and Beckman (1983) in discussing bubble resolution
conclude that because of the increased inert gas tension inherent
in breathing air at 6 bar, the enhanced reduction in bubble size
is countered by the reduced rate of gas clearance. This results in
a smaller rate of bubble clearance to that found while breathing
oxygen at 2.8 bar. The advantage of greater pressures is supposed
to be the rapid initial reduction in bubble size for the early
restoration of circulation.
The objectives in treatment are to stop further bubble growth,
restore oxygenation and circulation, and to increase inert gas
clearance. It is axiomatic that compression and a raised P02 are
necesary to achieve these aims. It has now been established that
an optimal P02 is about 2.0 bar. This has the advantage of being
less toxic than the currently used P02 of 2.8 bar. The degree of
vasoconstriction will be less which must be advantageous and it can
be breathed for longer periods without break. No effort has been
made to establish a pressure threshold in these studies but it has
been shown that pressures above 3 bar do not improve recovery in this
model. This conforms with the findings of Barnard and Hanson (1973)
and Leitch, et al. (1984a).
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A major remaining question is whether a failure of recovery at
a lower pressure can be reversed by further compression. In view
of the probable difference in pathology it seems unlikely. Certainly
there is little clinical evidence that further compression produces
a step improvement. It would take a difficult experiment to try and
test that hypothesis.
The disadvantages of breathing mixtures which include nitrogen
is that the nitrogen gradient is reduced. However breathing 34%
nitrogen at 3 bar only gives a PN2 of 1.02 bar; little more than
breathing room air at atmospheric pressure. In practice using 66%
oxygen at 3 bar does not appear to have any disadvantages when compared
with 2.8 bar of oxygen inspite of the additional nitrogen. Although
the outcome was the same the rate of recovery at the higher pressure
with the lower oxygen may be better. The reduction in risk from
oxygen toxicity would be the main reason to move away from the 2.8
bar oxygen treatment. The possibility of an increased rate of response
would also be a sound reason. A new treatment would take the form
of breathing 66 percent oxygen at 20 m (66 ft) for one or two hours
with a 10 min air break per hour followed by a bleed to 10 m (33 ft)
and a switch to oxygen and then complete a table similar to RN 62
(USN 6).
This model of spinal cord DCS now lends itself to testing
chemotherapy and also some of the more contentious treatment ploys
being suggested such as oxyhelium for treating air DCS.
12.6 DELAYED RECOVERY
Nine out of 35 dogs treated with oxygen at 2.0 bar or more
continued to improve throughout treatment. This was similar to
clinical experience. The maximum survivable period of ischaemia for
cord tissue is probably about 15 to 20 min. Successful late treat¬
ments suggest that the cord was not totally ischaemic but was in the
'ischaemic penumbra'. Transient recovery may indicate that oxygen¬
ation is sufficiently improved to restore function but that small
reductions in perfusion or oxygen can revert tissue to a non-
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functioning state. This'ischaemic penumbra' is the only rational
explanation for any response to compression in cases treated after
delays of days. In the success of repetitive therapies this would
also apply, but it is possible that non-functioning tissue might
need a greater than usual P02 to restore function, a sort of
physiological 'kick start'.
When late and prolonged recovery of function occurs after
cessation of pressure and oxygen treatment it must be assumed that
it is compensatory adjustment of remaining function, with activation
of normally redundant alternate sensory pathways and satellite
innervation of muscle fibres and not recovery of function (Brenowitz
and Pubols, 1981; De la Torre, 1981). Only when pressure and oxygen
are seen to have an effect is it possible to say that there is any





1. Spinal and cortical somotosensory evoked potentials have been
reproducibly recorded over periods of up to 5 hours. They were
recorded from multiple inputs and recording sites. Simultaneous
recording from 3 cord sites and the cortex allowed interroga¬
tion of gross cord segments.
2. It was demonstrated that while increasing air pressure caused
a progressive attenuation of the CEPs,the SEPs were not
significantly affected. Helium at the same pressures had no
attenuating effect.
3. It proved possible to diagnose and even apply numerical
values to spinal cord DCS using this model. It was demonstrated
that in a syndrome considered to be largely the result of
vascular obstruction, SEPs do not materially alter without
clear changes in spinal cord blood flows.
4. The provoking dive of 10 bar for 15 minutes produced a full
spectrum of systemic presentations of DCS and of cord pathology.
There was a commonality with clinical experience although the
results were clearly at the severe end of clinical experience
with frequent cerebral involvement.
5. The presentation of DCS generally tended to support the venous
obstruction mechanism of cord DCS. However the frequency of
cerebral DCS, cord grey matter haemorrhage, and very early onset
of SEP changes, suggest that autochthonous bubble formation and
arterial gas may have more than an incidental role in the
pathology of cord DCS.
6. It was confirmed that total cord ischaemia lasting more than
15 minutes is likely to result in only partial recovery of
function after restoration of blood flow. Once past 15 minutes
the duration of ischaemia is directly related to the amount of
permanently lost function. As there was about a 4 minute delay
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between onset of ischaemia and detection of SEP changes, 15
minutes was selected as the post diagnosis interval before
starting treatment in order to study the delayed treatment of
cord DCS. This proved to be an appropriate interval as few dogs
achieved full recovery at any time.
7. There was a strong association between poor recovery during
treatment and early onset of cord DCS. This, in association
with a tendency for poor recovery to be associated with exten¬
sive haemorrhage in other dogs, suggested that mechanical
tissue damage might be the problem. This lends support to the
possibility that early onset might be the result of autoch¬
thonous bubble formation which with its tissue disruption would
militate against recovery. Clinical experience tends to support
this observation.
8. In the more serious cases loss of plasma volume was a major
problem. There was a tendency for cases where haematocrit
was not adequately controlled to do less well than those with
lower haematocrits.
9. During treatment most recovery occurred by 15 minutes and group
mean recoveries tended to peak at about 60 minutes. Secondary
deterioration was common in all treatment groups. The only cases
to show minimal or no deterioration occurred in those groups
with 2.0 bar or more of oxygen.
10. Electrocardiographic changes were seen in 27 percent of cases
of DCS. At the end of 2 hours of compression therapy 30 percent
had still not returned to the control condition. This suggests
that in clinical practice moreattention should be paid to ECG
recording than is presently the case.
11. There is no indication that once a pressure threshold is exceeded,
the high levels of oxygen currently favoured for treatment are
better than lower oxygen levels. The lowest but at least equally
effective P02 was found to be the 2.0 bar.
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12. With the established optimum P02> there is no indication that
raising pressure beyond a threshold of the order of 3.0 bar
in any way improves SEP recovery.
13. The major outstanding question is whether cases which fail to
respond within 15 minutes at a lower pressure will improve if
taken to greater pressures. As it begins to appear that such
cases may be the result more of mechanical damage from autoch¬
thonous bubbles or from haemorrhage than of ischaemia, it is
likely that the answer will be no. It might be possible,
though difficult, to test this hypothesis with this model.
14. The anaesthetised dog model using evoked potentials to study
the treatment of spinal cord DCS has proved effective. It can
go on to test the use of helium or drugs to try and improve
recovery. It is probable that early recovery will not be
altered but that secondary deterioration might be reduced by
drugs. How valid extrapolation from this model to clinical
experience would be is unknown. It can only be said that the
course of DCS and recovery often mimicked the author's clinical
experience.
15. A new approach to treatment is proposed. It would be one to
two hours of 66 percent oxygen at 3 bar (20 m) followed by the
same duration of pure oxygen breathing at 2 bar (10 m). The
last 10 minutes of each hour would be spent breathing air. The
transit times between each stage would take 30 min. The form
is not much different from the current treatments RN 62 (USN 6).
The outcome with this new approach may not be any different from
current treatment. However the greatly reduced risk of oxygen
toxicity has much to recommend it. The presence of nitrogen
in the treatment mixtures is probably of limited significance
and would be well offset by the oxygen breathing at 10 m. Such
a protocol could be tested by doing a surface decompression dive
and doubling the surface interval before starting treatment.
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APPENDIX A
INDIVIDUAL DATA - OXYGEN STUDY
TABLE
A1 - Spinal Evoked Potentials - Primary Lesion
A2 - General Descriptive Data
A3 - Monitored Physiological Variables
A4 - Arterial Blood Analysis
1 po2 1.0 bar
2 p02 1.5 bar
3 p02 2.0 bar
4 p02 2.5 bar
5 o 10 3.0 bar
SYMBOLS AND UNITS
LP-L Left peroneal to lumbar SEP
RP-L Right peroneal to lumbar SEP
LM/p-C Left median to cervical SEP. Change first seen with
peroneal SEP
RP-T Right peroneal to thoracic SEP
* SEP recorded at pressure
[ ] ' Further SEP loss on compression




Pressures/Tensions - mm Hg
Fluid volume - ml
TABLE Al-1
TREATMENT WITH P02 1.0 BAR AT 5j0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 140 141 142 143 144
SEP RECORD LP-L LP-L LP-L LP-L RP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 111.3 96.6 96.0* 103.9 99.3
Pre-Diagnosis 105.9 92.0 104.4 101.0 97.6
Diagnosis (D) 65.5 78.3 89.3 84.0 64.9
Pre-R 20.9 71.9 7.9 25.1 [38.2]
& - 15 min 41.2 92.8 23.0 79.8 50.4
R - 40 min 31.7 79.5 20.0 76.1 52.7
R - 80 min 31.7 65.8 20.6 82.4 64.5
R - 120 min 30.7 35.0 18.6 67.8 56.9
LOSS OF SEP AND RECOVERY
% Lost 79.1 28.1 92.1 74.9 61.8
% Recovered @ 15 20.3 20.9 15.1 54.7 12.2
40 10.8 7.6 12.1 51.0 14.5
80 10.8 -6.1 12.7 57.3 26.3
120 9.8 -36.9 10.7 42.7 18.7
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min 25.7 74.4 16.4 73.0 19.7
40 min 13.6 27.0 13.1 68.1 23.5
80 min 13.6 0 13.8 76.5 42.6
120 min 12.4 0 11.6 57.0 30.3
ABSOLUTE CHANGE
Pre-Pre-D to Pre-D -5.4 -4.6 +8.4 -2.9 -1.7
Pre-D to D -40.4 -13.7 -15.1 -17.0 -32.7
D to Pre-R -44.6 -6.4 -81.4 -58.9 -27.6
Loss over com¬ 0 0 0 0 -31.3
pression
TIME INTERVALS (Min)
From Surface to D 9 10 6 13 24
Pre-D to D 4 5 5 2 4
D to R 15 15 17 15 15
Last SEP to Rr 0 8 4 0 0
TABLE Al-2
TREATMENT WITH P02 1.5 BAR AT 5.0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 150 151 152 153 154
SEP RECORD LP-L LP-L RP-L [LM/p-C] [LM/p-
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 110.7 101.8* 108.4* 97.2* 98.6*
Pre-Diagnosis 106.7 97.0 104.0 108.6 89.2
Diagnosis (D) 107.8 86.0 88.6 15.9 79.6
Pre-R 82.0 39.4 70.5 11.2 36.6
R 15 min 99.9 48.1 86.1 41.2 83.0
R 40 min 81.3 63.1 77.1 47.6 75.1
R 80 min 81.7 69.4 73.6 38.8 73.8
R 120 min 88.5 63.9 69.2 40.8 75.9
LOSS OF SEP AND> RECOVERY
% Lost 18.0 60.6 29.5 88.8 63.4
% Recovered @ 15 17.9 8.7 15.6 30.0 46.4
40 -0.7 23.7 6.6 36.4 38.5
80 -0.3 30.0 3.1 27.6 37.2
120 6.5 24.5 -1.3 29.6 39.3
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min 99.4 14.4 52.9 33.8 73.2
40 min 0 39.1 22.4 41.0 60.7
80 min 0 49.5 10.5 31.1 58.7
120 min 36.0 40.4 0 33.3 62.0
ABSOLUTE CHANGE
Pre-pre-D to Pre-D -4.0 -4.8 -4.4 +10.8 -4.7
Pre-D to D +1.1 -11.0 -15.4 -20.7 -9.6
D to Pre-R -25.8 -46.6 -18.1 -4.7 -43.0
Loss over com¬ 0 0 0 0 0
pression
TIME INTERVALS (Min)
From Surface to D 18 7 13 25 12
Pre-D to D 3 5 5 7 8
D to R 15 15 15 17 15
Last SEP to R 0 0 3 2 2
TABLE Al-3
TREATMENT WITH P02 2-0 BAR AT 5.0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 160 161 162 163 164
SEP RECORD LP-L RP-L RP-L LP-L LP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 93.0 97.5 96.4 110.8 101.3
Pre-Diagnosis 94.2 92.4 119.7 103.6 103.4
Diagnosis (D) 40.9 47.0 117.5 65.5 67.2
Pre-R 27.8 29.1 51.1 0 45.6
R 15 min 90.1 68.8 100.0 39.1 83.7
R 40 min 98.0 64.7 98.5 65.5 90.9
R 80 min 76.3 61.4 83.9 75.7 91.2
R 120 min 77.6 53.1 81.0 77.7 104.9
LOSS OF SEP AND RECOVERY
% Lost 72.2 70.9 48.9 100.0 54.4
% Recovered @ 15 62.3 39.7 48.9 39.1 38.1
40 70.2 35.6 47.4 65.5 45.3
80 48.5 32.3 32.8 75.7 45.6
120 49.8 24.0 29.9 77.7 59.3
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min 86.3 56.0 100.0 39.1 70.0
40 min 97.2 50.2 96.9 65.5 83.3
80 min 67.2 45.6 67.1 75.7 83.8
120 min 69.0 33.8 61.1 77.7 109.0
ABSOLUTE CHANGE
Pre-Pre-D to Pre-D +1.2 -5.1 +23.3 -7.2 +1.9
Pre-D to D -53.3 +4.6 -2.2 -38.1 -36.2
D to Pre-R -13.1 -67.9 -66.4 -65.5 -21.6
Loss over com¬ 0 0 0 0 0
pression
TIME INTERVALS(Min )
From Surface to D 19 14 20 22 24
Pre-D to D 7 5 6 5 4
D to R 15 18 15 15.5 15
Last SEP to R 1 5 0 1 1
TABLE Al-4
TREATMENT WITH P02 2.5 BAR AT 5.0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 170 171 172 173 174
SEP RECORD RP-T LP-L LP-L LP-L LP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 100.0* 94.4 84.5 109.3 97.6
Pre-Diagnosis 100.0 88.4 92.8 106.7 101.3
Diagnosis(D) 96.1 28.4 81.8 66.7 91.6
Pre-ft 16.9 0 8.6 46.7 85.4
B 15 min 71.4 27.6 43.5 94.7 91.1
ft 40 min 89.6 31.9 56.2 100.0 96.2
ft 80 min 88.3 31.0 62.8 94.7 98.1
ft 120 min 63.6 23.0 63.8 92.0 100.5
LOSS OF SEP AND RECOVERY
% Lost 83.1 100.0 91.4 53.3 14.6
% Recovered @ 15 54.5 27.6 34.9 48.0 5.7
40 72. 7 31.9 47.6 53.3 10.8
80 71.4 31.0 54.2 48.0 12.7
120 46.7 23.0 55.2 45.3 15.1
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min 65.6 27.6 38.2 90.1 39.0
40 min 87.5 31.9 52.1 100.0 74.0
80 min 85.9 31.0 59.3 90.1 87.0
120 min 56.2 23.0 60.4 85.0 103.4
ABSOLUTE CHANGE
Pre-Pre-D to Pre-D 0 -6.0 +8.3 -2.6 +3.7
Pre-D to D -3.9 -60.0 -11.0 -40.0 -9.7
D to Pre-ft -79.2 -28.4 -73.2 -20.0 -6.2
Loss over com¬ 0 0 0 0 0
pression
TIME INTERVALS (Min)
From Surface to D 20 21 20 25 10
Pre-D to D 20 5 4 5 5
D to ft 14 15 16.5 17 15
Last SEP to ft 2 5 5 1 0
TABLE Al-5
TREATMENT WITH P02 3.0 BAR AT 5.0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 180 181 182 183 184
SEP RECORD LP-L RP-L LP-L LP-L RP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 94.7 100.0* 100.7 85.2 100.0*
Pre-Diagnosis 82.9 100.0 101-8 95.3 91.4
Diagnosis (D) 70.9 77.4 80.1 69.8 69.5
Pre-B 42.4 23.0 55.5 0 [2.5]
B 15 min 70.9 77.4 80.1 38.3 7.9
B 40 min 70.9 87.1 85.2 57.7 8.4
B 80 min 76.1 58.5 74.0 39.6 10.9
B 120 min 71.4 62.7 79.9 40.9 14.4
LOSS OF SEP AND RECOVERY
% Lost 57.6 77.0 44.5 100.0 97.5
% Recovered @ 15 28.5 54.4 24.6 38.3 5.4
40 28.5 64.1 29.7 57.7 5.9
80 33.7 35.5 18.5 39.6 8.4
120 29.0 39.7 24.4 40.9 11.9
RATIO OR RECOVERY TO LOSS AS A PERCENT
15 min 49.5 70.6 55.3 38.3 5.5
40 min 49.5 83.2 66.7 57.7 6.0
80 min 58.5 46.1 41.6 39.6 8.6
120 min 50.3 51.6 54.8 40.9 12.2
ABSOLUTE CHANGE
Pre-Pre-D to Pre-D -11.8 0 +1.1 +10.1 -8.6
Pre-D to D -12.0 -22.6 -21.7 -25.5 -21.9
D to Pre B -28.5 -54.4 -24.6 -69.8 -67.0
Loss over com¬ 0 0 0 0 -7.9
pression
TIME INTERVALS (min)
From Surface to D 21 9 13 17 4
Pre-D to D 2 9 6 5 4
D to B 17 14 17 15 15
Last SEP to B 1 4 3 1 7
TABLE A2-1




























RVP T Time 4 6 6 14 13
CSFP ? Time 9 6 1 1 3
EEG A Time - 1 4 1 3
CEP X Time 9 1 6 11 3
SEP A Time 9 10 6 13 24
ECG A Time - - - 5 J
BP t Time - 12 10 - -
BP A Time - - - - -
BP A on com¬ -20 -25 -15 -35 -35
pression (mm Hg)
Fluid Balance(ml) +265 +420 +285 +210 +125
Pre-& Fluid 40 100 170 355 110
fr Fluid 400 470 190 0 90
Fluid Out 185 150 75 145 75
TABLE A2-2
TREATMENT WITH P02 1.5 BAR AT 5.0 BAR
GENERAL DESCRIPTIVE DATA
DOG 150 151 152 153 15'
Weight 10.0 13.6 10.9 9.1 11
Bottom Time 12 15 15 15 15
Ascent Time 5.5 5.7 5.0 5.3 5
2nd Bottom Time — 10 — — 12
2nd Ascent Time 5.6 - - 5
RVPT Time 16 6 1 4 8
CSFPT 16 6 2 1 6
EEG 4- - 3 4 1 6
CEP* 22 7 5 1 6
SEP* 17 7 13 25 14
ECGA - 3 21 - 6
BP T 24 - 14 14 6
BP * - 3 - 34 -
BPAon corn- -5 -15 -40 +10 -40
Fluid Balance +200 -35 + 130 +275 +450
Pre-& Fluid 80 95 60 402 100
& Fluid 300 300 180 0 480
Fluid Out 180 430 110 125 130
TABLE A2-3
TREATMENT WITH PO 2 2.0 BAR AT 5.0 BAR
GENERAL DESCRIPTIVE DATA
DOG 160 161 162 163 164
Weight 13.6 12.7 13.6 11.3 11.
Bottom Time 14 15 15 15 15
Ascent Time 5.6 5.0 6.0 5.3 5J
2nd Bottom Time _ — 12 12 _
2nd Ascent Time - - 5.0 5.0 -
RVPt Time _ 13 16 — 6
CSFPt ? 13 6 7 6
EEGJ, - - 16 7 11
CEP J, 16 18 20 7 11
SEP ir 16 14 20 22 24
ECG A - - - y y
BP t - - - - -
BP 4. - - - - -
BP A on corn- -5 -25 -20 -10 0
Fluid Blance +65 +295 +40 -45 +115
Pre-Br Fluid 60 100 40 no 30
R Fluid 180 295 250 70 185
Fluid Out 175 100 250 225 10C
TABLE A2-4
TREATMENT WITH P02 2.5 BAR AT 5.0 BAR
GENERAL DESCRIPTIVE DATA
DOG 170 171 172 173 17.
Weight 13.6 10.9 10.7 10.4 12
Bottom Time 12 15 15 15 15
Ascent Time 5.0 5.7 5.4 5.0 5
2nd Bottom Time _ _ _
2nd Ascent Time - - - - -
RVPT Time 8 _ _ 2
CSFPt 3 - 2 13 2
EEGJ. 3 - 6 - 2
CEP4- 6 12 6 25 2
SEP4. 20 12 20 25 10
ECG A - - y - -
BP T 13 - - - -
BP ± - - 6 - -
Bp A on com¬ -20 -25 -5 -10 -25
pression
Fluid Balance +270 -20 +210 +25 +290
Pre-R Fluid 245 30 130 20 210
R Fluid 65 100 140 60 180
Fluid Out 140 150 60 65 100
TABLE A?-5
TREATMENT WITH P02 3.0 BAR AT 5.0 BAR
GENERAL DESCRIPTIVE DATA
DOG 180 181
Weight 11. 3 10
Bottom Time 15 15
Ascent Time 5. 0 5
2nd Bottom Time 9 —
2nd Ascent Time 6. 0 -
RVPT Time 5 9
CSFPt 5 9
EEGJ. 1 -
CEP J, 1 11
SEPJ, 19 9
ECG A J -
BP t 19 10
BP i 5 15
BP A on com¬ -50 +35
pression
Fluid Balance +472 +305
Pre-B Fluid 380 120
B Fluid 320 285




































































































































DOG 140 141 142 143 144
a 15 Min
BP 118 93 153 145 127
RVP 26/4 16/4 28/0 22/0 12/8
CSFP 18 6 50 15 44
PP 100 87 103 130 83
HR 156 136 132 96 120
f 18 12 9 10 9
fetco* 0.76 0.76 0.94 0.76 0.86
Br 40 Min
BP 118 93 128 137 135
RVP 24/2 16/4 22/0 20/0 10/0
CSFP 13 6 45 15 48
PP 105 87 83 112 87
HR 156 136 120 108 135
f 14 12 9 8 8
FetC°a 1.08 0.73 1.01 0.98 0.91
80 Min
BP 113 73 118 118 122
RVP 16/0 12/2 19/0 16/0 8/0
CSFP 9 3 40 12 34
PP 104 70 78 106 88
HR 125 120 120 108 140
f 16 11 9 8 9
fetc°a 1.08 0.51 1.02 0.87 0.91
B 120 Min
BP 97 65 103 157 130
RVP 16/0 10/2 22/0 25/0 6/0
CSFP 7 2 44 11 30
PP 90 63 59 146 100
HR 125 120 108 156 144
f 10 11 9 9 10
fetco* 1.14 0.58 1.00 1.10 0.94
TABLE A3-2
TREATMENT WITH P02 1.5 BAR AT 3.0 BAR
MONITORED PHYSIOLOGICAL VARIABLES
DOG 150 151 152 153 154
CONTROL
BP 123 123 113 110 125
RVP 20/0 22/2 7 22/0 10/2
CSFP ? 5 8 5 9
PP (107) 118 105 105 116
HR 108 120 150 150 144
f 11 11 8 10 8
fetc°a 3.6 3.9 3.4 3.9 3.8
ARRIVE SURFACE
BP 135 113 100 123 107
RVP 20/0 22/0 7 24/0 36/2
CSFP ? 1 11 11 17
PP (127) 112 89 112 90
HR 96 160 120 135 150
f 10 12 5 8 18
Fetc°2 3.2 5.0 3.7 3.5 4.0
LOWEST PRE-Rr
BP 108 67 75 70 80
RVP 20/0 22/0 7 24/0 30/0
CSFP 7 1 10 11 14
HR 132 144 120 120 150
f 9 6 5 8 10
fetco* 2.7 3.5 3.7 3.5 3.6
HIGHEST PRE-R
bP 167 110 257 190 253
RVP 66/4 32/2 7 105/0 95/10
CSFP ? 7 82 32 60
HR 140 180 156 195 228
f 16 19 9 14 18
fetco* 3.3 5.0 4.3 4.9 4.0
PRE-ft
BP 108 110 149 . 70 77
RVP 66/4 32/2 7 30/0 32/12
CSFP 7 6 45 27 14
PP (83) 104 104 43 63
HR 132 150 150 165 168
f 9 6 9 14 12
fetc°2 3.3 3.5 4.3 4.9 3.8
TABLE A3-2 (cont.)
DOG 150 151 152 153 154
B 15 Min
BP 118 120 98 230 120
RVP 36/0 26/0 7 40/0 34/4
CSFP 1 7 28 30 15
PP (96) 113 70 200 105
HR 132 144 150 160 180
f 11 12 5 12 10
fETc°2 0.82 1.02 0.87 1.23 0.82
B 40 Min
Fp 117 120 113 143 68
RVP 34/0 26/0 7 25/0 22/0
CSFP ? 4 56 32 11
PP (97) 116 57 111 57
HR 108 144 96 206 120
f 12 16 8 14 10
fETC°2 0.82 0.99 0.85 1.07 0.92
B 80 min
BP 105 120 103 108 68
RVP 20/0 22/0 7 24/0 18/0
CSFP ? 5 48 28 11
PP (85) 115 55 80 57
HR 132 144 108 194 120
f 11 12 7 14 10
fetco* 0.83 1.00 0.82 00o•rH 0.92
B 120 Min
BP 112 125 122 107 72
RVP 22/0 26/0 7 25/0 8/0
CSFP ? 3 45 26 11
PP (96) 122 77 81 61
HR 144 180 120 160 120
f 14 14 6 14 8
fetc°2 0.84 1.00 0.87 0.95 0.86
table a3-3












































































DOG 160 161 162 163 164
R 15 min
BP 97 92 112 138 143
RVP 20/0 28/6 14/0 18/0 26/0
CSFP ? 3 6 18 9
PP (90) 89 106 120 134
HR 120 120 140 144 108
f 11 10 15 12 9
fETc°2 0.69 1.05 0.95 0.97 0.90
B 40 Min
BP 112 123 125 123 123
RVP 20/0 20/8 12/0 16/0 22/0
CSFP ? 1 5 16 11
PP (96) 122 120 107 112
HR 120 96 140 108 105
f 10 12 15 11 9
fetco> 0.63 1.05 1.14 0.80 0.94
B 80 Min
BP 112 123 115 113 118
RVP 20/0 20/6 10/0 14/0 22/0
CSFP 3 ? 1 14 11
PP 109 117 114 99 107
HR 84 96 140 108 108
f 7 12 12 9 8
fetc°2 0.95 0.84 0.86 0.86 1.00
R 120 Min
BP 108 125 120 120 115
RVP 16/0 22/6 10/0 14/0 20/0
CSFP 1 1 1 13 12
PP 107 124 119 107 103
HR 108 96 144 105 120
f 8 13 10 10 8
fetc°2 0.97 0.84 0.99 0.89 1.18
TABLE A3-4
TREATMENT WITH P02 2.5 BAR AT 5.0 BAR
MONITORED PHYSIOLOGICAL VARIABLES
DOG 170 171 172 173 174
CONTROL
BP 108 132 107 117 100
RVP 22/0 30/12 35/5 20/0 30/4
CSFP 14 1 10 8 5
PP 84 131 97 109 95
HR 132 144 150 150 120
f 11 16 13 11 8
fETc°2 3.4 4.2 3.8 3.2 3.5
ARRIVE SURFACE
BP 112 113 97 117 100
RVP 18/0 26/14 34/8 18/0 28/4
CSFP 40 2 11 13 12
PP 72 111 86 104 88
HR 132 132 150 132 132
f 12 12 11 9 8
fetco* 2.6 4.4 3.3 3.4 3.7
LOWEST PRE-ft
BP 80 108 77 100 70
RVP 18/0 24/12 34/3 18/0 28/4
CSFP 21 2 11 5 12
HR 132 120 144 132 105
f 8 8 4 9 6
fETc°2 2.9 3.6 2.9 3.4 3.7
HIGHEST PRE-R
BP 152 118 98 117 100
RVP 60/8 32/22 36/6 28/0 85/3(
CSFP 35 7 18 13 38
HR 144 150 160 144 132
f 13 16 12 10 8
fetc°2 2.9 4.4 3.3 4.4 3.9
PRE-R
Bp 112 118 92 110 70
RVP 22/0 32/22 37/4 28/0 38/6
CSFP 25 7 11 11 1
PP 87 111 81 99 (57)
HR 140 120 144 144 105
f 11 16 11 10 6
fetc°2 3.1 4.2 3.3 4.4 3.9
TABLE A3-4 (Cont)
dog 170 171 172 173 174
ft 13 min
bp 115 118 97 113 120
rvp 25/0 22/10 36/7 20/0 32/8
csfp 25 1 30 12 18
pp 90 (100) 67 101 102
hr 150 120 144 132 96
f 15 13 8 10 8
fetco* 0.77 0.96 0.86 0.95 0.91
ft 40 Min
bp 110 118 92 117 143
rvp 20/0 22/10 34/6 20/0 34/7
csfp 29 1 30 7 12
pp 79 (100) 62 110 131
hr 132 110 144 132 108
f 10 15 9 10 7
fetco* 0.80 0.68 0.87 1.07 0.97
ft 80 Min
bp 97 133 87 107 143
rvp 18/0 22/8 30/6 16/0 36/10
csfp 28 ? 31 14 10
pp 69 (118) 56 93 133
hr 120 132 135 132 120
f 8 16 9 10 7
fetco* 0.72 0.67 0.78 1.07 0.96
ft 120 Min
bp 80 138 93 100 112
rvp 16/0 22/8 36/8 16/0 26/4
csfp 35 ? 31 13 10
pp 45 (120) 62 87 102
hr 120 132 132 115 140
f 7 18 8 10 8
fetc°2 0.87 0.67 0.85 0.90 1.00
TABLE A3-5
TREATMENT WITH P02 3.0 BAR AT 5.0 BAR
MONITORED PHYSIOLGICAL VARIABLES
DOG 180 181 182 183 184
CONTROL
BP 107 88 123 125 108
RVP 18/0 30/12 34/0 22/0 28/4
CSFP 5 5 18 3 4
PP 104 83 ' 105 122 104
HR 120 180 135 105 120
f 11 14 10 9 10
Fetc°2 4.3 4.0 3.8 3.9 4.3
ARRIVE SURFACE
BP 110 93 147 118 100
RVP 20/0 20/0 20/0 16/0 22/0
CSFP 20 ? 17 11 4
PP 90 (81) 130 107 96
HR 110 150 140 120 120
f 11 14 7 8 10
fetc°2 4.0 4.1 4.1 2.5 3.6
LOWEST PRE-R
BP 75 70 113 110 88
RVP 18/0 20/0 16/0 16/0 20/0
CSFP 12 ? 17 11 4
HR 170 110 140 120 105
f 10 6 7 8 9
fetc°2 4.2 4.1 4.1 2.5 3.5
HIGHEST PRE-Rr
BP 127 130 147 123 100
RVP 60/2 32/4 20/0 34/0 28/0
CSFP 24 7 32 30 11
HR 170 180 156 144 120
f 12 6 9 11 10
fETc°2 4.2 4.1 5.2 3.4 3.8
PRE-R'
BP 80 70 113 110 87
RVP 34/0 24/0 20/0 34/0 24/0
CSFP 12 7 32 24 6
PP 68 (55) 81 86 81
HR 170 180 156 144 105
f 10 6 8 8 9
fETc°2 4.0 4.1 5.2 3.4 3.6
table a3-5
DOG 180 181 182 183 184
B 15 Min
BP 128 98 148 140 110
RVP 41/0 28/4 32/0 32/2 18/0
CSFP 42 1 18 22 13
PP 86 (78) 130 118 97
HR 180 180 132 84 84
f 12 16 9 7 10
fETc°2 1.03 1.00 0.83 0.92 0.95
B AO Min
BP 102 103 150 125 120
RVP 20/0 20/0 24/0 28/0 18/0
CSFP 26 1 18 20 18
PP 76 (90) 132 105 102
HR 144 180 144 90 105
f 12 15 9 7 9
fetc°2 0.84 0.86 0.80 0.95 1.00
B 80 Min
BP 90 113 138 137 123
RVP 12/0 22/2 20/0 28/0 20/0
CSFP 22 ? 16 20 19
PP 68 (100) 122 117 104
HR 132 110 144 96 105
f 9 16 10 8 10
fETc°2 0.77 0.84 0.90 0.98 1.01
120 Min
bF 73 131 135 148 110
RVP 12/0 20/2 28/0 26/2 18/0
CSFP 16 1 12 20 26
PP 57 (117) 123 128 84
HR 120 110 140 132 105
f 8 18 10 9 9
fetco* 1.09 0.36 0.82 0.95 1.00
TABLE A4-1
TREATMENT WITH P02 1.0 BAR AT 5.0 BAR
ARTERIAL BLOOD ANALYSIS
DOG 1A0 141 142 143 144
CONTROL
Hct 50 45 46 46 42
pH 7.A1 7.43 7.36 7.33 7.40
PaC02 31 40 32 35 33
Pa02 91 93 98 89 101
PRE-ft
Hct 55 60 56 47 42
pH 7.A2 7.25 7.28 7.21 7.38
PaC02 30 54 43 52 32
Pa02 104 68 69 52 . 108
ft AO Min
Hct 57 52 48 50 49
pH 7.36 7.35 7.35
PaC02 34 39 33
Pa02 221 227 210
ft 80 Min
Hct 51 50 48 50 51
pH 7.36 7.43 7.35 7.42 7.37
PaC02 34 48 39 34 34
Pa02 221 209 227 196 215
TABLE A4-2
TREATMENT WITH P02 1.5 BAR AT 5.0 BAR
ARTERIAL BLOOD ANALYSIS
DOG 150 151 152 153 154
CONTROL
Hct 40 43 45 47 49
pH 7.44 7.41 7.35 7.36 7.41
P3CO2 32 33 32 41 34
Pa02 93 96 103 84 86
PRE-8
Hct 55 49 61 56 64
pH 7.29 7.32 7.28 7.34 7.32
PaC02 36 40 34 42 37
Pa02 75 75 96 63 92
8 40 Min
Hct 41 41 48 54 50
pH 7.46 7.32 7.40
paC02 31 39 36
Pa02 302 232 249
8 80 Min
Hct 41 45 44 52 50
pH 7.46 7.35 7.38 7.35 7.40
PaC02 31 37 32 53 36
Pa02 302 290 357 261 249
TABLE A4-3
TREATMENT WITH P02 2.0 BAR AT 5.0 BAR
ARTERIAL BOOD ANALYSIS
DOG 160 161 162 163 164
CONTROL
Hct A5 46 42 43 33
pH 7.34 7.36 7.43 7.37 7.40
PaC02 34 34 40 36 29
Pa02 92 89 89 95 96
PRE-R
Hct 47 55 48 44 47
pH 7.42 7.35 7.33 7.32 7.30
PaC02 32 35 50 41 40
Pa02 104 98 82 87 77
R AO Min
Hct 48 44 41 47 42
pH 7.45 7.33 7.31 7.43
PaC02 26 38 55 28
Pa02 392 284 360 378
R 80 Min
Hct 46 44 41 46 42
PH 7.39 7.39 7.34 7.35 7.35
PaC02 33 36 50 35 40
Pa02 375 442 352 372 443
TABLE A4-4
TREATMENT WITH P02 2.5 BAR AT 5.0 BAR
ARTERIAL BLOOD ANALYSIS
DOG 170 171 172 173 174
CONTROL
Hct 44 44 52 45 44
PH 7.46 7.40 7.43 7.42 7.35
PaC02 28 34 30 32 35
Pa02 101 93 98 99 85
PRE-B
Hct 46 45 46 45 48
PH 7.37 7.25 7.41 7.25 7.27
PaC02 32 47 31 45 41
Pa02 109 85 109 82 83
B 40 Min
Hct 38 46 45 45 45
PH 7.41 7.37 7.36
PaC02 30 42 37
Pa02 433 387 409
B 80 Min
Hct 37 45 44 45 54
PH 7.42 7.39 7.40 7.43 7.33
PaC02 29 40 30 37 34
PaO a 417 417 405 283 376
TABLE A4-5
TREATMENT WITH P02 3.0 BAR AT 5.0 BAR
ARTERIAL BLOOD ANALYSIS
DOG 180 181 182 183 184
CONTROL
Hct 44 41 43 46 49
PH 7.40 7.37 7.42 7.37 7.41
PaC02 36 39 30 33 34
Pa02 93 88 101 92 97
PRE-R
Hct 47 44 53 52 49
pH 7.31 7.22 7.33 7.36 7.37
PaC02 42 52 38 34 34
Pa02 83 72 86 104 100
Br 40 Min
Hct 52 42 50 48 47
pH 7.42 7.35 7.38
PaC02 30 38 33
Pa02 521 443 415
R 80 Min
Hct 49 41 48 50 51
pH 7.48 7.32 7.43 7.35 7.38
PaC02 27 52 30 36 34
Pa02 428 404 483 433 436
APPENDIX B
INDIVIDUAL DATA - PRESSURE STUDY
TABLE
B1 - Spinal Evoked Potential - Primary Lesion
B2 - General Descriptive Data
B3 - Monitored Physiological Variables
B4 - Arterial Blood Analysis
- 1 P 3.0 bar
- 2 P 5.0 bar
- 3 P 7.0 bar
- 4 P 2.8 bar
SYMBOLS AND UNITS
As for Appendix A
TABLE Bl-1
TREATMENT WITH P02 2.0 BAR AT 3.0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 200 201 202 203 204
SEP RECORD RP-L LP-L LP-L RP-L LP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 98.8 100.0 90.2 102.5 104.1
Pre Diagnosis 109.5 115.6 86.4 95.1 105.0
Diagnosis (D) 69.0 95.0 73.7 79.3 60.1
Pre-ft 0 0 [34.9] 23.6 10.4
B 15 min 104.5 88.1 78.1 70.9 52.5
R 40 min 94.5 88.1 112.5 91.9 59.3
B 80 min 61.8 82.5 111.8 80.9 64.9
B 120 min 30.6 83.7 97.8 86.2 50.2
LOSS OF SEP ANE) RECOVERY
% Loss 100.0 100.0 65.1 76.4 89.6
% Recovered @ 15 100.0 88.1 43.2 47.3 42.1
40 94.5 88.1 65.1 68.3 48.9
80 61.8 82.5 65.1 57.3 54.5
120 30.6 83.7 62.9 62.6 39.8
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min 100.0 88.1 66.4 61.9 47.0
40 min 94.5 88.1 100.0 89.4 54.6
80 min 61.8 82.5 100.0 75.0 60.8
120 min 30.6 83.7 96.6 81.9 44.4
ABSOLUTE CHANGE
Pre-Pre-D to Pre-D +10.7 +15.6 -3.8 -7.4 +0.9
Pre-D to D -40.5 -20.6 -12.7 -15.8 -44.9
D to Pre-B -69.0 -95.0 -2.5 -55.7 -49.7
Loss over Com¬ 0 0 -36.3 0 0
pression
TIME INTERVALS (Min)
From Surface to D 8 23 18 17 11
Pre-D to D 4 4 2 4 5
D to 8 15.7 16 15.3 15 17
Last SEP to B- 4 0 1 1 1
TABLE Bl-2
TREATMENT WITH P02 2.0 BAR AT 5.0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 211 213 126 127 128
SEP RECORD LP-L RP-L LP-L LP-L LP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diangnosis 85. A* 99.5* 86.8 93.6 90.5
Pre-Diagnosis 83.5 91.9 83.8 88.2 93.2
Diagnosis (D) 91.1 83.A 71.7 67.1 90.A
Pre-R 1.2 [A8.2] A.8 22.8 71.A
& 15 min 70.6 60.8 87.8 73.A 79.5
R AO min 61.5 57.7 93.5 75.2 79.0
R 80 min 69.6 5A.6 92.8 70.A 85.8
R 120 min 70.6 55.0 AO. 0 75.8 90.A
LOSS OF SEP AND RECOVERY
% Loss 98.2 51.8 95.2 77.2 28.6
% Recovered @ 15 69.A 12.6 83.0 50.6 8.1
AO 60.3 9.5 88.7 52.A 7.6
80 68. A 6.A 88.0 A7.6 1A.A
120 69. A 6.8 85.2 53.0 19.0
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min 70.7 2A.3 87.2 65.5 28.3
AO min 61.A 18.3 93.2 67.9 26.6
80 min 69.7 12.A 92.A 61.7 51.7
120 min 70.7 13.1 99.5 68.7 66. A
ABSOLUTE CHANGE
Pre-Pre-D to Pre-D -1.9 -7.6 -3.0 -5.A +2.7
Pre-D to D +7.6 -8.5 -12.1 -21.1 -2.8
D to Pre-R -89.9 -13.8 -66.9 -AA.3 -19.0
Loss over com¬ 0 -21.A 0 0 0
pression
TIME INTERVALS (Min)
From Surface to D 6 6 29 30 17
Pre-De to D A A 5 A A
D to R 16 15 15.5 17 15
Last SEP to R 1 6 1 2 1
TABLE Bl-3
TREATMENT WITH P02 2.0 BAR AT 7.0 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 220 221 222 22A 225
SEP RECORD RP-L RP-L LP-L LP-L RP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 95.2* 75.8 92.3* 101.9* 10A.6
Pre-Diagnosis 91.2 78.A 93.3* 98.7* 10A.9
Diagnosis (D) 67.5 52.A 82.3 90.8 87.3
Pre-R 63.5 0 1.0 9.6 6.5
R 13 min 75.9 A8.1 A.2 10.7 72.9
R AO min 53.1 Al.l 11.9 37.0 76.0
R 80 min 58.3 50.0 6.8 29.9 58.5
R 120 min 70.A AO. 7 7.7 31.8 56.0
LOSS OF SEP AND RECOVERY
% Loss 36.5 100.0 99.0 90.A 93.5
% Recovery @ 15 12.A A8.1 3.2 1.1 66.A
AO -10.A Al.l 10.9 27.A 69.5
80 -5.2 50.0 5.8 20.3 52.0
120 6.9 AO. 7 6.7 22.2 A9.5
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min 3A.0 A8.1 3.2 1.2 71.0
AO min 0 Al.l 11.0 30.3 7A.3
80 min 0 50.0 5.9 22.5 55.6
120 min 18.9 AO.7 6.8 2A.6 52.9
ABSOLUTE CHANGE
Pre-Pre-D to Pre-D -A.0 +2.6 +1.0 -3.2 -0.3
Pre-D to D -23.7 -26.0 -11.0 -7.9 -17.6
D to Pre-R -A. 0 -52. A -81.3 -81.2 -80.8
Loss over com¬ 0 0 0 0 0
pression
TIME INTERVALS (Min)
From Surface to D 16 1A 2 3 13
Pre-D to D 1A 5 2* 3* 5
D to R 15 16 16 15 15
Last SEP to R 3 0 0 2 A
TABLE Bl-A
TREATMENT WITH P02 2.8 BAR AT 2.8 BAR
SPINAL EVOKED POTENTIAL - PRIMARY LESION
DOG 231 232 233 23A 235
SEP RECORD LP-L RP-L LP-L LP-L LP-L
EVOKED POTENTIAL AS PERCENT OF CONTROL
Pre-Pre-Diagnosis 72.1 91.A* 88.9 110.1* 110.3
Pre-Diagnosis 68.8 80.0 90.3 111.0 101.8
Diagnosis (D) 65.7 117.9 59.0 103.A 86.9
Pre-R 0 [10.1] 35. A [41.1] 7.3
R 15 min Al.A 27.2 55.0 AA.8 65.0
R AO min 53.1 21.8 69.6 72.9 62.A
R 80 min 55.6 25.0 72.3 7A.A 68.1
R 120 min 55. A 26.2 79.3 A7.2 63.1
LOSS OF SEP AND RECOVERY
% Loss 100.0 89.9 6A.6 58.9 92.7
% Recovered @ 15 Al.A 17.1 19.6 3.7 57.7
AO 53.1 11.7 3A.2 31.8 55.1
80 55.6 1A.9 36.9 33.3 60.8
120 55.A 16.1 A3.9 6.1 55.8
RATIO OF RECOVERY TO LOSS AS A PERCENT
15 min Al.A 19.0 30.3 6-3 62.2
AO min 53.1 13.0 52.9 5A.0 59.A
80 min 55.6 16.6 57.1 56.5 • 65.6
120 min 55.A 17.9 68.0 10.A 60.2
ABSOLUTE CHANGE
Pre-Pre-D to Pre—D -3.3 -11. A +1. A +0.9 -8.5
Pre-D to D -2.1 +37.9 -31.3 -7.6 -1A.9
D to Pre-R -65.7 -106.2 -23.6 -51.A -79.6
Loss over com¬ 0 -1.6 0 -10.9 0
pression
TIME INTERVALS (Min)
From Surface to D 27 6 20 6 22
Pre-D to D 5 A 5 5 A
D to R 16 17 15 15 16
Las SEP to R 1 2 2 2 1
TABLE B2-1
TREATMENT WITH P02 2.0 BAR AT 3.0 Bar
GENERAL DESCRIPTIVE DATA
DOG 200 201 202 203 204
Weight (kg) 11.8 10.9 13.6 10.0 10.-!
Bottom time (min) 15 15 15 15 15
Ascent time 5.3 5.4 5.7 5.5 5. (
2nd Bottom time — _ 9 — —
2nd Ascent time - - 5.6 - -
RVP TTime (min) 6 _ 18 — 10
CSFP T - 14 18 17 10
EEG 4- - 14 9 8 -
CEP i 8 27 16 11 11
SEP I 8 23 18 17 11
ECG A - - - - 21
BP T 23 - 20 - 25
BP 1 - - - - -
BP A on com- -35 -15 -50 -20 -60
pression(mm Hg)
Fluid Balance (ml) +360 +10 -20 +25 +10
Pre-Rr Fluid 80 0 0 125 130
& Fluid 330 60 230 200 130
Fluid Out 40 50 250 300 250
TABLE B2-2
TREATMENT WITH P02 2.0 BAR AT 5.0 BAR
GENERAL DESCRIPTIVE; DATA
DOG 211 213 216 217 218
Weight 10.9 14.5 10.9 10.9 10.'
BottomTime 15 15 15 15 15
Ascent time 5.6 5.5 5.5 5.6 5.
2nd Bottom time _ 9 _ _ —
2nd Ascent time - 5.6 - - -
RVPT Time 5 6 _ — 17
CSFPT 5 - - 9 9
EEG4, 7 - - - 9
CEP1 1 6 29 30 9
SEPJ. 5 6 29 30 17
ECG A - - 41 29 17
BP T - - - - -
BP i - - - - -
BP t on com¬ -70 +10 -5 +10 0
pression
Fluid Balance +75 +138 0 +300 +185
Pre-& Fluid 80 38 0 140 30
& Fluid 120 200 60 270 280
Fluid Out 125 100 60 110 125
TABLE B2-3
TREATMENT WITH P02 2.0 BAR AT 7.0 BAR
GENERAL DESCRIPTIVE DATA
DOG 220 221 222 224 225
Weight 12.7 10.0 12.0 10.5 11.8
Bottom time 15 15 15 15 15
Ascent time 5.0 5.7 5.6 5.5 5.6
2nd Bottom time 8 — — — -
2nd Ascent time 5.2 - - - —
RVP t Time _ 11 17 — -
CSFP t 5 11 - 18 3
EEG 4 3 - 17 2 3
CEP 4 3 21 11 2 3
SEP 4 17 17 2 3 13
ECG A 9 - - 18 3
BP t - - - - -
BP 4 - - - - -
BP A on com¬ +15 -10 0 -50 0
pression
Fluid Balance +130 +165 +125 +110 +10
Pre-R Fluid 320 40 140 220 70
R Fluid 70 160 110 100 40
Fluid Out 260 35 125 210 100
TABLE B2-4
TREATMENT WITH P02 2.8 BAR AT 2.8 BAR
GENERAL DESCRIPTIVE1 DATA
DOG 231 232 233 234 235
Weight 10.A 13.2 12.3 12.7 11.8
Bottom time 15 15 15 15 15
Ascent time 5.7 5.5 5.6 5.6 5.7
2nd Bottom time — — 9 - -
2nd Ascent time - - 5.5 — -
RVP t Time 13 7 4 14 22
CSFP t - 7 - 11 6
EEG 4- - - 4 2 -
CEP 4 38 7 4 6 27
SEP 4 28 7 20 6 22
ECG A - - - 14 38
BP t - - 35 14 -
BP 4 - - - - -
BP A on com¬ 0 -30 -30 -60 -25
pression
Fluid Balance -60 -45 -100 +165 +60
Pre-R Fluid 0 40 70 110 0
B' Fluid 40 140 30 130 160
Fluid Out 100 225 200 75 100
table b3-1
treatment with p02 2.0 bar at 3.0 bar
monitored physiological variables
DOG 200 201 202 203 204
control
bp 100 120 152 123 155
rvp 34/0 21/0 45/0 22/0 21/4
csfp 13 2 2 3 8
pp 87 118 150 120 147
hr 120 156 144 135 150
f 8 10 9 9 13
fetco> 3.56 4.18 4.07 3.94 3.60
arrive surface
bp 113 115 128 105 130
rvp 96/0 23/0 32/0 20/0 1
csfp 24 6 3 10 16
pp 89 109 125 95 114
hr 144 144 120 132 135
f 7 8 7 5 8
fetc°2 2.18 3.74 3.85 3.61 3.85
lowest pre-r
bp 113 107 115 88 118
rvp 80/0 22/0 32/0 20/0 ?
csfp 10 3 1 4 9
hr 144 140 108 105 135
f 5 8 6 5 7
fETc°2 2.18 3.74 3.79 3.23 2.66
highest pre-&
bp 147 123 170 105 185
rvp 170/0 28/6 52/4 22/0 49/12
csfp 22 10 4 10 22
hr 180 144 120 132 135
f 11 10 11 6 11
fetc°2 3.80 3.90 3.92 3.86 4.10
pre-b-
bp 147 123 113 90 185
rvp 170/0 28/6 40/0 20/0 49/12
csfp 11 10 3 4 22
hpp 136 113 110 86 163
hr 150 144 108 120 135
f 10 9 6 5 11
fETc°2 3.80 3.75 3.79 3.23 4.10
TABLE B3-1 (Cont.)
DOG 200 201 202 203 204
Br 15 Min
BP 158 117 123 113 138
RVP 200/0 25/3 32/0 33/0 ?
CSFP 15 10 1 7 17
PP 143 107 122 106 121
HR 150 150 120 120 150
f 9 7 7 5 7
fetc°2 1.10 1.62 1.31 1.42 1.70
B- 40 Min
BP 137 113 118 110 123
RVP 60/8 20/2 32/0 34/0 21/4
CSFP 18 10 1 8 18
PP 119 103 117 102 105
HR 144 150 120 120 156
f 8 7 7 5 7
Fetc°2 1.12 1.63 1.34 1.64 1.56
R 80 Min
BP 133 108 138 118 117
RVP 56/10 18/0 38/2 35/0 • 22/6
CSFP 18 12 1 8 18
PP 115 96 137 110 99
HR 144 144 132 156 150
f 8 11 8 5 8
fetco* 1.12 1.62 1.48 1.68 1.56
& 120 Min
BP 108 103 117 123 118
RVP 28/4 18/0 32/0 36/1 30/14
CSFP 15 13 1 5 15
PP 93 90 116 118 103
HR 135 135 132 132 132
f 8 8 8 6 11
fetc°2 1.23 1.66 1.48 1.66 1.62
table b3-2
treatment with p02 2.0 bar at 5.0 bar
monitored physiological variables
dog 211 213 126 127 218
control
bp 115 115 107 123 162
rvp 10/0 22/2 17/8 21/1 29/0
csfp 6 3 4 10 4
pp 109 112 103 113 158
hr 144 132 132 135 108
f 8 9 7 7 12
fetco* 3.79 4.21 3.70 3.65 4.10
arrive surface
bp 123 120 97 113 157
rvp 12/2 22/0 20/2 18/4 20/4
csfp 20 7 10 18 17
pp 103 113 87 95 140
hr 144 144 144 120 120
f 8 9 8 5 8
fetco* 4.17 5.28 2.40 3.13 4.15
lowest pre-R
bp 82 113 87 98 108
rvp 12/0 22/0 14/0 14/0 18/0
csfp 14 3 2 4 14
hr 144 144 135 120 120
f 7 9 6 6 5
fetc°2 4.17 3.80 2.14 3.25 3.31
highest pre-r
bp 117 127 100 117 162
rvp 20/0 34/0 24/2 22/4 24/0
csfp 22 3 4 7 20
hr 156 156 144 120 132
f 14 13 9 7 13
fetc°2 5.31 4.06 2.72 4.17 3.54
pre R
bp 117 114 92 98 140
rvp 20/0 34/0 24/2 24/4 21/0
csfp 22 3 4 7 20
pp 95 111 88 91 120
hr 156 144 135 120 132
f 10 13 6 7 10
fetc°2 4.68 3.80 2.20 4.00 3.31
TABLE B3-2 (Cont.)
DOG 211 213 216 217 218
a 15 Min
BP 157 135 115 133 182
RVP 17.2 24/0 16/0 20/6 23/4
CSFP 24 3 3 4 22
PP 133 132 112 129 160
HR 120 120 120 120 132
f 10 9 6 9 13
fetco* 1.12 0.79 0.72 0.76 0.84
a AO Min
BP 137 125 130 107 157
RVP 14/0 22/0 20/0 18/5 20/4
CSFP 40 3 4 10 18
PP 97 122 126 97 139
HR 144 132 120 135 120
f 10 9 7 9 12
fetco2 1.07 0.88 0.77 0.80 0.89
a 80 Min
BP 123 122 133 102 123
RVP 10/0 22/0 17/0 20/6 18/4
CSFP 50 3 4 14 14
PP 73 119 129 88 109
HR 160 144 132 120 108
f 10 8 6 7 13
fetco* 0.98 0.89 0.87 0.92 0.92
a 120 Min
BP 118 120 130 102 127
RVP 10/0 22/0 20/0 20/8 22/5
CSFP 52 3 4 19 12
PP 66 117 126 83 115
HR 150 144 132 135 132
f 10 10 7 8 12
fktc°2 1.06 0.84 0.80 0.85 0.90
table b3-3
treatment with p02 2.0 bar at 7.0 bar
monitored physiological variables
dog 220 221 222 224 225
control
bp 137 115 113 105 147
rvp 82/0 45/0 22/0 30/0 21/0
csfp 7 8 3 1 1
pp 130 107 110 104 146
hr 108 120 120 108 108
f 7 7 10 8 8
fetco* 3.80 4.25 3.79 3.20 3.85
arrive surface
bp 110 115 112 95 127
rvp 60/0 90/0 24/0 35/6 30/3
csfp 33 7 6 4 6
pp 77 108 106 91 121
hr 132 120 120 96 96
f 7 5 8 5 6
Fetc°2 3.00 3.61 4.62 3.03 2.50
lowest pre-r
bp 80 108 97 80 113
rvp 60/0 70/0 26/0 10/4 24/4
csfp 20 5 2 1 5
hr 120 120 120 84 108
f 8 5 7 6 6
fetco* 4.03 3.79 4.13 3.01 1.83
highest pre-r
bp 110 115 112 103 127
rvp 75/0 110/0 34/0 22/5 30/0
csfp 28 8 2 8 13
hr 150 120 140 100 120
f 14 8 9 8 8
fetco* 4.03 3.81 4.13 3.01 2.58
pre-&
bp 82 115 97 103 120
rvp 75/6 110/0 34/0 22/5 28/1
csfp 20 8 2 8 13
pp 162 107 95 95 107
hr 150 120 140 84 120
f 8 8 7 8 8
fetco> 4.03 3.81 4.13 3.01 1.83
TABLE B3-3 (Cont.)
DOG 220 221 222 224 225
R 15 Min
BP 143 128 128 127 140
RVP 70/5 95/0 26/1 30/8 30/0
CSFP 40 8 6 42 11
PP 103 120 122 85 129
HR 105 120 120 90 96
f 7 7 12 8 5
Fetc°2 0.70 0.67 0.66 0.59 0.56
R 40 Min
BP 127 128 123 120 145
RVP 70/0 80/0 28/1 23/6 26/3
CSFP 34 7 3 36 15
PP 93 121 120 84 130
HR 100 120 120 96 108
f 8 7 13 8 6
fetco* 0.82 0.61 0.74 0.60 0.58
R 80 Min
BP 110 108 117 122 152
RVP 60/0 80/0 22/0 20/5 26/4
CSFP 37 8 4 38 22
PP 73 100 113 84 130
HR 120 140 120 84 108
f 8 7 14 7 9
fetco* 0.71 0.65 0.73 0.62 0.51
ft 120 Min
BP 120 120 105 122 150
RVP 50/0 95/0 22/0 20/6 24/4
CSFP 32 8 5 44 28
PP 88 112 100 78 122
HR 100 132 120 84 108
f 8 7 13 8 9
fetc°2 0.84 0.47 0.65 0.63 0.5b
table b3-4
treatment with p02 2 .8 bar at 2.8 bar
monitored physiological variables
dog 231 232 233 234 235
control
bp 143 130 133 97 113
rvp 60/8 30/0 29/3 34/0 24/3
csfp 28 16 8 8 1
pp 115 114 125 89 112
hr 96 144 108 132 132
f 9 9 9 10 9
fetc°2 4.20 4.30 4.35 4.21 00
arrive surface
bp 145 123 120 100 112
rvp 52/0 22/0 23/0 22/0 25/2
csfp 40 14 13 17 13
pp 105 109 107 83 99
hr 108 156 120 135 132
f 9 8 7 9 7
Fetc°2 4.26 2.48 4.39 3.19 3.98
lowest pre-B
bp 117 108 112 90 102
rvp 52/0 18/0 18/0 22/0 25/2
csfp 30 6 9 12 5
hr 108 150 140 120 135
f 7 6 8 7 7
fetc°2 3.91 2.55 2.83 4.54 3.44
highest pre-B
bp 140 110 132 203 110
rvp 60/0 34/2 36/0 115/0 30/5
csfp 34 15 10 56 15
hr 135 160 150 180 168
f 7 10 12 9 8
fetc°2 4.26 3.34 3.75 4.57 3.90
pre-b
bp 117 108 132 120 110
rvp 52/0 34/2 36/0 115/0 30/5
csfp 30 12 10 32 15
pp 87 96 122 88 95
hr 108 150 150 180 168
f 7 8 8 9 7
f c02 3.91 2.55 3.75 4.54 3.56et 2
TABLE B3-4 (Cont.)
DOG 231 232 233 234 235
B 15 Min
BP 128 117 158 102 100
RVP A8/0 24/0 32/0 32/8 17/0
CSFP 30 6 8 36 5
PP 98 111 150 66 95
HR 108 120 108 120 135
f 7 8 11 10 7
fetco* 1.58 1.58 1.54 1.56 1.34
B AO Min
BP 123 103 • 140 100 100
RVP 50/0 20/0 26/0 20/0 14/0
CSFP 28 10 9 32 7
PP 95 93 131 68 93
HR 120 135 96 108 144
f 7 8 10 10 7
fETc°2 1.67 1.86 1.62 1.54 1.52
R 80 Min
BP 120 112 123 100 130
RVP A4/0 22/0 24/0 24/2 24/4
CSFP 28 10 7 32 11
PP 92 102 116 68 119
HR 120 150 108 96 150
f 7 8 10 10 8
fetc°2 1.A8 1.47 1.53 1.53 1.51
a 120 Min
BP 120 112 127 90 128
RVP 40/0 22/0 22/0 16/0 21/0
CSFP 28 10 8 40 5
PP 92 102 119 50 123
HR 136 144 96 120 132
f 7 8 9 10 8
fetc°2 1.60 1.59 1.49 1.60 1.40
TABLE B4-1
TREATMENT WITH P02 2.0 BAR AT 3.0 BAR
ARTERIAL BLOOD ANALYSIS
DOG 200 201 202 203 204
CONTROL
Hct (%) 42 41 43 50 44
pH 7.38 7.39 7.36 7.43 7.37
PaC02 (mm Hg) 32 31 33 34 34
Pa02 96 92 96 100 84
PRE-R
Hct 52 43 40 53 47
PH 7.29 7.39 7.35 7.36 7.36
PaC02 33 31 31 25 40
Pa02 95 102 109 146 87
R 40 Min
Hct 50 45 44 60 46
PH 7.41 7.33 7.28 7.32 7.36
PaC02 27 37 37 38 43
Pa02 457 387 529 439 505
R 120 Min
Hct 48 45 41 54 44
PH 7.43 7.38 7.34 7.36 7.34
PaC02 26 34 39 45 40
Pa02 521 441 523 501 496
TABLE B4-2
TREATMENT WITH P02 2.0 BAR AT 5.0 BAR
ARTERIAL BLOOD ANALYSIS
DOG 211 213 216 217 218
CONTROL
Hct A9 45 40 44 44
PH 7.37 7.35 7.37 7.40 7.34
PaC02 32 32 35 33 36
Pa02 92 100 94 94 101
PRE-R
Hct 49 45 40 50 51
PH 7.38 7.29 7.41 7.32 7.31
PaC02 40 43 31 38 38
Pa02 112 81 101 90 111
R AO Min
Hct 56 45 43 45 46
PH 7.35 7.40 7.40 7.48 7.42
PaC02 38 38 30 26 37
Pa02 316 375 295 403 376
Br 120 Min
Hct 51 45 43 42 44
pH 7.39 7.34 7.42 7.44 7.43
PaC02 33 45 30 31 34
Pa02 321 330 297 607 361
TABLE B4-3
TREATMENT WITH P02 2.0 BAR AT 7.0 BAR
ARTERIAL BLOOD ANALYSIS •
DOG 220 221 222 224 225
CONTROL
Hct 43 45 42 41 42
pH 7.35 7.42 7.40 7.35 7.43
P3CO2 30 32 31 40 32
P3O2 100 90 96 88 85
PRE-ft
Hct 44 46 47 38 42
PH 7.32 7.42 7.30 7.28 7.37
PaC02 39 31 42 45 35
Pa02 99 92 78 80 97
ft 40 Min
Hct 40 46 44 43 44
pH 7.21 7.43 7.35 7.50 7.40
PaC02 60 32 43 32 35
Pa02 284 256 257 318 309
ft 120 Min
Hct 40 48 43 44 46
PH 7.23 7.38 7.37 7.46 7.41
PaC02 57 34 45 33 34
Pa02 248 259 262 295 294
TABLE B4-4
TREATMENT WITH P022.8 BAR AT 2.8 BAR
ARTERIAL BLOOD ANALYSIS
DOG 231 232 233 234 235
CONTROL
Hct 48 49 45 42 42
PH 7.40 7.36 7.36 7.37 7.43
PaC02 35 35 36 35 34
Pa02 90 90 86 86 100
PRE-ft
Hct 49 50 47 46 45
PH 7.36 7.28 7.22 7.33 7.37
PaC02 35 41 52 47 40
Pa02 97 69 49 61 95
ft 40 Min
Hct 47 50 41 45 40
pH 7.35 7.34 7.41 7.38 7.42
PaC02 40 40 43 37 32
Pa02 654 316 613 692 226
ft 120 Min
Hct 46 49 47 45 38
PH 7.36 7.33 7.42 7.38 7.38
PaC02 37 36 36 35 38
Pa02 631 330 698 674 558
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The development of dog electrophysiologicalmodels for study¬
ing the treatment of cerebral arterial air embolism and spinal
cord decompression sickness, required that the effects of the
treatment gases on spinal and cortical somatosensory evoked
potentials (SEP and CEP) be known. We found an inverse linear
relationship between CEP amplitude and air pressure to 230 ft.
An asymptote was approached when pressure was increased to
300 ft. This effect was not seen with 20% oxy-helium. The waves
representing local cord eventswere depressed to a lesser extent
than were the CEPs. We were able to detect an equilibration
time in the EP suppression comparable to estimated inert gas
wash-in time for the brain. A small depression of CEPs that did
not reach significance was seen with exposure to 2.8 bar of oxy¬
gen and continuous exposure for up to 120 min caused no further
diminution in amplitude than would be caused by time alone.
VISUALAND AUDITORY evoked responses (VER,AER) have been widely used as measures of inert
gas narcosis (6). Somatosensory cortical evoked poten¬
tials have been applied in this condition less commonly
(14,15). Whether or not evoked potentials provide a
true measure ofnarcosis continues to be debated because
they do not necessarily correlate well with independent
measures of cortical performance (6). The elfect of nar¬
cosis is thought to be one of interference with synaptic
transmission, primarily in the brain (2,4). It is interesting,
however, that although in any given group the overall
effect on evoked responses is one ofdepression, the range
of effect can often be very wide, even showing a slight
increase above baseline values at pressures of up to 11
bar in some individuals (2). The narcotic effect has also
been attributed to oxygen as well as to nitrogen (5,10).
A series ofexperiments were undertaken to study the
relative efficacy of different pressures and gas mixtures
in the treatment ofcerebral arterial gas embolism (AGE)
and spinal cord decompression sickness (DCS). The
model used dogs anesthetized with pentobarbital and
prepared for the measurement of spinal cord somato¬
sensory evoked potentials (SEP) and cortical somato¬
sensory evoked potentials (CEP) from the peroneal and
median nerves. A requirement of the experimental de¬
sign was that many of the measurements were to be
made at pressure so the full range of possible effects of
the expected hyperbaric conditions upon the parameters
to be measured had to be defined. Most of the obser¬
vations reported were made during the preparatory
phases of DCS experiments but a small number were
made during specifically dedicated experiments.
The questions asked were:
a) How much of a depressing effect did various pres¬
sures of air have upon CEP and SEP, and what correc¬
tions if any should be applied to measurements made
at pressure?
b) Is there an equilibration time for the expected
changes in EPs following a step change in pressure?
c) Does hyperbaric oxygen have any effect upon EPs?
d) Does prolonged exposure to high pressure air or
oxygen have any progressive effect?
e) For comparative purposes, how does 20% oxygen-
helium mix affect EPs over the same pressure range as
air?
f) Are SEPs and CEPs equally affected, or are any
components more affected than others?
MATERIALS AND METHODS
In these studies 61 conditioned male mongrel dogs
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weighing between 9 and 21 kg were used. Studies were
terminated with the intracardiac injection of saturated
KC1 solution. The dogs were sedated with xylazine (1.1
mg-kg"1, s.c.) and atropine (0.05 mg-kg"1, s.c.). They
were then anesthetized with sodium pentobarbital (13.5
mg-kg"1, i.v.) and maintained on a routine of half the
initial dose after 20 min and a maintenance dose of 4
mg-kg"1 -h"1 given in divided doses at 20-min intervals.
Small adjustments to the maintenance regimen were
made if required. After intubation, ventilation was
maintained with a modified Bird® Mark 7 respirator.
The animals were prepared for physiological observa¬
tions with bilateral femoral arterial cannulation for
pressuremonitoring and arterial blood sampling. A Mil¬
lar (7F gauge) pressure tip catheter was introduced via
the right femoral vein into the right ventricle. A poly¬
ethylene catheter was placed in the left foreleg cephalic
vein for the administration of anesthesia and fluids.
Rectal temperature was maintained between 37.5 and
39.0°C by means of a hot water circulating plate incor¬
porated into the base of the head-holding stand. The
dog was placed prone into the head-holding stand and
secured by ear bars. Skin, muscle, and periosteum were
cleared from the skull over the right sensorimotor cortex
and a stainless steel electrode inserted into a hole drilled
into the cancellous bone over either the cortical sen¬
sorimotor forelimb area or between the fore and hind
limb areas as required. The indifferent electrode was
placed into the distal end of the nasal bones. Pairs of
sharpened 1 -mm diameter stainless steel wires insulated
except for 2-3 mm at the tip were hammered into the
spinal lamina in the mid-line. These were placed in
adjacent intervertebral spaces in the vicinity of L,, Tg,
and C7. The peroneal and median nerves were stimulated
through pairs of 20 gauge stainless steel needles placed
percutaneously adjacent to the respective nerves on the
left side at the neck of the fibula and the distal end of
the humerus. The details of materials and method are
reported elsewhere (Leitch, in preparation). Cortical and
spinal electrode impedences were less than 2 and 6
kohms, respectively.
A Grass S88 stimulator and two Nicolet Computers
of Average Transients (CAT) (Models 1074 and 1072)
were driven by aNicolet Stimulus Pulse Generator (NIC-
502). The stimulus at 100 to 120 V (three times motor
threshold) and 10 mA was delivered through a Grass
Photoelectric Stimulus Isolation and Constant Current
Unit (PISU 6C) and directed through a 4-way switching
TABLE I. DIVE
box on the outside of the chamber. The output from all
four recording sites was averaged simultaneously on the
two CAT's, the three SEPs by the 1074 with a 26-30
ms span and the CEP by the 1072 with a 110 ms span
(n = 128). The outputs were observed on two Tektronics
oscilloscopes (5110) and recorded on three Hewlett-
Packard X-Y plotters (HP 7045 A&B). The signals were
amplified to 104 by differential amplifiers (NIC-200A)
outside the chamber before being further amplified (gain
40) and filtered on a 30-3000 Hz bandpass (NIC-501A).
The EP's were recorded with the positive up convention
and with a 2-ms delay before stimulation. The primary
measurements were peak-to-peak amplitudes of P^
and N,P2 in the CEPs, and of PiNi in the SEPs.
When the animal was placed in the compression
chamber, and was stable within the desired range of
physiological measurements, between four and six sets
of control evoked potentials were obtained for each
stimulus site. The chamber was then closed and, with
the appropriate breathing gas on line to the ventilator
compression with air at a rate of 75 ft/min-1 was begun.
Modifications to the ventilator allowed control of cycle
rate and inspiratory flow rate from outside the chamber
so that FetCOz was maintained at 3.5-4.5% surface
equivalent asmeasured by a Beckman LB2 C02 analyzer.
The animals were subjected to the dive profiles shown
in Table I.
About 2 min after each pressure change, EP recording
was begun. All records were made in pairs. Results are
expressed as a percent of mean control EP amplitude
values for each dog. One way analysis of variance was
performed where a significant difference between groups
was sought.
RESULTS
Examples ofactual recordings taken from one dog are
shown in Fig. 1, where the effect ofbreathing air at 300
ft may be seen. All animals were maintained within the
normal range for rectal temperature, acid-base state, and
blood gases.
The records from the six dogs followed at the surface
for 5 h, showed a slight tendency for amplitude to fall
and variance to increase with time (Table II).
The results from each profile were first studied sep¬
arately. This revealed that regardless ofprofile, the effect
ofany given condition with the same breathing gas, was
the same. Therefore, the results ffom all profiles using
the same gas were pooled. At no time was any effect on
DESCRIPTIONS.




60(02)x10; 165(A)xl0; 60(02)x10; 0(A)x40; 165(A)xlO; 60(02)x120




230(He)xl0; 300(He)xl0; 165(He)xlO; 60(He)xl0; 60(02)xl0













All profiles proceeded by 60-100 min control period. Profile 10 followed profile 5, and profile 6 followed profile 9
in the same dogs with a 60 min surface interval. Times are approximate. Breathing gases were (02)—100%; (A)—
air; (He)—20% O2/80% He. Total N = 61. In profiles 7 and 8 only Median CEP was recorded:
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PERONEAL
Fig. 1. Records of cortical and
spinal evoked potentials resulting
from peroneal and median nerve
stimulation at 100 v 10 mA at 2.5
Hz(n = 128) in the same dog. Peaks
of interest are designated P and N
with an arbitrary division to A and
B in the SEPs for summing peak to
peak amplitude. The first record of
each pair was the control record
and the second was at 300 ft.
TIME TIME




0-1 1-2 2-3 3-4 4-5 Overall
p\ (min)
(max)
Peroneal p,n, X 100.0 93.2 91.9 92.7 90.1 93.6 7
CEP SE 5.9 5.2 5.7 6.3 8.7 6.9 108
Peroneal n,p2 X 100.0 97.6 91.9 88.3 92.8 94.5 7
CEP SE 5.4 5.8 9.6 6.5 7.9 7.4 97
Lumbar p.n, X 100.0 97.8 95.9 91.9 90.2 95.2 5
SEP SE 2.1 3.7 5.4 5.0 5.6 5.0 101
Median p.n, X 100.0 101.6 99.6 97.0 97.4 99.1 4
CEP SE 2.7 5.3 6.3 6.9 8.6 6.0 74
Median n,p2 X 100.0 98.5 100.2 96.6 96.0 98.3 1
CEP SE 4.1 5.7 6.0 7.7 7.2 6.3 38
Cervical p.n, X 100.0 97.0 94.2 92.5 94.6 95.7 3
SEP SE 1.4 2.7 2.6 3.0 3.1 2.9 53
Cervical Late X 100.0 95.8 95.2 94.5 91.9 95.5 3
SEP p SE 2.2 3.9 4.3 5.8 5.4 4.5 113
Expressed as a percent of control. N = 6 2-6 Measurements
latency seen which could be attributed to gas, pressure,
or time. The data used in the air and oxygen study were
drawn from the first 20 min of any given exposure.
While breathing oxygen at 60 ft (2.8 bar), there was
a marginal but insignificant depression ofP,N, in pero¬
neal and median CEP, which tended to be restored on
returning to air breathing at the surface.
The effects of the various pressures on CEP and SEP
in air breathing dogs are shown in Table III and Fig. 2
and 3. There was a significant depression of both P,N,
and N,P2 proportional to pressure up to 230 ft. It ap¬
peared that by 300 ft there was at least a leveling off of
the effect ifnot an actual reversal. When breathing 20%
oxyhelium instead of air no effect of pressure was seen
(Table IV). In those profiles (4, 5, 7, and 8 in Table I)
where dogs were returned to the surface free from the
risk of decompression sickness, CEPs returned towards
control values upon surfacing.
No significant depression of P,N, was seen in the
SEPs. The SEPs measured in air and oxyhelium were
almost the same. (Table III and IV and Fig. 3). Flowever,
the amplitude of the cervical SEP late P wave was sig¬
nificantly reduced while breathing air, although to a lesser
extent than were the CEP's (Table III, and Fig. 3).
The effects of continuous exposure to pressure for up
to 2 h are shown in Table V. Neither with continuous
oxygen at 60 ft nor air at 165 ft, was there any evidence
of an accelerated deterioration beyond that due to time
alone as seen at atmospheric pressure. The actual changes
seen were comparable with acute changes shown in the
pooled data presented in Table III. On return from 2 h
of oxygen breathing at 60 ft, to air breathing at atmos¬
pheric pressure, there was no change in CEP amplitude
so that the final level was comparable with what time
alone might produce (Table II).
An attempt was made to detect an effect of inert gas
wash-in from the data given in Table VI. Routinely after
every step change in pressure, two peroneal CEPs were
recorded followed by two median CEPs. If the exposure
was longer than 15 min, the cycle was repeated. Table
VI contains the results from all three gases at all pressures
tested. Firstly, the direction of change between the first
and second recordings (peroneal) and third and fourth
recordings (median) was tested by chi-square. There were
significantly more reductions from first to second re¬
cordings than from third to fourth recordings (P < 0.01).
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TABLE III. EFFECT OF PRESSURE ON EVOKED POTENTIALS WHILE
BREATHING AIR OR OXYGEN.
Depth(fsw) Surface 60(Q2) 60(A) 165 230 300
Peroneal P,N, X 100.0 94.6 95.8 85.6 77.6 85.4
CEP SE 1.2 2.9 1.4 2.1 3.7 3.2
n 46 17 5 23 18 17
Peroneal n,p2 X 100.0 98.2 97.3 86.4 78.3 87.1
CEP SE 2.1 2.7 2.4 2.4 3.9 2.8
n 46 17 5 23 18 17
Lumbar PIN, X 100.0 99.1 97.6 94.3 91.7 92.6
SEP SE 1.1 3.2 3.3 2.3 2.7 2.4
n 45 17 5 23 17 17
Median pin, X 100.0 95.0 99.5 80.8 70.5 68.8
CEP SE 1.2 2.3 3.4 2.4 2.8 3.3
n 39 17 5 23 16 12
Median n,p2 X 100.0 96.9 94.7 82.9 77.8 77.2
CEP SE 2.3 2.8 4.9 3.3 3.9 6.9
n 39 17 5 23 16 12
Cervical P.N, X 100.0 96.8 100.0 95.6 97.8 97.0
SEP SE 0.7 1.9 0.6 3.0 3.6 2.3
n 40 17 5 23 17 12
Cervical Late P X 100.0 97.4 103.2 92.4 88.3 90.0
SEP SE 1.2 1.7 4.4 1.6 1.7 3.6
n 40 17 5 23 17 12
Percent of mean surface control ± S.E.M. The pooled results from dive profiles 1-6 but
excluding the last 80 min of the 120 min studies at 60 ft(02) and 165 ft(A). Control data
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0 60 165 230 300
Fig. 2. The mean CEP, P1N1 and
NiP], and SEP PiN| are shown for
peroneal and median nerve stim¬
ulation while breathing air at the
pressures shown. Results are ex¬
pressed as percent of mean control
values and the shaded area indi¬
cates the range of measurements
seen. Details of SE and n for each
point are given in Table III. The
level of significance of the differ¬
ence between groups by ANOVAR
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This effect was apparent over approximately the first 6
min after a step change of pressure while breathing air.
It was not apparent when breathing oxygen or oxy-
helium.
There appeared to be a further reduction between the
second and third recordings although its significance
was not tested because this would have entailed crossing
between peroneal and median recordings. This suggests
an asymptote for narcotic effect at about 10 min.
In the 230 ft air breathing group, which followed the
trend already outlined, it is noteworthy that the next
pair of peroneal recordings (No. 5 and 6) were the same
(70.8%) as the preceeding median recordings (70.5%)
and also the final pair ofmedians (No. 7 and 8) (69.6%),
indicating a plateau.
In a group in which only median CEPs were measured
the same observations were made. There was no con¬
sistent change seen with oxygen at 60 ft. Mean values
for four consecutive measurements (n = 17) were 96.8
±4.1, 96.2 ± 4.6, 89.9 ± 4.6, and 94.7 ± 5.6. With
air breathing at 165 ft there was again a significant dif¬
ference for the direction of change by chi-square
(p < 0.001) between the first and second pairs of
recordings. This was also evident by paired "t" test
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(p < 0.01). The mean values for the four consecutive
measurements (n = 17) were 86.5 ± 3.4, 79.5 ± 3.4,
77.3 ± 4.6, and 78.1 ± 4.5. Evidence for wash-out was
sought in the dogs which went from 165 ft on air to 60
ft on oxygen (profiles 4, 5, 7, and 8 in Table 1). There
was an insignificant increase in the group means between
first and second recordings of from 1 to 3% following
arrival at 60 ft.
In assessing SEP, we began our study using the first
of the travelling waves PiN,. Later we adopted to a
summation of amplitude. We compared P,N, and the
summed amplitude (2 amp) in section A (Fig. 1) in 48
sets ofSEP measurements from the 16 dogs entered into
the new system. A linear correlation was performed on
the data plotting 2 amp against PiN,. This produced
the relationship 2 amp = 22.12 + 0.733(P1N1) with r2
= 0.6686. At about 79% the 2 amp and P,N, regression
lines crossed. The two parameters were not significantly
different by paired "t" test (t = 2.00 with 47 df).
DISCUSSION
The objective in making these observations, was to
explore the effects of breathing nitrogen mixtures and
oxygen, on SEP and CEP recordings made during animal
experiments studying the treatment of arterial air em¬
bolism and decompression sickness. We observed that
as deep as 230 ft (8 bar) there was a linear relationship
between pressure and the reduction in CEP amplitude
TABLE IV. EFFECT OF PRESSURE ON EVOKED POTENTIALS WHILE
BREATHING 20% OXYGEN IN HELIUM.
Depth(fsw) Surface 60 165 230 300
Peroneal PiN, X 100.0 104.6 101.8 98.5 96.7
CEP SE 3.0 6.1 5.1 5.0 3.8
Peroneal n,p2 X 100.0 104.0 102.7 101.3 97.5
CEP SE 3.0 3.4 5.3 5.9 3.9
Lumbar PiN, X 100.0 95.7 94.6 96.0 95.0
SEP SE 1.4 1.3 2.6 1.5 1.6
Median P,Ni X 100.0 96.3 95.7 93.4 98.0
CEP SE 2.1 3.5 4.3 3.5 5.0
Median n,p2 X 100.0 98.5 98.7 98.6 99.1
CEP SE 2.9 4.1 7.2 4.3 4.8
Cervical PiN, X 100.0 97.2 96.3 98.1 96.0
SEP SE 0.3 2.2 2.3 1.8 1.9
Cervical Late P X 100.0 97.2 96.3 98.1 96.0
SEP SE 0.3 2.2 2.3 1.8 1.8
Percent ofmean surface control ± S.E.M., N = 5. Control data has four replicates
per dog and other entries, two replicates.
TABLE V. THE EFFECT OF 2 h EXPOSURE TO 2.8 bar OF OXYGEN AND 6 bar OF










Peroneal PiN, X 100.6 105.1 106.5 86.7 85.8 83.7
CEP SD 9.6 18.3 21.0 2.1 2.1 3.6
Lumbar PiN, X 93.5 91.9 94.3 92.8 94.7 91.4
SEP SD 23.4 29.9 28.0 7.8 7.0 5.0
Median PiN, X 96.7 92.5 95.7 89.2 88.0 86.6
CEP SD 12.9 13.7 21.4 4.0 4.5 3.2
Cervical P,N, X 96.8 98.9 101.5 94.7 91.6 88.9
SEP SD 3.6 5.9 6.3 2.9 5.3 7.1
Cervical Late P X 98.3 96.7 95.5 93.3 94.6 94.8
SEP SD 8.0 7.8 6.6 4.0 6.4 6.6
Results expressed as a percent of surface control values ± S.D.
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Fig. 3. The lata P wave means from the cervical SEP following
median nerve stimulation while breathing air at the pressures
indicated are shown. Results are expressed as percent of mean
control values and the shaded area indicates the range of meas¬
urements seen.
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when breathing air. Between 230 ft and 300 ft there
appeared to be a leveling offof the amplitude reduction.
No significant effect was seen with oxygen at 60 ft or
with 20% oxy-helium up to 300 ft. Exposure to oxygen
at 60 ft and air at 165 ft for up to 2 hr did not cause
any exaggerated loss of amplitude with time. None of
the conditions tested caused a significant loss of SEP
amplitude either as assessed by P^ or summed am¬
plitude although there was a downward trend related to
pressure. However, the late P wave, representing local
cord events (8), was significantly affected by increasing
air pressure. We were also able to detect an effect, pos¬
sibly attributable to inert gas wash-in, in that CEP am¬
plitude decreased over the first 6-10 min after a step
pressure increase before plateauing. A hint ofthe reverse
effect was also seen. No effect was seen on peak latency
under any condition.
Two facts emerge from the literature regarding evoked
potential measurement at pressure. One is that exper¬
imental numbers are commonly very small and the other
is that reported results are widely divergent even within
the same experimental group. Only one group has re¬
ported the use of somatosensory cortical evoked poten¬
tials in studies of the effects of nitrogen. They reported
the effects to be similar to those on other EPs (14,15).
All other groups have relied on auditory or visual evoked
potentials. Another variable involves the subjects, which
have included man, awake animals and anesthetized
animals.
Breathing gases from a mask in contrast to ventilation
through an endotracheal tube, is also a potential source
of variability. The surrounding gas can leak through
poor seals; a problem well recognized in older mask
designs. Masks are also prone to cause some C02 build¬
up because of the increased dead space, a factor known
to exacerbate narcosis (4). Clearly, breathing chamber
atmosphere or gas supplied through a cuffed endotracheal
tube are the only reliable ways of supplying a precisely
known breathing gas. Any circumstances where an an¬
imal breathes one gas while surrounded by another will
result in some cutaneous transfer, although the effect
will undoubtedly be trivial.
In both the median and peroneal CEP results, an ap¬
proach to an asymptote is suggested between 230 and
300 ft while air breathing. Bennett et al. (5) saw a similar
effect but regarded it as experimental variation. Kinney
etal. (13) refer to an asymptote for nitrogen in the region
of 300 to 400 ft. There are no clear reasons why this
should occur. The possibility ofa saturation of the effect
ofnitrogen seems unlikely at this pressure as behavioural
changes continue to increase at greater pressures. If it
were not that oxygen is also alleged to be narcotic and
should therefore have a synergistic effect (5,10), the pos¬
sibility of a stimulating effect from the oxygen with a
partial pressure approaching 2 bar might be considered
as having some reversal effect on the EP suppression
by nitrogen. However, the short time scale excludes a
mechanism associated with classical acute cerebral oxy¬
gen toxicity.
The range of individual responses seen in our data
was similar to that reported by Bartus et al. (2), where
even at a pressure of about 11 bar some records were
greater than controls. The degree of mean suppression
of groups is also widely variable. Air breathing at 200
to 300 ft has produced EP suppressions ranging from
levels similar to ours (1) to twice as great as ours (5,17).
We can confirm that the effect of air at pressure on
somatosensory CEP is similar to that on auditory and
visual CEP. The only report ofa latency shift by Kinney
et al. (12) is at oddswith our findings and those ofothers
(1,5,10).
The reported work on EPs while breathing oxy-helium
in the pressure range of interest to us has largely been
done with awake men and animals (5,17). They report
a depression of about 30% in AER at 300 ft and about
20% at 200 ft where we saw no apparent change. It may
be that the anesthesia in our animals has already caused
that amount of suppression. Certainly if one deducts
30% from those results and also the air results reported
by the same authors then our findings are the same.
This might suggest a synergistic effect of narcosis with
pentobarbital. It may also be that the many extraneous
effects of compression, of which the conscious man/
animal is aware, could also have an adverse influence
upon EP measurement.
Bennett (3) reported a reduction in cat spinal reflex
activity during air breathing at pressures of 7-9 bar. He
likened the effect to the asphyxia effects on the segmental
SEPs recorded from the cord dorsum described by Gel-
fan and Tarlov (8). Looking at the initial travellingwave
TABLE VI. EFFECT OF INERT GAS WASH-IN ON CORTICAL EVOKED
POTENTIAL AMPLITUDE.
Gas Air 02/He o2
Depth (fsw) 60 165 230 300 60 165 230 300 60
Peroneal 1 96.0 87.1 80.1 88.3 101.3 97.1 92.0 92.6 94.0
1.9 2.3 5.1 4.0 4.8 4.6 3.5 2.7 2.2
2 95.5 84.2 74.0 85.1 96.6 96.3 94.7 91.1 94.7
2.2 2.2 3.0 4.9 6.8 5.2 3.9 4.3 2.3
A -0.5 -2.3 -5.9 -3.2 -4.7 -0.8 +2.7 -1.5 +0.7
Median 3 96.3 82.1 70.6 67.7 96.3 97.3 92.0 88.1 97.2
3.3 2.5 3.1 3.5 4.3 4.2 5.0 3.9 2.2
4 96.7 81.2 70.1 69.9 96.8 94.4 91.0 90.1 95.8
3.1 2.6 3.2 3.3 4.0 5.0 4.8 5.3 2.6
A +0.4 -0.9 -0.5 +2.2 +0.5 -2.9 -1.0 +2.0 -1.4
Results expressed as percent ofmean control value ± S.E.M. The first pair of CEPs (Peroneal) were
recorded between 1 and 6 min after arrival at the stated pressure. The second pair ofCEPs (Median)
were recorded between 6 and 12 min after arrival at the stated pressure. The mean values at 230 ft
(Air) for a second pair of peroneal CEPs taken at 20 - 30 min were 70.7 ± 3.29 and 71.0 ± 3.50.
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as opposed to the static wave of the root entry in the
SEPs and also the summed amplitude of the principal
early waves, we saw a slight downward trend in am¬
plitude which was no significant. However, the late slow
P wave in the median—cervical SEP showed a significant
change inversely related to air pressure. The depression
was considerably less than that seen in the CEP at the
same pressures. This wave may be related to interneu-
ronal activity and possibly to local reflexes (8). Our find¬
ings would therefore tend to corroborate those ofBennett
(3). The relationship between the three types of EPs;
SEP long tract travelling waves (mostly non-synaptic),
SEP late P waves (interneuronal local events), and CEP
(multiple synaptic transmission) and the relative effects
of narcosis, lend support to the idea that the inert gas
effect is the result of interference with synaptic trans¬
mission (4). The effect is evidently mostly in the brain,
as suggested by Bartus and Kinney (2), where the density
of synapses is greater.
The literature appears to contain no references to the
ability to detect the effect of inert gas wash-in upon the
EPs. The appearance of a plateau by about 8 to 10 min
is compatable with opinions regarding the time for inert
gas exchange in the brain (11,18). With much smaller
pressure changes in the decompression phase, a similar
but insignificant reverse trend was observed.
After reaching equilibrium following a step pressure
change, there was no indication that the additional pres¬
sure caused an acceleration of the small deterioration
expected as a result of time alone.
Although other authors (5,10) have stated that oxygen
has a narcotic effect comparable with that of nitrogen,
we could not confirm this; even though a slight reversible
effect was seen in the 10-min exposures, it was not seen
in the 20- and 120-min exposures. Ray and Hawgood
(16) also failed to find the effect, although the late effects
of acute oxygen toxicity caused a progressive loss of EP
amplitude after between 60 and 100 min breathing 5.76
bar of oxygen. Their animals, like ours, were anesthe¬
tized. The possibility of the surrounding influences con¬
tributing to the effect in alert men or animals must again
be considered as an alternative to an effect attributable
to the gases breathed. For this reason, in the clinical
area efforts are made to remove all extraneous influences
when measuring CEPs (7,9). In compression experiments
this is well nigh impossible.
The discrepency between our observations of no sig¬
nificant change in EP while breathing oxygen or oxy-
helium at pressure, and the observations of others that
a decrement occurs (5), although without any observable
loss of performance, clearly supports Fowler and Ackles'
doubts concerning EPs as measures of narcosis (6).
However, these studies allowed us to provide a correc¬
tion factor for the CEP measurements made under pres¬
sure during treatment experiments and indicated that
this was not necessary for SEP measurements.
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Spinal evoked potentials (SEPs) and cortical
evoked potentials (CEPs) are being increasingly
used experimentally, diagnostically and as a moni¬
toring device in neurosurgical procedures (Gross¬
man 1979). For proposed studies of the treatment
of spinal cord decompression sickness, a system
that would permit remote interrogation of the
neuraxis and localization of lesions to major cord
divisions was required.
Design constraints required that the model be
controlled and maintained remotely in a pres¬
surized chamber for periods of up to 5 h. The
chamber containing an animal, once pressurized,
could not be easily decompressed and opened
without putting the experiment at risk; not even in
the brief period when near atmospheric pressure,
between the first dive and the treatment. In addi¬
tion, the neuraxis and its integument could not be
invaded, as such procedures might predispose to
localized decompression sickness (DCS) (Kidd and
Elliott 1975). The development of lesions resulting
from decompression sickness is often rapid (Rivera
1964; Hallenbeck et al. 1975; Leitch 1979), so it
was imperative that each interrogation and record¬
ing be short in order that onset times of decom¬
pression sickness be known within narrow limits,
and the degree of severity be known before treat¬
ment.
The selected inputs were left and right peroneal
nerves (usual roots in the dog L6, L7, S1; S2), left
tenth or eleventh intercostal nerve, and left median
1 Royal Navy Exchange Medical Officer to United States
Navy.
nerve (usual roots C8, T,, T2) (Hoerlein 1978). The
evoked potentials (EPs) were recorded at segments
L, or L2, T8 or T9, C7 or C8, and at the right
somatosensory cortex. This permitted localization
to 5 broad regions: lumbar, caudal thoracic, rostral
thoracic and caudal cervical cord, and the cortical
and intervening regions. Experiments were con¬
ducted to determine a suitable anesthetic regimen
and observe the effects of varying stimulus
strengths.
Method
Conditioned male mongrel dogs weighing 9-20
kg were sedated with subcutaneous xylazine (2.2
mg/kg) and atropine (0.05 mg/kg) prior to being
anesthetized intravenously with sodium pento¬
barbital or a-chloralose. The dogs were intubated
and respiration was maintained with a Bird® Mark
7 ventilator using air. A catheter was placed in the
left forepaw cephalic vein for anesthesia mainte¬
nance and infusions. Physiological monitoring of
aortic and right ventricular pressures, EKG, EEG,
rectal temperature, end-tidal gases, blood gases
and acid-base status was carried out. Experiments
were terminated by the intracardiac injection of
saturated potassium chloride solution.
The dog was placed prone in a rigid head-hold¬
ing stand (patterned after a stereotaxic frame),
which incorporated a hot water plate. Rectal tem¬
perature was kept between 37.5 and 39.0°C. The
skull was exposed by reflecting skin, muscle and
periosteum over the right somatosensory cortex. A
0013-4649/84/503.00 © 1984 Elsevier Scientific Publishers Ireland, Ltd.
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skin flap over the distal part of the nasal bones
was also excised. Holes were drilled in the nasal
bones and into the cancellous bone of the skull.
The electrodes made from No. 4 stainless steel
sheet metal screws were inserted. The cortical elec¬
trode was placed at a point one-third of the skull
length, anterior to the inion and approximately 7
mm laterally. This was a point midway between
the forelimb and hind limb regions of the
sensorimotor cortex. Putting standard electrode
gel into the drilled hole ensured an electrode im¬
pedance below 2 kf2.
The reusable spinal electrodes were made from
shortened stainless steel orthopedic finger wires
(C-wires Concept Inc.) with a pin connector
soldered to the cut end. The insulation consisted
of 4 coats of clear polyurethane baked for 48 h at
110°C. Testing of the insulation revealed infinite
resistance up to 500 V. Two millimeters of the tip
were bared and the- end was lightly sanded to
allow easy passage through tissues.
The spinal electrodes were placed in a bipolar
configuration. They were pushed into adjacent in-
terspinous spaces in the plane of the spinal
processes until they touched the posterior lamina
in the midline. The electrodes were anchored by
hammering them approximately 2 mm into the
bone. Impedance was generally between 3 and 6
k 12.
The stimulating electrodes were 20-gauge stain¬
less steel needles on double banana pins secured
with heat shrink plastic. The peroneal electrodes
were introduced percutaneously so that they strad¬
dled the peroneal nerve where it was palpable over
the neck of the fibula. The intercostal electrodes
were placed one subcutaneously and one subcos-
tally from the caudal side of the tenth or eleventh
rib. Both these electrodes were secured to the skin
by safety pins. The median nerve was stimulated
at the point where it was palpable medially at the
distal end of the humerus. The needles were laid
subcutaneously over the nerve in an A-P direction
with the cathode proximal. The arrangement was
secured by taping the attached banana plug to the
leg.
A Grass S88 stimulator and two Nicolet Com¬
puters of Average Transients (CAT) (Models 1074
and 1072) were driven by a Nicolet stimulus pulse
generator (NIC-502). The 0.3 msec stimulus of 120
V (3 times motor threshold) at 10 mA was de¬
livered through a Grass photoelectric stimulus iso¬
lation and constant current unit (PISU 6C) at a
rate of 2.5/sec and directed through a 4-way
switching box on the outside of the chamber. The
output from all 4 EP sites was averaged simulta¬
neously on the 2 CATs, the 3 SEPs by the 1074
with a 26-30 msec span and the CEP by the 1072
with a 110 msec span. For each recording 128
epochs were summed. The outputs were observed
on 2 Tektronix oscilloscopes (5110) and recorded
on 3 Hewlett-Packard X-Y plotters (HP 7045 A
and B). On leaving the chamber the signals went
to differential amplifiers (NIC-200A) (gain 104),
before being further amplified (gain 40) and filtered
on a 30-3000 Hz bandpass (NIC-501A). The EEG
signal for the CEP was tapped between the ampli¬
fier and filter and presented simultaneously on a
Tektronix oscilloscope (5103N) and after amplifi¬
cation by a Gould Universal amplifier, on a Gould
chart recorder (Model 2800) with the other physio¬
logical outputs.
The EPs were recorded with the positive up
convention and with a 2 msec delay before stimu¬
lation. The CEP records had 3 principal peaks
(P,N]P2) and up to 11 far-field potentials (FFPs)
mostly observed before N, (Fig. 1). These FFPs
were best seen in the median records.
PERONEAL
110 ms.
Fig. 1. Representative cortical evoked potentials. The principal
cortical peaks are marked P,N,, etc., and the far-field poten¬
tials are marked 1-8.
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The SEPs produced complex polyphasic wave
forms with up to 10 easily identifiable pairs of
peaks (Fig. 2). The more rostral to the stimulus
was the recording, the longer the latency, the
greater the spread, and the smaller the amplitude
(Fig. 3). Records from close to the root input were
dominated by a large negative wave and a later
slow positive wave at 8-10 msec (Figs. 2, 3 and 4).
Analysis of these records took two forms. The
CEPs were measured primarily for P,N, ampli¬
tude. The OP! and N,P2 amplitudes were also
measured as were the latencies of the primary
peaks and the FFPs. Spinal evoked potential re¬
cords were also measured for the principal peak-
to-peak amplitude and for the amplitude of the
late slow positive wave. Each trace was marked for




Fig. 2. Representative spinal evoked potentials. The records are
labeled with stimulus and recording site. The numerals are
placed by the positive peaks considered relevant. The succeed¬































PERONEAL N.-SPINAL CORD EVOKED POTENTIALS
TnO 82X 7 OCT 81 STIMULUS 90V AT 10mA AT 2.5 Hzl
Fig. 3. Peroneal nerve-spinal cord evoked potentials. Sequential
bipolar SEPs are shown from unilateral peroneal nerve stimula¬
tion at the neck of the fibula. Observe the large negative and
late, slow positive waves that dominate the root entry zone.
Latency and spread increase with distance from the stimulus,
while amplitude decreases. The classical root entry zone record¬
ings are inverted caudal to the root entry.









STIMULUS 5 10 15 20 m«
II MEDIAN N. SPINAL CORD EVOKED POTENTIALS
I [NO. 82X 7 OCT 81 STIMULUS 90V AT 10mA AT 2.5Hz]
Fig. 4. Median nerve-spinal cord evoked potentials. Sequential
bipolar SEPs are shown for unilateral median nerve stimulation
at the distal end of the humerus. The SEPs show classical cord
dorsum recordings for a root entry-zone evoked potential.
the peaks of interest and given an arbitrary base¬
line to compensate for occasional wandering slow
voltage changes. They were then entered into a
computer (PDP 11-70) using an Elographics dig¬
itizer (Model E241 with an Orthoplex Coordinator
Sensor Type 3825-1). Latency change was of minor
importance compared with amplitude, so peak-to-
peak amplitudes were used for simple analysis.
The SEP waves fell into two types in each trace,
large early waves, assumed to be of greater impor¬
tance, and small later waves. These were arbi¬
trarily separated for descriptive purposes and des¬
ignated A and B respectively (Fig. 2).
Prior to this study the maintenance regimen for
pentobarbital or a-chloralose anesthesia was
guided by indications of a lightening plane of
anesthesia. Any regimen which depended on shift¬
ing planes of anesthesia could well have a variable
effect upon evoked potentials (Pimmel et al. 1976;
Parker 1978a; Arezzo et al. 1979). Practical prob¬
lems regarding anesthesia were the injection of
large volumes of a-chloralose from outside a
chamber pressurized to as much as 10 bar and the
use of continuous infusion. Pentobarbital was cho¬
sen for the chamber studies because it could be
injected in small quantities.
A retrospective analysis of the anesthetic regi¬
mens of 24 dogs showed that with an initial
pentobarbital dose of 12.5 mg/kg (i.v.) the inter¬
vals for the maintenance dose of 25 mg varied
between 1 and 155 min. Plotting the cumulative
anesthesia given to each dog showed that the dose
required in unit time was linear after about 40 min
and was much less than the amount given during
the first 40 min. The mean interval between doses
after 40 min was 22 min. The dose-time slope was
4 mg/kg/h. To arrive at the 40 min point the
initial dose was increased to 13.5 mg/kg and half
that dose was repeated at 20 min. The mainte¬
nance dose was then given at 20 min intervals
unless two successive 20 min checks failed to elicit
a corneal reflex, then a dose was withheld. By the
time the dog was placed in the chamber it was
usually clear whether or not the maintenance dose
should be changed.
Ten dogs were used to study the effect of
stimulus voltage under each anesthetic regimen at
the start of various experiments. Stimulus voltage
was varied in 20 V steps between 20 and 140 V in
either ascending or descending sequence. The CEP
from the median nerve input was recorded. The
latencies of P,, N,, P2 and the peak-to-peak ampli¬
tudes were measured.
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Median and peroneal CEP and SEP at the 3
cord sites were recorded in a further 7 dogs to see
how SEP amplitude and CEP related under
pentobarbital anesthesia.
Because the experiments leading to treatment of
decompression sickness were likely to last about 5
h, it was important to know the stability of the
preparation with regard to time. Six dogs were
prepared and recordings of CEP and SEP were
carried out at 20 min intervals over 5 h.
Fifteen dogs were used in the exploration of the
use of evoked potentials in diagnosing and quanti¬
fying spinal cord lesions produced by decompres¬
sion sickness. The dogs were prepared as described
and placed in the compression chamber. The ce¬
phalic vein catheter was connected to a port in the
chamber wall, through which pentobarbital and
fluids could be given. Before diving, 4 sets of
control EPs were collected for each of the 4 stimu¬
lus inputs.
Nine dogs participated in air dives to 230 ft for
between 39 and 60 min, depending on their weight,
and 7 dogs participated in air dives to 300 ft for
between 10 and 17 min. After returning to the
surface the functions of the left and right halves of
the cord were studied alternately by stimulating
the left or right peroneal nerves. This allowed
observation of most of the length of the cord. A
diagnosis of cord decompression sickness was made
when the SEP changed. If the SEP changes were
confined to the cervical electrodes, the median
input was tested, and if confined to thoracic and
cervical sites, then the intercostal and median in¬
puts were tested. Usually changes were progres¬
sive, confirming the diagnosis. Treatment was de¬
liberately delayed in order to prevent immediate
complete recovery.
After a delay of approximately 17 min after
diagnosis, treatment by recompression was begun.
Eight dogs were treated with oxygen at 60 ft for 2
h and 7 dogs were treated at 165 ft breathing air
for the 2 h. The magnitude of the SEP deficit was
assessed on a final pretreatment recording of the
first SEP site to show a change. Those inputs
showing changes were measured at 5 min after
arrival at pressure, at 15 min post arrival, and at
15 min intervals thereafter. The remaining inputs
were measured at 0.5 h intervals. A simple numeri¬
cal description of the SEPs was needed for statisti¬
cal purposes. Pilot studies showed that fine dis¬
crimination techniques were not required for the
gross changes that occurred. The SEPs were quan¬
tified by adding the peak-to-peak amplitudes
(P^, + N,P2 + P2N2, etc.). All measurements
made after the control period were expressed as a
percent of the mean control values. The final
pretreatment measurement was converted to indi¬
cate the amount of SEP amplitude lost. Cord
lesions resulting from decompression sickness were
both unpredictable and uncontrollable, therefore,
it was desirable to apply a normalizing procedure.
This was done by expressing all recovery as a
percentage of what was lost.
Results
In comparing the effects of increasing stimulus
voltage in dogs anesthetized with either pentobar¬
bital or a-chloralose, it was shown that pentobar¬
bital had a depressing effect upon CEP (Table I).
The voltage of the 3 primary peaks was generally
less than half that of the voltage in the a-chlo-
ralose dogs.
By 60-80 V the latency (Table II) was fixed
under pentobarbital and the peak-to-peak ampli¬
tudes exceeded 90% of the maximum obtained at
140 V. Under both regimens the visible motor
threshold was between 30 and 40 V, although CEP
was clearly identifiable before them. A working
voltage in which the response was asymptotic and
the latency fixed was about 3 times motor threshold
at 100-120 V.
In the 7 dogs in which the relationship between
SEP and CEP was studied, amplitude grew pro¬
portionally in both SEP and CEP. The relation¬
ship was best between the early (3-5 msec) lumbar
SEP waves designated 'A' and the peroneal CEP.
The same applied for the comparable waves (1-4
msec) with the median-cervical SEP and CEP.
In the 5 dogs in which the effect of time on EPs
was studied, no change in latency was seen. There
was, however, a progressive fall in both cortical
and spinal evoked potential mean amplitudes of
between 1 and 2%/h and an increase in variance
with time (Table III). In this group the direction of
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TABLE I
Somatosensory cortical evoked potentials. Peak-to peak amplitude — effect of voltage and anesthesia.
Peaks Condition OIIZ Stimulus voltage Amplitude in
/iV at 140 V20 40 60 80 100 120 140
OP, PENTO x (%) 6.6 60.0 81.6 90.1 91.2 97.2 100 39.2
± 95% -0.7-13.9 38.1-81.9 67.2-96.0 80.7-99.5 79.6-102.8 89.4-105.0 - 28.0-57.4
CHLOR x (%) 5.3 57.8 75.3 83.9 90.1 96.9 100 78.2
+ 95% -1.2-11.8 39.2-76.4 63.8-86.8 74.6-93.2 82.9-97.3 92.7-101.1 - 60.0-96.4
P,N, PENTO x (%) 4.4 56.8 87.5 91.5 96.8 98.9 100 72.7
±95% -0.3-9.1 36.6-77.0 74.3-100.7 85.6-97.4 89.8-103.8 94.1-103.7 - 40.7-104.7
CHLOR x (%) 4.7 55.5 74.1 82.7 91.0 96.5 100 170.1
±95% -1.4-10.8 38.7-72.3 62.7-85.5 72.9-92.5 84.2-97.8 91.6-101.4 - 116.0-224.2
n,p2 PENTO x (%) 3.5 53.0 83.2 84.4 91.7 95.8 100 48.7
±95% 0.6-6.4 30.6-75.4 67.3-99.1 76.4-92.4 82.2-101.2 90.4-101.2 - 29.4-68.0
CHLOR x (%) 3.9 58.4 81.1 87.0 96.1 98.0 100 137.0
±95% -1.2-9.0 42.2-75.6 65.0-97.2 73.1-100.9 83.2-109.0 91.2-104.8 - 71.6-202.4
PENTO = pentobarbital 4 mg/kg/h, bandpass 30-3000 Hz, nasal reference.
CHLOR = a-chloralose 40 mg/kg/h, bandpass 30-3000 Hz, nasal reference.
change of SEP and CEP P,N, amplitude was ob¬
served, from both median and peroneal nerve
stimulation, with regard to maintenance doses of
pentobarbital. There was no clear indication that
EPs decreased after anesthesia or increased during
pre-anesthesia intervals. Only the late, slow posi¬
tive wave at 8 msec in the median-cervical SEP
showed a tendency to decrease after adminis¬
tration of pentobarbital (P < 0.05, chi-square).
Two examples of the EP changes in decompres¬
sion sickness affecting the spinal cord are shown
in Figs. 5 and 6. The first shows the diagnosis of a
lesion in the lumbar region and the second that of
a lesion in the thoraco-cervical region.
A common indication of imminent decompres¬
sion sickness that would affect the cord was an
TABLE II
Somatosensory cortical evoked potential. Peak latency — effect of voltage and anesthesia.
Peak Condition N = 10 Stimulus voltage
20 40 60 80 100 120 140
p, pento x (msec) 18.9 13.7 13.3 13.3 13.3 13.3 13.3
±95% 15.1-22.7 12.4-15.0 12.5-14.1 12.5-14.1 12.3-14.3 12.3-14.3 12.3-14.3
chlor (1) x (msec) 15.0 14.4 14.1 13.8 13.7 13.6 13.6
±95% 13.1-16.9 13.3-15.5 13.1-15.1 12.9-14.7 12.8-14.6 12.7-14.5 12.7-14.5
N, pento x (msec) 32.1 21.6 20.3 20.0 20.0 19.9 20.0
±95% 25.7-38.5 19.4-23.8 19.0-21.6 18.6-21.4 18.5-21.5 18.5-21.3 18.5-21.5
chlor (1) x (msec) 30.0 25.9 23.9 23.5 23.2 22.6 22.4
±95% 25.4-34.6 22.6-29.2 21.1-26.7 20.9-26.1 20.5-25.9 20.3-24.9 20.1-24.7
Pz pento x (msec) 44.7 35.6 33.9 34.0 34.2 33.7 34.0
±95% 40.2-49.2 32.8-38.4 31.3-36.5 31.3-36.7 31.6-36.8 31.1-36.3 30.7-37.3
chlor (1) x (msec) 53.3 45.4 43.8 43.4 43.4 43.4 43.0
±95% 35.7-70.9 37.9-52.9 36.5-51.1 35.9-50.9 35.7-51.1 35.5-51.3 34.7-51.3
PENTO = pentobarbital 4 mg/kg/h, bandpass 30-3000 Hz, nasal reference.
CHLOR = a-chloralose 40 mg/kg/h, bandpass 30-3000 Hz, nasal reference.
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TABLE III
Effect of time on evoked potentials (expressed as a percentage of control). N = 6, 2-6 measurements per dog, per period.
Time period (h)




Peroneal P,n, X 100.0 93.2 91.9 92.7 90.1 93.6 7
CEP S.E. 5.9 5.2 5.7 6.3 8.7 6.9 108
Peroneal n,p2 X 100.0 97.6 91.9 88.3 92.8 94.5 7
CEP S.E. 5.4 5.8 9.6 6.5 7.9 7.4 97
Lumbar p,n, X 100.0 97.8 95.9 91.9 90.2 95.2 5
SEP S.E. 2.1 3.7 5.4 5.0 5.6 5.0 101
Median p,n, X 100.0 101.6 99.6 97.0 97.4 99.1 4
CEP S.E. 2.7 5.3 6.3 6.9 8.6 6.0 74
Median n,p2 X 100.0 98.5 100.2 96.6 96.0 98.3 1
CEP S.E. 4.1 5.7 6.0 7.7 7.2 6.3 38
Cervical p,n, X 100.0 97.0 94.2 92.5 94.6 95.7 3
SEP S.E. 1.4 2.7 2.6 3.0 3.1 2.9 53
Cervical Late X 100.0 95.8 95.2 94.5 91.9 95.5 3











Fig. 5. Decompression sickness of the lumbar-caudal thoracic spinal cord. An illustration of the sequence of EP recordings leading to
the diagnosis of DCS. Record 3 shows an occasional prodromal sign of DCS with some increase in amplitude associated with wave
form changes in the later peaks. The thoracic record was destroyed by noise, another prodromal sign. The CEP shows no sign of
change. Record 4 shows clear changes at all sites, beginning in the lumbar region. Checks of intercostal and median inputs revealed no
changes which localizes the lesion to below T8. The remaining records show the progressive failure of conduction with time.
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Fig. 6. Decompression sickness of the thoraco-cervical spinal cord. The large sweeping records of the antidromic EPs from the median
nerve are not shown. Record 4 shows the earliest indication of change with a latency shift in the cervical record. A possible change in
the later peaks of the lumbar record may also be relevant. Similar changes are evident in record 5. Records 6 and 7 of the
median-cervical EP show a progressive loss of the later waves and some changes in the earlier peaks. The final two records show some
lumbar involvement and the failure of any transmission through the thoracic region. No cortical records are shown because early
postdive cerebral DCS developed, obliterating much of the CEP and most of the FFPs.
outbreak of high-frequency, high-voltage noise in
the thoracic electrodes. It was possible to suppress
this electrical activity using pancuronium bromide,
which suggests a myogenic origin. Occasionally the
noise was just signal breakup similar to a series of
cardiogenic artifacts.
Experience showed that looking for small
changes was futile because they were hard to dis¬
tinguish from normal variation. Generally, if small
changes were due to decompression sickness, they
would develop into significant changes. Fig. 7
illustrates a bilateral loss of peroneal-lumbar SEP,
which was first observed on the right side. The
apparent loss before diagnosis is an artifact result-
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Fig. 7. Decompression sickness of the bilateral peroneal-lumbar cord. The numbers under 2 AMP (%) indicate the summed
peak-to-peak amplitude as a percent of control. The SEP change was first seen in the right peroneal input. The apparent low pre-onset
value for 2 AMP (%) was present after the start of the first dive and may therefore be considered an artifact. The left peroneal-lumbar
SEP lost all wave form before treatment. Because the duration of the lesion was shorter than that of the right peroneal-lumbar lesion,
however, it showed a better recovery in treatment.
TABLE IV
SEP loss ir decompression sickness and recovery with treat¬
ment *.
60 ft oxygen 165 ft air
n 8 7
Delay (min) 16.7 ± 4.4 17.2+ 3.7
Loss ** (% of control) 60.6 ± 22.4 64.1 + 16.9
Recovery *** 15 min 25.1+23.4 16.7 + 22.9
(% of loss) 40 min 28.4 + 37.0 20.6 + 20.9
80 min 33.9 + 33.3 22.3 + 19.7
120 min 24.8 + 28.8 24.7 + 18.6
* The values are x ± S.D.
** The SEP loss is expressed as a percent of the mean control
value.
*** The recovery results are the ratio of SEP recovery to SEP
lost expressed as a percent.
ing from a step change in amplitude that occurred
during the first dive. There was a better return in
the lesion of shorter duration on the left side than
in the lesion of longer duration on the right side.
The onset of SEP changes after return to the
surface varied between 2 and 38 min in the 15
dogs. By the time treatment was begun, both groups
had a similar loss of SEP of about 60% in the
primary site (Table IV)- Most lesions occurred in
the lumbar and lower thoracic cord with an occa¬
sional cervical lesion. During treatment most re¬
covery occurred within 15 min. There was no
difference between the two treatments after 120
min; each recovered approximately 25% of the lost
SEP.
Occasional dogs developed brain-stem lesions.
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These could be identified in dogs with normal
SEPs and apparently normal EEGs, but abnormal
CEPs with varying numbers of missing FFPs.
Discussion
The effects of chloralose and pentobarbital on
CEP revealed a considerable depression in ampli¬
tude attributable to pentobarbital. Because the
comparison did not include unanesthetized
animals, it is impossible to comment on how CEP
or SEPs deviated from normal. In comparing these
two anesthetics, Harding et al. (1979) observed
that pentobarbital reduced the number of active
cortical neurons when compared with choralose. It
has also been observed that barbiturate anesthesia
in low doses tends to facilitate CEP but that
higher (surgical anesthesia level) doses tend to
depress CEP (Pimmel et al. 1976; Dafny 1978;
Nordwall et al. 1979). Dafny attributes this to an
effect upon the reticular activating system. Abra-
hamian et al. (1963) also point to an extralemnis-
cal influence but on the later waves. Other authors
observed that in general only the late non-specific
parts of the CEP were depressed (Clark and Rosner
1973; Allison et al. 1963). These slightly conflict¬
ing observations may result from the maintenance
of different levels of anesthesia and the fact that
all those observations, that suggested that the early
waves (< 100 msec) were unaffected, were made in
man. The tentative observation that the late posi¬
tive wave in the SEP recorded close to the root of
entry might be affected by anesthesia may be
supported by Robson's (1971) observation that
presynaptic inhibition is potentiated by barbitu¬
rates leading to monosynaptic reflex depression.
No dogs in the chloralose experiments were pre¬
pared for SEP measurement. It seems probable,
however, that relative to the unanesthetized state
and to chloralose anesthesia, the SEPs were also
depressed by pentobarbital as seen by Nordwall et
al. (1979). Rosner and Clark (1973) observed that
pentobarbital caused a reduction in excitatory ac¬
tivity in cord and suppression of transmission in
small fibers (cutaneous receptive field) in the ante¬
rolateral columns at moderate doses. These find¬
ings are all largely in accord with those of Albe-
Fessard et al. (1970) who compared these two
anesthetic agents.
The bipolar cord electrode configuration with
the electrodes embedded in bone close to the spi¬
nal cord produced relatively noise-free SEPs, with
a useful amplitude and sufficient detail to enable
early changes to be detected in decompression
sickness. This was preferable to the larger ampli¬
tude but less detailed SEP obtained with mono¬
polar electrodes by others (Cracco 1973; Ertekin
1978). Sarnowski et al. (1975) and Ertekin (1978)
similarly observed that SEP amplitude and defini¬
tion improved with the proximity of the electrode
to the cord.
The first 3 primary cortical waves, P,, Nj and
P2, were monitored to the exclusion of the later
waves, which were more variable. The observed
mean latencies in a comparable group of 11 from
the median nerve were 10.2, 15.9 and 26.8 msec
respectively and from the peroneal nerve 14.0, 20.9
and 31.8 msec respectively. These CEPs are com¬
parable with those observed in dogs by Norrsell
(1966) and Parker (1978a, b). Norrsell, in cord
transection experiments, showed that the P,N,
components were transmitted ipsilaterally in the
dorsal columns and in the dorsal part of the lateral
funiculus. He also observed that waves with the
latencies of P2 and later were transmitted through
both ipsilateral and contralateral ventral funiculi.
While remembering that species differences ex¬
ist in the neuroanatomy (Arezzo et al. 1979), simi¬
lar findings were reported by Simpson et al. (1981)
in monkeys. Large diameter fibers in the dorsal
columns contributed to waves of latency less than
40 msec and small diameter fibers in the antero¬
lateral columns contributed to latencies greater
than 70 msec. The waves between 35 and 70 msec
(P2N2) had a dual contribution from both col¬
umns. These findings are generally supported by
human work which shows that cord lesions which
cause the greatest reduction in the early CEP
waves are associated with impairment of vibration
and position sense while the impairment of the
P2N2P3 waves is associated with loss of pain and
temperature sense (Sances et al. 1978; Yamada et
al. 1978).
Between 4 and 7 FFPs were commonly ob¬
served in the CEP; the majority preceded N,. They
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could be observed bilaterally with a unilateral
stimulus. They were most pronounced with median
nerve stimulation, which showed as many as 11
FFPs. The earliest observed was the stationary
wave closest to the stimulus which was sometimes
also seen in the SEP and is attributed to the entry
of the dorsal root to the cord. We failed to find
any descriptions of FFPs in dogs in the literature,
and as we did not investigate their origin in the
dog any inferences regarding their site of origin
remain speculative. The fixed nature of their
latency indicates that they are volume conducted
potentials arising from events fixed anatomically.
Wiederholt and Iragui-Madoz (1977) observed
4 FFPs on the rising slope of P, in rats. They
attributed them in sequence to dorsal column,
dorsal column nucleus and medial lemniscus,
ventral posterior thalamic nucleus and sensory
radiation and possibly also cerebellar pathways
and cerebellum. Using cats allowed a better sep¬
aration of the FFPs, and they were localized to
dorsal column, dorsal column nucleus and/or me¬
dial lemniscus, cerebellum and/or cerebellar path¬
ways, ventral posterior nucleus of thalamus, and
sensory radiation with some thalamic contribution
(Wiederholt and Iragui-Madoz 1977). Human work
has produced similar observations but with more
complexity, including observation of the periph¬
eral nerve or dorsal root (Cracco and Cracco 1976;
Anziska and Cracco 1980; Desmedt and Cheron
1980; Pratt and Starr 1981). Future work may
produce more detailed knowledge of these origins
as clearly, if we can see up to 11 FFPs; those
smaller numbers reported by other authors may be
broken into more separate peaks.
The number of axonal volleys observed with
this preparation probably reflects the supramax¬
imal stimulation of a distant peripheral nerve al¬
lowing time for separation of synchronous volleys
in axons of different sizes and, therefore, different
conduction velocities (Figs. 3 and 4). The similar¬
ity of the root entry segment potentials recorded
by Bernhard (1953) from the cord dorsum and
these records suggests that they are basically those
that might be recorded from the cord dorsum,
although the activity seen is not necessarily con¬
fined to the dorsal columns. Others using similar
electrode placings but with monopolar recordings
found less complex wave forms than these (Holli-
day et al. 1979; Nordwall et al. 1979).
It was observed that as the recording site moved
rostrally, additional peaks separated from those
evident around the entry segment (Figs. 3 and 4).
These progressively lost amplitude and increased
in latency with a wider separation of peaks as the
distance increased. It is assumed that the loss of
amplitude is the result of the giving off of collater¬
als so that neuronal bulk is reduced, and that the
apparently different conduction velocities repre¬
sent axons of different sizes or synaptic activity
(Sarnowski et al. 1975). It would be fair to assume
that the variation in axonal size is a continuum.
Therefore, in order to account for the clear separa¬
tion of peaks, it must be assumed that different
groups of similar sized axons are synchronous and
are perhaps grouped by modality, these need not
be discretely separated anatomically. It was not
possible to correlate different SEP peaks with
cortical FFPs or with a particular anatomical posi¬
tion in the cord, but it may be presumed that the
earlier and larger peaks contribute most to the
CEP and, therefore, are mainly in the dorsal col¬
umn. Certainly the late peaks may be lost in
decompression sickness without apparent change
in the CEP, and the early peaks must change in
order for CEP to change.
In dogs, dorsal column potentials recorded from
light touch, hair, joint movement and deep pres¬
sure can also be produced by electrical stimula¬
tion. The physical stimuli cannot be detected in
the anterolateral columns (spinothalamic) al¬
though electrical stimulation produces a response
commensurate with A/3 and AS fibers, the so-called
'fast-pain fibers' (Illingworth and Molina-Negro
1974). Shimoji and Kano (1975) recording epidur-
ally in man found that moving from the posterior
to the anterior space simply inverted the potentials
recorded dorsally, which suggests that all cord
activity can be observed from the cord dorsum.
Clinical and experimental experience suggests
that the use of SEP and CEP has considerable
potential in predicting outcome and in monitoring
cases of acute cord injury (Nash et al. 1977; Parker
1978b; Rowed et al. 1978).
These initial efforts to develop the evoked
potential technique to monitor the occurrence and
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treatment of spinal cord decompression sickness
proved effective in allowing diagnosis and a degree
of localization of the lesions, without invasion of
the spinal canal and neuraxis. The two treatments
used to test the model were similar to clinical
treatments in current use. Therefore, it was not
surprising that the recoveries should be similar.
The delay of approximately 17 min was sufficient
to prevent complete recovery. The observation of
cortical FFPs was a useful adjunct to the method.
It enabled differentiation between brain-stem le¬
sions and lesions rostral or caudal to the brain¬
stem.
The simple method of summing peak-to-peak
amplitudes gave an adequate description of the
SEP changes seen in decompression sickness and
its subsequent treatment. There appeared to be no
reason to use the fine discrimination techniques
described by John (1974) and Dill et al. (1976).
The development of this model will permit for the
first time a proper study of the relative merits of
pressure and oxygen in treating spinal cord de¬
compression sickness.
Summary
This paper describes the development of an
electrophysiological model using spinal and corti¬
cal evoked potentials (SEP, CEP), for the diagno¬
sis and monitoring of spinal cord decompression
sickness (DCS) in anesthetized dogs. A compari¬
son of a-chloralose with sodium pentobarbital
showed that the latter caused a reduction in CEP
amplitude. Continuous observation of EPs over 5
h showed a small reduction and an increasing
variance of amplitude with time. The effectiveness
of the method in the diagnosis of DCS and in
studies of the adequacy of treatment is illustrated
with several examples.
Resume
Exploration fonctionnelle a distance du nevraxe chez
le chien anesthesie en chambre de compression
La mise au point d'un modele electrophysiolo-
gique applicable au chien pour le diagnostic et la
surveillance a distance du traitement des accidents
de decompression touchant la moelle epiniere est
decrit. Des potentiels evoques spinaux (PES) et
corticaux (PEC) par stimulation des nerfs median,
intercostal et des deux nerfs perineaux ont ete
enregistres au niveau lombaire, thoracique, cervi¬
cal et cortical. Une comparaison des effets sur le
PEC, de l'alpha-chloralose et du pentobarbital
sodique a montre que ce dernier diminue leur
amplitude.
L'enregistrement en continu pendant 5 h des
PES a montre une legere diminution de l'ampli-
tude et une augmentation de sa variance au cours
du temps. Des exemples d'utilisation sous pression
de cette methode pour l'exploration des accidents
de decompression touchant la moelle epiniere sont
presentes.
This work was carried out under Naval Medical Research
and Development Command, Research Task No. M0099
PN001.1151. The opinions and assertions contained herein are
the private ones of the writers and are not to be construed as
official or reflecting the views of the Navy Department or the
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the Care and Use of Laboratory Animals,' Institute of Labora¬
tory Resources, National Research Council, DHEW, Publ. No.
(NIH) 78-23.
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